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YHTEENVETO 
Avidiini löydettiin ensimmäistä kertaa kanasta, mutta myöhemmin sitä on todettu 
esiintyvän yleisesti lähes kaikissa munivien eläinlajien munissa. Avidiinin uskotaan 
estävän vieraiden organismien kasvua, koska se sitoo niiden kasvulle tärkeätä 
biotiinia, ja siten toimivan munassa puolustusproteiinina. Avidiinin kolmiulotteisen 
rakenteen ratkaiseminen paljasti, miksi se sitoo sen luonnollista ligandia biotiinia 
hyvin tiukasti. Avidiinin rakenteesta kävi ilmi, että sen ja biotiinin välille 
muodostuu useita vetysidoksia, sekä että ligandin sitomispaikan muoto on hyvin 
ideaalinen biotiinille. Vahvan sitoutumisen vuoksi avidiinin ja sen bakteerista 
löydetyn vastineen, streptavidiinin, käyttö monissa biotieteiden sovellutuksissa on 
ollut runsasta. Avidiinin tai streptavidiinin käyttöä biotieteiden sovelluksissa 
kutsutaan yleisesti (strept)avidiini-biotiini teknologiaksi. Molempien proteiinien 
käyttökelpoisuutta on edistänyt niiden kestävyys.  
  Tässä tutkimuksessa kehitettiin uusia avidiinin muotoja ja tutkittiin 
kehitettyjen uusien proteiinien ominaisuuksia. Avidiinin ja samaan geeniperheeseen 
kuuluvien avidiinin kaltaisten geenien koodaamien proteiinien (AVR) 
lämmönkestävyyksissä on eroja. Avidiinia lämpökestävämmän AVR4/5 proteiinin 
lämmönkestävyydelle tärkeitä alueita pyrittiin kartoittamaan kohdennetun 
mutageneesin avulla. Samalla haluttiin tutkia, onko mahdollista siirtää AVR4/5:n 
kriittisiä alueita avidiiniin ja siten parantaa sen lämmönkestävyyttä. Tuloksena 
syntyi kimeerinen avidiini, ChiAVD(I117Y), jonka lämmönkestävyys on 
ylivertainen aikaisempiin avidiiniproteiineihin nähden. Jatkotutkimuksena 
selvitettiin korreloiko lämmönkestävyys orgaanisissa liuottimissa selviytymisen 
kanssa. Havaitsimme, että vaikka kimeeristä avidiinia käsiteltäisiin erilaisilla 
orgaanisilla liuottimilla, se säilyttää useimmiten sitomiskykynsä. Siten kimeerista 
avidiinia on mahdollista hyödyntää aivan uudenlaisissa avidiini-biotiini teknologian 
sovellutuksissa.  
 Tutkimuksen toisessa osatyössä tutkittiin avidiinin ȕ-juosteiden 3 ja 4 välisen 
silmukka-alueen (L3,4) vaikutusta biotiinin sekä 4’-hydroksiatzobentseeni-2-
karboksyyli hapon (HABA) sitoutumiseen. Avidiinin, jonka silmukka-alue L3,4 
poistettiin sirkulaarisella permutaatiolla, sitomisominaisuuksia verrattiin 
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isotermaalisella titraatio kalorimetrialla (ITC) villityypin avidiiniin. Silmukka-
alueen poiston (L3,4) ja yhden pistemutaation (Asp118Met) avulla pystyimme 
heikentämään biotiinin sitoutumista ja parantamaan HABA:n affiniteettia 
huomattavasti. Muokatun avidiinin (cpAVD4ĺ3(N118M)) biotiinin ja HABA:n 
välinen suhteellinen sitomiskyky muuttui villityypin avidiiniin nähden yli miljardi-
kertaisesti (109). 
Tämän työn kolmannessa osatyössä pyrittiin selvittämään kananmunan 
keltuaisessa esiintyvän biotiinia sitovan proteiini A:n (BBP-A) ominaisuuksia. 
Proteiinin röntgensädekristallograffisesti määritetty rakenne ja ITC:llä määritetyt 
sitomisominaisuudet paljastivat, että BBP-A sitoo tiukasti paitsi biotiinia, myös d-
biotiini-d-sulfoksidia (BSO). Proteiini muistuttaa rakenteeltaan avidiinia, mutta on 
lämmönkestävyydeltään heikompi. 
Kokonaisuudessaan tämä monitieteellinen tutkimus selventää avidiinin ja sen 
kaltaisten proteiinien pienmolekyylien sitoutumiseen vaikuttavia tekijöitä ja lisää 
siten tietoa avidiinin rakenteen ja toiminnan välisestä suhteesta. 
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ABSTRACT 
Avidin was first found in chicken, but is now known to be present in the avian egg-
whites or egg-jellies. Avidin is thought to work as a defensive agent in the egg 
preventing the growth of unwanted organisms by creating a biotin drain. It binds its 
natural ligand, biotin, with very tight affinity. The determinants of this tight binding 
have been solved with the 3D structure of the avidin-biotin complex. It revealed that 
there are several hydrogen bonds between the avidin and biotin molecules and that 
the shape of the binding pocket is well optimized for biotin. Due to their tight 
affinity to biotin and good stability, avidin and its bacterial analogue streptavidin, 
have been used in a wide range of applications in biosciences. Collectively, 
applications based on avidin or streptavidin are referred to as strept(avidin)-biotin 
technology. 
The aim of this study was to develop engineered forms of avidin and to 
characterise their properties. Avidin related proteins 1-7 (AVRs) belong to the 
avidin protein family. Their properties differ from each other and interestingly 
AVR4/5 was previously found to be more thermostable than avidin. To study the 
structural reasons behind the high thermostability of AVR4/5, we used genetic 
engineering to transfer parts of the sequence of AVR4/5 to avidin. As a result, we 
produced the chimeric avidin Ile117Tyr mutant (ChiAVD(I117Y)), the most 
thermostable avidin so far. Furthermore, we wanted to see if the high thermal 
stability of chimeric avidin correlated with stability in harsh organic solvents. 
Chimeric avidin was found equal or superior in stability when compared to avidin or 
streptavidin in most of the conditions studied. Therefore, chimeric avidin may prove 
useful in applications where high stability is required. 
The loop region between the ȕ-strands 3 and 4 (L3,4) of avidin is important for 
ligand binding. This region was removed by circular permutation and the properties 
of the resulting deletion mutant were then compared to those of wild type avidin. 
The deletion of L3,4 combined with the point mutation Asp118Met 
(cpAVD4ĺ3(N118M)) reduced biotin binding affinity and increased affinity to 4’-
hydroxyazobenzene-2-carboxylic acid (HABA). Based on isothermal titration 
calorimetry (ITC) analysis the relative HABA/biotin binding affinity of 
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cpAVD4ĺ3(N118M) increased over a billion fold (109) when compared to that of 
wt avidin. 
The third part of the study aimed at characterising the structure and properties of 
a novel chicken biotin-binding protein A (BBP-A). The structure of the protein in 
complex with the ligand revealed that the ligand-binding site was occupied by d-
biotin d-sulfoxide (BSO). ITC analysis confirmed that BBP-A binds both BTN and 
BSO with comparable affinities, a property unique among avidins. The structure of 
the protein resembles that of avidin, but its thermostability is lower.  
In summary, this multidisciplinary study clarified factors affecting the ligand-
binding properties of avidin and novel avidin-like proteins, and therefore, increased 
the knowledge of the structure-function relationship of avidins. Furthermore, this 
work may offer new tools for avidin-biotin technology. 
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1. Introduction 
Proteins are an essential part of living organisms. They are made of amino acids 
attached to each other by peptide bonds (primary structure). The resulting 
biopolymer, a linear polypeptide chain of amino acid residues, is folded into a three-
dimensional form (secondary structure). The final structure of the protein is 
achieved when secondary structures are organized into a three-dimensional form 
(tertiary structure). Further still, folded proteins can be arranged into multi-subunit 
complexes, referred to as quaternary structures. The function of a protein is defined 
by its three-dimensional structure and is based on the recognition of other molecules 
such as in enzyme-substrate, antibody-antigen or protein-ligand interactions. A 
reversible binding reaction is the sum of the formed and broken non-covalent 
interactions and the dissociation of water from the binding site. The binding force, 
or affinity, influences the function of the protein; if binding is too strong, the 
biological reaction might not proceed forward, and if too weak, specific binding 
might not occur. For example enzymes have to recognise their substrate efficiently 
and binding to the active site must be tight enough for an enzyme-substrate complex 
to form. After the substrate has been transformed to the product, it has to be released 
for the enzyme to perform the process again. Therefore, binding cannot be too tight 
either, or catalytic efficiency would be poor. 
The chicken egg-white protein avidin together with the analogous protein 
streptavidin from the bacterium Streptomyces avidinii is known to non-covalently 
bind the water soluble vitamin D-biotin, with the strongest non-covalent protein-
ligand interaction found in nature (Green 1975). The reason for this tight biotin 
binding is not known for sure, but is thought to prevent the growth of foreign 
bacteria. This remarkable affinity is one reason for using avidin-biotin binding in 
several life science applications and is at the origin of (strept)avidin-biotin 
technology (Wilchek, Bayer 1990, Wilchek, Bayer 1999). Other reasons that have 
expanded the (strept)avidin-biotin technology are the known structures of avidin 
(Livnah et al. 1993b) and streptavidin (Weber et al. 1989), new ligands (Livnah et 
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al. 1993a, Hofstetter et al. 2000, Skerra, Schmidt 2000, Korndorfer, Skerra 2002, 
Hirsch et al. 2002, Lamla, Erdmann 2004, Repo et al. 2006), modifiable structure 
(Nordlund et al. 2004, Hytönen et al. 2005b, Nordlund et al. 2005, Laitinen et al. 
2006, Laitinen et al. 2007), and stable structure of the complex (Green 1963b, Green 
1975). 
In this study we modified the properties of avidin by circular permutation and 
rational mutagenesis yielding proteins with novel binding properties. We also 
characterized a new avidin like protein, the biotin-binding protein A (BBP-A). In 
addition, we were able to produce the most thermostable avidin made so far, named 
chimeric avidin (I117Y). The three-dimensional structures of these proteins were 
solved and ligand-binding analyses were done, to explain structure-function 
relationships. The structure of ChiAVD(I117Y) revealed that small differences in 
structure are responsible for the improved thermal and solvent stabilities when 
compared to those of avidin or AVR4/5. These novel avidin forms have revealed 
important factors affecting binding or other functional properties, like stability, and 
therefore make a valuable contribution to avidin-biotin technology.             
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2. Review of the literature 
Understanding the thermodynamic principles of non-covalent interactions and 
examples of ligand binding are the main focuses of this thesis. In addition, I will 
review the physicochemical properties and some modified forms of the avidin 
protein, which was the principle subject of interest throughout the thesis study.  
2.1 Covalent bonds and non-covalent interactions 
Because atoms have different electronic structures they can become bonded together 
in different ways. In 1916 Walter Kössel noted that stable ions tend to form when 
atoms gain or lose electrons in sufficient numbers so that they attain the nearest 
noble-gas configuration (Fessenden, Fessenden & Logue 1998). Soon after Kössels 
work Gilbert N. Lewis published the concept of shared electron pairs, which after a 
couple of years was named the covalent bond by Irwin Langmuir (Langmuir 1919). 
Since then these findings have led to the subsequent theories of the ionic and 
covalent bond. To illustrate the concepts, an ionic bond is usually considered a bond 
where one atom donates its outermost electron or electrons to another atom or 
atoms, and the resulting positive cation and negative anion attract each other. 
Cations and anions can rotate relative to each other without affecting the bond, and 
therefore, ionic bonds are non-rigid and non-directional. In a covalent bond, instead 
of the transfer of electrons like in an ionic bond, electrons are shared between the 
two nuclei, and therefore, the bond is very directional. For example in the sigma 
bond (ı-bond) the two electrons of overlapping orbitals form the molecular orbital 
that is cylindrically symmetrical around an axis joining the two nuclei. Therefore, in 
a covalent bond, two atoms are always oriented in a certain way relative to each 
other. Covalent bonds can be classified as single, double and triple bonds, which all 
have different kinds of properties. They form the backbones of molecules but 
typically do not participate directly in the recognition of ligands or the interactions 
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between bio-molecules. Nor do covalent bonds alone define the shape of bio-
molecules like proteins, because the shape is also determined by non-covalent 
bonds.  
Non-covalent interactions differ from covalent and ionic bonds in that they do 
not share or transfer electrons in the bonding event. They can be seen as variations 
of different kinds of electromagnetic interactions. This means that non-covalent 
interactions have similar properties but their nomenclature is case-dependent.  Non-
covalent interactions include: hydrogen bonds, both attractive and repulsive van der 
Waals forces, entropic force, chemical polarity, mechanical bonds, halogen bonds, 
aurophilicity, intercalation and stacking (ʌ – ʌ interactions). 
2.2 Introduction to non-covalent interactions in protein-
ligand binding 
Proteins are organic compounds made of amino acid residues arranged in a linear 
chain and folded into a 3D structure. Their binding properties are the essence of 
many fields of biological sciences. A binding reaction is a two-step process; first, 
two components have to recognize each other before the actual binging can take 
place. Binding itself can be considered the sum of non-covalent interactions 
between molecules. The proper function of proteins is dependent on both selective 
recognition and sensible binding affinity. Therefore, many fields of research aim to 
characterize, modify, strengthen or destroy interactions between bio-molecules. For 
example, in functional genomics, which uses a vast set of data from genomic 
projects to describe protein functions and interactions, algorithms are used to predict 
potential protein-protein interactions to foresee previously unknown interactions 
between molecules (Kanaan et al. 2009). In medicine, the resolved structures of 
mutated proteins behind medical conditions are used to design new drugs or to 
improve existing ones. These modifications are usually made in hope of discovering 
new non-covalent interactions, which could improve the binding affinity of drug 
molecules. However, too many hydrogen bonds could also be unfavourable. The 
amounts of hydrogen bond donor and acceptor sites in a good drug molecule are 
generalised by the “Lipinski’s rule of Five” (Lipinski et al. 2001). It states that poor 
absorption or permeation is more likely if two of the following parameters are out of 
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range: there are more than five hydrogen-bond donors or 10 hydrogen-bond 
acceptor sites, or the complex has a molecular weight greater than 500 (MW500 
g/mol) or Log P (CLogP, lipophilicity expressed as the ratio of octanol solubility to 
aqueous solubility) is over five (ClogP5) (Lipinski et al. 2001).  
In almost every study on protein-ligand binding, it is of interest to understand the 
overall binding mechanism, but also to know, where ligands are bound in the 
protein. Every protein-ligand binding pair has a specific non-covalent interaction 
network. Factors thought to be involved in the network are first and foremost 
hydrogen bonds, van der Waals interactions and entropic/hydrophobic forces. These 
bonds have a typical interaction energy of 1~5 kcal/mol (4-21 kJ/mol) (Lodish et al. 
2000), which is significantly weaker than that of a covalent bond, 35-230 kcal/mol 
(150-960 kJ/mol) (Fessenden, Fessenden & Logue 1998). However, non-covalent 
interactions act together to produce stable and specific associations between 
different parts of a large molecule or between different macromolecules. In some 
cases it is important that the bond is stable, whereas sometimes it might be 
necessary to form relatively weak interactions to enable biological function. These 
non-covalent interactions enable proteins to recognize and bind their ligands like 
enzymes do their substrates or antibodies their antigens. 
2.3 Thermodynamics of ligand binding 
The experimental observation that energy can be neither created nor destroyed is the 
basic postulate of thermodynamics. Usually this means the conversion of heat to 
mechanical, chemical or electrical energy or vice versa. Variables like temperature, 
pressure and volume are the basic elements of thermodynamics and changing one of 
these variables results in a change in the total energy ('U) of a system, which in 
thermodynamics is called the internal energy (U). The internal energy of a system is 
the total kinetic energy due to the motion of molecules and the total potential energy 
associated with the vibration and electric energy of atoms within molecules or 
crystals. The mathematical statement of the first law of thermodynamics is 
wqU  '                    (1) 
where q is the energy transferred as heat to a system and w is the work done on the 
system. The SI unit of internal energy is the joule (J) and a change in the molar 
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internal energy is expressed in kilojoules per mole (kJ mol–1) or occasionally in the 
old unit of measure - calories per mole (cal mol–1) (Atkins 1998). Because calories 
are used in most of the original publications, they are also used in this thesis. 
In chemical reactions, energy is needed to break chemical bonds in the starting 
substances, and energy is released when new bonds in the final product are formed. 
The sum of these tells us if the reaction consumes or releases energy. Like in 
chemical reactions, energy is needed in biological ligand-binding events. It is 
needed to break non-covalent bonds, to make conformational changes, to promote 
hydrophobic transfer of ligand from solution to binding site, in polyelectrolyte 
contributions for coupled ion release and to change the rotational/translational 
motion. Conversely, when non-covalent bonds are formed, energy is released. 
Together these events either release or absorb energy into or from the system. 
Binding reactions that release energy as heat to the solution are called exothermic 
reactions, and reactions that absorb heat energy from solution during the binding are 
called endothermic reactions. 
2.3.1 Enthalpy, entropy - Gibbs energy of binding 
Enthalpy (H) is a thermodynamic function of a system and defined as 
pVUH                     (2) 
where U is the internal energy of the system, p is the pressure and V is the volume 
of the system. The change in enthalpy ('H) is independent of the path between the 
initial and final states and it is the sum of the heat change caused by the breaking 
and formation of bonds. Because the release of heat signifies a decrease in the 
enthalpy of a system, an exothermic process at constant pressure has a 'H<0. 
Conversely, the absorption of heat results in an increase of enthalpy, meaning that 
an endothermic process at constant pressure has 'H>0.  
The enthalpy change can be measured calorimetrically by monitoring the 
temperature changes. In the calorimeter there is no net loss of heat from the 
calorimeter to the surroundings (adiabatic system). Thus the change in temperature 
('T) in the calorimeter is proportional to the heat that the reaction releases or 
absorbs. Already in the 19th century chemists used calorimetry to measure chemical 
reactions (e.g. Pierre Eugène Berthelot, 1860), and since then new, more sensitive 
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technologies have made it possible to use calorimetry also for the meaningful study 
of biological molecules and interactions (Ladbury, Doyle 2004). 
Entropy (S), a measure of the molecular disorder of a system, can be used to 
express the second law of thermodynamics: The entropy of an isolated system 
increases in the course of a spontaneous change. 
0!' totS                          (3) 
where Stot is the total entropy of the system and its surroundings. A spontaneous 
change in an isolated system occurs with an increase in entropy. Accordingly, this 
means that when water molecules are usually displaced by the ligand from the 
binding site they are more randomly organized and entropy increases. In addition to 
enthalpy, entropy determines the free energy of the system. The thermodynamic 
definition of entropy is only valid for a system at equilibrium. 
The Clausius inequality declares that for any change in a system: 
T
dqdS t                      (4) 
where dq is the heat supplied to the system during the process and T is absolute 
temperature. When heat is transferred at constant pressure, and there is no other 
work than the expansion, dqp = dH and the Clausius equation can be rearranged to 
obtain: 
dHTdS t                     (5) 
which can also be written: 
0dTdSdH                    (6) 
which can in turn be expressed more simply by a new thermodynamic quantitative, 
the famous Gibbs energy G: 
TSHG                      (7) 
At constant temperature and pressure the change in Gibbs energy can be defined: 
STHG '' '                    (8)  
An isobaric calorimeter measures q, and so the change in enthalpy (dH) is obtained. 
In other words q = dH is the basis of a titration calorimetric experiment (Ladbury, 
Chowdhry 1998). Components of the Gibbs energy are well-known – the enthalpic 
term ('H) and the entropic term T'S. The Gibbs energy (function), which is 
enthalpy minus the product of thermodynamic temperature and entropy, was 
formerly called free energy or free enthalpy. However, the International Union of 
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Pure and Applied Chemistry (IUPAC) recommends using the term Gibbs energy 
(McNaught, Wilkinson 1997). The enthalpic term consists of changes in bonding, 
van der Waals interactions, hydrogen bonding and charge interactions. The entropic 
term is respectively a sum of arrangement of the solvent together with rotational and 
transitional changes (Freire 2004). Figure 1 shows three examples of a binding 
reactions, where the thermodynamically important components differ significantly 
from each other. 
 
 
Figure 1. A schematic presentation to show the different imaginary thermodynamic 
profiles, which all have the same Gibbs binding energy 'G: (A) example of an 
enthalpy-driven ('H) reaction, which is due to a high degree of hydrogen 
bonding in addition to conformational changes; (B) example of an entropy-driven 
('S) reaction, which is dominated by the hydrophobic effect; (C) hydrogen 
bonding along with a hydrophobic contribution are favourable for a binding 
reaction. 
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2.4 Water, hydration and hydrophobic effect 
Water participates in most chemical processes on earth. Among its unique properties 
is the flexibility to interact with a wide variety of molecules, determining, for 
instance, the three-dimensional structure, dynamics and function of biologically 
active macromolecules (Steinbach, Brooks 1993, Ooi 1994, Bryant 1996, Steinbach, 
Brooks 1996, Luecke et al. 1999, Ben-Amotz, Widom 2007). Nearly all protein-
ligand interactions must compete with interactions with water. During complex 
formation water dissociates from the binding interface of both the protein and the 
ligand. At ligand binding sites, individual water molecules can stabilize ligand 
binding and have a considerable effect on binding affinity (Poornima, Dean 1995a, 
Poornima, Dean 1995b, Poornima, Dean 1995c, Bailly et al. 2003). Water is used as 
a classical example of hydrogen bonding and is also, as is apparent from its name, 
the, main component of the hydrophobic effect. The properties of hydrogen-bonds 
and the hydrophobic effect are briefly discussed in the following sections.   
2.4.1 Hydrogen bonding 
Many unique properties of water arise from its ability to form hydrogen bonds (H-
bond). In the H-bond, a hydrogen atom is covalently linked to a electronegative 
atom and therefore has a partial positive charged, and can be bonded to an 
electronegative acceptor as shown in figure 2. The H-bond is an interaction that has 
covalent, electrostatic, and van der Waals characteristics (Desiraju 2002). 
 
Figure 2. Hydrogen bond. A partially positive hydrogen atom of one molecule (X) is 
attracted to the unsheared pair of electrons of the electronegative atom of 
another molecule (A). 
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The nature of X and A in figure 2 are important for the character of the H-bond. 
It has been proven that electronegative oxygen, nitrogen, fluorine or sulphur form 
H-bonds, but also weaker bonds like C—H…O and C—H…ʌ are possible. The 
formation of the X—H…Y H-bond results in the weakening of the X—H bond. 
This weakening is accompanied by bond elongation and a concominant decrease in 
the X—H stretch vibration frequency compared to the noninteracting atoms. A shift 
to lower frequencies, called a red shift, is the most easily detectable evidence of the 
formation of an H-bond. An improper, blue-shifting X—H…Y H-bond, is also 
known. It strengthens the X—H bond and causes a blue shift of the X—H stretch 
frequency. Overall, there are dozens of different types of X—H…A H-bonds that 
occur commonly in their condensed phases as well as in less common ones (Steiner 
2002). All kinds of H-bonds probably participate in determining the shapes, 
properties, and functions of biomolecules (Derewenda, Lee & Derewenda 1995, 
Wahl, Sundaralingam 1997, Pierce, Sandretto & Bemis 2002, Jiang, Lai 2002). For 
example H-bonds are important in bio-molecular recognition and protein-ligand 
binding, but they also affect the physicochemical properties of a molecule, such as 
solubility, partitioning, distribution and permeability (Abraham et al. 2002). 
2.4.1.1 Furcation of hydrogen bonds 
Strong and weak H-bonds are ubiquitously present in protein-ligand interfaces 
(Pierce, Sandretto & Bemis 2002, Pierce et al. 2005, Panigrahi, Desiraju 2007). 
They are often furcated, which means that the donor can interact with several 
acceptors simultaneously or an acceptor can interact simultaneously with many 
donors as presented in figure 3. Donors and acceptors are furcated equally and the 
level of furcation can range from bifurcated to hexafurcated (Panigrahi, Desiraju 
2007). Strong interactions like O—H…O tend to go towards non-furcated 
geometries, in contrast to weak interactions, which occur more often in the furcated 
form due to better interaction geometry and more efficient space filling (Panigrahi, 
Desiraju 2007). 
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Figure 3. A schematic presentation of furcated hydrogen bonds. A; Bifurcated donor, B; 
Bifurcated acceptor.  
2.4.2 Hydrophobic effect, desolvation of water molecules from 
the surface of the macromolecules 
According to thermodynamics, matter seeks to be in a low-energy state, and 
bonding reduces chemical energy. Hydrophobes are electrically unpolarized 
molecules that are unable to form hydrogen bonds. Water repels them and they 
favour bonding with themselves. It is this effect that causes the hydrophobic 
“interaction”, which in itself is incorrectly named as the energetic force comes from 
the hydrophilic molecules. Therefore, the proper term instead of “hydrophobic 
interaction” would be hydrophobic effect.  
Hydrophobic effect can be connected to various different terms. The dissolution 
of nonpolar solutes into an aqueous solution is referred to as hydrophobic hydration, 
the association of nonpolar substances in water is referred to as contact hydrophobic 
energy and associations, in which water intervenes, are referred to as solute 
separated hydrophobic forces (Franks, Eagland 1975). The Gibbs energy of 
hydration is defined as the transfer energy from the gas phase to the aqueous 
solution, which again is one form of the two contributions of the Gibbs energy of 
unfolding; the other one is the intramolecular interaction (Oobatake, Ooi 1993).  
The stabilization and dynamics of macromolecules, protein-protein and protein-
ligand binding are affected by the hydrophobic effect (Makhatadze, Privalov 1993, 
Privalov, Makhatadze 1993). The hydrophobic effect is also involved in self-
assembly phenomena such as the formation of membranes and micelles (Tanford 
1978, Cheng, Rossky 1998). Already sixty years ago Kauzmann demonstrated the 
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importance of the hydrophobic effect for protein folding (Kauzmann 1959) and later 
it was shown to be involved especially in early protein-folding events (Choe et al. 
2000). 
 Nonpolar groups in proteins and ligands are covered by water molecules in 
aqueous solutions as schematically presented in figure 4. Water molecules in this 
shell are hydrogen bonded to each other and to the next shell. The movement of the 
water molecules decreases depending on how close they are to the macromolecule. 
If movement is restricted, also the freedom of water molecules is decreased and 
therefore the entropy of the system decreases. The entropy (ǻS) of the system 
increases if the water network is interrupted and water is removed from the shells of 
both protein and ligand as presented in figure 5. This also affects to the enthalpy ǻH 
of the system, because hydrogen bonds are broken. 
 
Figure 4. A schematic presentation of a hydration shell around a molecule. Water forms a 
hydration shell with three degrees of order: an inner shell with completely 
ordered water molecules, an outer hydration shell with semi-ordered water 
molecules and bulk water with only little order. 
Due to the lower water solubility of small nonpolar molecules, nonpolar groups 
in proteins tend to associate with each other in an aqueous solution (Oobatake, Ooi 
1993). This rearrangement of hydrophobic components, releases energy, because it 
frees water molecules from the contact site to form the common structure of water, 
i.e., the high-quality hydrogen bonding network between water molecules. 
Simultaneously, the entropy of the system increases, because the water has more 
freedom to rotate and move. This is described schematically in figure 5. 
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Figure 5. The release of ordered water molecules from a protein (P) binding site and from 
the inner hydration shell of a ligand (L). The dissociation of water molecules 
increases the entropy of the system. 
Computational methods for the understanding of protein denaturation and 
hydration energy in an aqueous solution at the molecular level have improved 
(Mancera 2007, Rumfeldt et al. 2008, Sarupria et al. 2009). More sophisticated 
analyses have led to a better understanding of how solvents affect the Gibbs energy 
of denaturation or binding. For example, MD simulations are used for these 
purposes (Zhang et al. 1997). Protein hydration has been a central problem in 
structural biology for many years and despite increased knowledge, the influence of 
the solvent on ligand binding and protein folding is often not taken into account. 
The hydration shell can be detected with cryogenic X-ray crystallography at the 
molecular and atomic level (Nakasako 2004) but the hydrodynamic radius of the 
protein-water complexes can also be measured by many scattering methods (Koch, 
Vachette & Svergun 2003) like dynamic light scattering (DLS) (Lisy et al. 2001). 
However, quantitative information about several aspects of protein hydration can 
only be achieved by magnetic relaxation dispersion (MRD). MRD can provide the 
number and residence times of long-lived water molecules and the mean rotational 
correlation time of water molecules at the protein surface (Halle 2004). Also 
different kinds of NMR methods based on incoherent magnetization transfer 
between water and protons in proteins by cross-relaxation and chemical exchange 
have been used to study protein hydration (Otting, Wuethrich 1989). 
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2.4.3 Bridging water in binding interfaces 
Hydrophobic hydration is characterized by an increase in entropy. The release of 
water around non-polar groups into bulk solvent increases a system’s entropy and is 
the reason for so-called entropy-driven binding events. Water can participate in the 
binding process also by forming a bridge between the macromolecule and the 
ligand. Therefore, fixed or transient water may have structural or functional roles 
and is not just an inert participant (Levitt, Park 1993, Wuthrich 1993, Billeter et al. 
1996, Kosztin, Bishop & Schulten 1997, Nakasako 2004). 
Water molecules have been found in the critical point of many protein systems 
(Smith et al. 1996, Hyre et al. 2002, Petrone, Garcia 2004, Hyre et al. 2006, Määttä 
et al. 2009). They can be classified as presented in figure 4 or in a more detailed 
way by four classes as suggested by Nakasako (Nakasako 2004): The “inside” class, 
the “contact” class and the “first- and second-layer” classes. In the two first classes, 
water molecules are either inside the solvent-accessible area (SAS) and occupy 
cavities in the protein molecules or they are located outside the SAS but still 
mediate intermolecular interactions between adjoining molecules. Water molecules 
outside the SAS (first-layer class) make hydrogen bonds and/or van der Waals 
contacts with the atoms of the protein surface, but molecules in the second-layer no 
longer directly interaction with the protein. Bound water molecules in the interface 
have two main tasks: (1) to fill empty spaces; or (2) to make bridging hydrogen 
bonds between the protein and the ligand. Such water molecules have been found 
for example in the class I MHC complex, the streptavidin-mutant – biotin complex 
(Hyre et al. 2006, Petrone, Garcia 2004) and recently also in the xenavidin-biotin 
complex as presented in figure 6 (Määttä et al. 2009). 
2.5 Ligand binding kinetics 
The starting point for most binding studies is the experimental determination of the 
equilibrium association constant (Ka) or the dissociation constant (Kd). These 
constants define the equilibrium between bound and free components in the 
reaction. They can be also called affinity constants or equilibrium constants. 
These constants can be determined accurately in a number of ways, usually by 
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measuring the concentrations of free and bound ligand as shown later. The 
relationship between the Gibbs energy and the equilibrium constant (described 
elsewhere (Atkins 1998) can be determined by considering chemical potentials. As a 
result, the equilibrium constant can be related to the standard Gibbs energy change 
for the reaction at a given temperature and constant pressure by the equation (9):  
            
                                                                                            (9) 
 
where R is the universal gas constant, T is the absolute temperature in Kelvin, and 
Keq is the equilibrium constant. The association constant and the dissociation 
constant, which is the reciprocal of the association constant, are specific types of 
equilibrium constants: The dissociation constant measures the propensity of a larger 
object to separate into two smaller objects (P,L) and conversely, the association or 
binding constant (Ka,  Kb) measures the formation of a molecular complex (PL) as 
shown by equation (10) and in figure 7. 
 
Figure 6. A simplified presentation of the ligand-binding site of xenavidin. A, unliganded 
xenavidin; B, xenavidin-BTN complex. Water molecules are shown as red 
spheres. An arrow pinpoints the water molecule in the binding pocket. Figure 
from Määttä et al. (2009). 
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Figure 7. A schematic presentation of protein-ligand complex formation. The association 
and dissociation constants are derived from the concentrations of the protein and 
ligand, and the complex, respectively. 
PLLP l                                      (10) 
The association and dissociation constants that characterize a reversible equilibrium 
between a protein and a ligand are given by equation (11): 
> @
> @> @LP
PLK a  ,
a
d K
K 1                 (11) 
Therefore, one way to determine Ka or Kd, is to measure the concentrations of free 
protein, free ligand, and protein-ligand complex in an equilibrated mixture. Another 
way to do this is to measure the change in Gibbs energy and calculate the 
equilibrium constant using equation (9). 
2.5.1 Rate of reaction, kinetics 
In a chemical reaction, the rate of the reaction refers to the change in the 
concentration of a reactant or a product in a given period of time. The rate can be 
determined by measuring the concentration of a certain component over time. The 
rate constant k whose unit dependents on the particular way of expression, but is 
usually s–1, includes all other factors (for example, temperature) that affect the 
reaction rate except concentration. The reaction rate (r) can be related to the 
concentration of the individual reactants by a rate equation in the form of: 
> @ > @nm BAkr                      (12) 
where k is the rate constant, [A] and [B] are the concentrations of the reactants and 
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m and n are the orders of the reactions, respectively. The overall order of a reaction 
is the sum of the powers of the concentrations of the individual reactants. 
 In biological systems reagents often do not form an end-product. For example, 
protein (P) and ligand (L) do not form a fused product X. However they bind each 
other reversibly, forming a binary complex (PL). Typical examples of biologically 
important binding reactions are for instance the binding of agonist or antagonist to a 
receptor, protein-protein and protein-nucleic acid binding reactions, binding of 
substrate, activator or inhibitor to an enzyme, and binding of a metal ion or cofactor 
to a protein. The lifetime of the complex depends on the strength of non-covalent 
interactions, which eventually form an equilibrium between ligand-protein 
complexes and free ligands and proteins in the solution. This complex formation and 
dissociation was already described in formula (10). However, rate constants can be 
now included in this first order reaction formula: 
PLLP
kass
kdiss
l                  (13) 
where kass (equate with kon and k1) is the association rate constant and kdiss (equate 
with koff and k-1) is the dissociation rate constant. The equilibrium dissociation 
constant can therefore be described as the ratio of these constants: 
ass
diss
d k
kK                    (14) 
This means that the association rate constant could also be determined by measuring 
the association rate over a range of different concentrations, because for reversible 
binding, it can be shown (Copeland 2000) that the value of kobs is directly 
proportional to the concentration of ligand present as follows: 
> @ fassdissobs Lkkk                   (15) 
where [L]f is the concentration of free ligand. As illustrated in the following figure 
8, the linear function can be fitted to the data. The values for kass and kdiss can then 
be estimated from the values of the slope and the y intercept, respectively. These 
estimations can be then be used to calculate the dissociation constant Kd. 
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Figure 8. A schematic presentation of the observed association rate as the function of 
ligand concentration. 
Dissociation, also called “off rate” can be measured as a function of time. Each 
ligand-protein complex dissociates stochastically at a given time, and the 
dissociation process is typically exponential decay. Exponential equations are used 
to model processes where the rate at which something happens is proportional to the 
amount of starting material left. For example, when ligands dissociate from protein, 
the number of molecules that dissociate in any short time interval is proportional to 
the number that were bound at the beginning of that interval. Equivalently, each 
individual molecule of ligand bound to a protein has a certain probability to 
dissociate from the protein in any small time interval. That probability does not 
increase when the ligand stays on the protein longer. 
If we define Y to be the number of protein-ligand complexes still present at any 
given time X, the rate of change of Y is proportional to Y. This is expressed as a 
differential equation (16) and presented in figure 9: 
 
Yk
dX
dY
X
Y u  '
'                         (16) 
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Figure 9. The exponential dissociation of specific protein-ligand complex.  
Exponential function has a derivative that is proportional to Y and can be 
achieved by the integration of both sides of the equation. A new exponential 
equation (17) defines Y as a function of X, the rate constant k, and the value of Y at 
zero time, Y0. 
XkeYY  0                  (17) 
Where the variable k is the dissociation constant (koff or  k-1) expressed in units of 
inverse time. This term can be used to evaluate the binding affinity of proteins. 
2.5.1.1 Factors influencing the rate of the reaction 
The rate of the reaction is dependent on many things like concentration, temperature 
and solvent. The nature of the reactants also affects the reaction, for example gases 
tend to react much faster than solid materials. Concentration does not have an effect 
on reaction rate in a zero order reaction and only the concentration of one 
component has an influence on a one order reaction. The rate of the second-order 
reaction depends on the concentrations of one second-order reactant, or two first-
order reactants as shown in following example: 
> @ > @> @ > @22 BkBAkAkr                            (18) 
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Usually, an increase in temperature is accompanied by an increase in the reaction 
rate. Temperature is a measure of the kinetic energy of a system, so a higher 
temperature implies a higher average kinetic energy of molecules and more 
collisions per unit time. 
Catalyst or competitors (inhibitors) also have an effect on reaction rate. In 
biology enzymes are considered catalysts. They increase the reaction rate by 
lowering the activation energy. 
2.5.1.2 Methods to determine equilibrium constants 
Theories described in the previous chapters have been used in many different 
methods to determine interactions and affinities of protein-ligand or protein-protein 
pairs. The energies of these biological events are so small that building an 
instrument to measure them is challenging. However, the sensitivity and accuracy of 
such instruments have increased dramatically in the last few decades allowing the 
direct measurement of sub-millimolar to nanomolar binding constants (10–2 M to 
10–9 M). Nowadays, the limit of binding constant measurements with isothermal 
titration calorimetry has reached the picomolar (10–12 M) level with the competitive 
method (Sigurskjold 2000). Increased sensitivity has also reduced the concentration 
of macromolecules needed for the assay, which was previously one of the obstacles 
of the measurements. 
There are plenty of other methods for measuring binding. Stopped flow 
instruments allow the study of relatively fast binding reactions (Schechter 1970). 
The quartz microbalance measures the binding of molecules on the surface of a 
quartz crystal and this can be used to measure both association and dissociation 
events (Marx 2003, Pei et al. 2007, Pei et al. 2006). Ligands labelled with 
fluorescent groups or radio active molecules can be used for this purpose (Sharma, 
Schulman 1999). One powerful method for evaluating interactions is high-field 
solution nuclear magnetic resonance (NMR), which can also be used to estimate the 
structural, thermodynamic and kinetic aspects of a binding reaction (Skinner, 
Laurence 2008). Differential scanning calorimetry (DSC) has proven its 
applicability for poorly defined stoichiometries and low ligand solubilities and in 
instances where binding is more tight than normal (109 M–1<  Kb <1020 M–1) 
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(Brandts, Lin 1990, Plotnikov et al. 2002, D'Souza et al. 2009a, D'Souza et al. 
2009b). However, two of the most popular techniques for measuring interactions 
between biomolecules are surface plasmon resonance (SPR) (Jonsson et al. 1991, 
Jonsson et al. 1993) and isothermal titration calorimetry (ITC) (Langerman, 
Biltonen 1979, Biltonen, Langerman 1979).  
SPR-instruments use an optical method to measure the refractive index near a 
sensor surface, and in order to detect an interaction one molecule is immobilised 
onto the sensor’s surface (figure 10A). When an analyte e.g. protein binds to the 
ligand on the surface, the accumulation of protein results in an increase in the 
refractive index also know as resonance units (RU). The glass surface of the 
instrument is coated with a thin film of a noble metal, which changes the normal 
reflection of this surface. Some of the light is “lost” into the metallic film and when 
the loss is greatest at a certain angle, the reflected light reaches its minimum. This 
angle is called the surface plasmon resonance angle. The loss of light is due to 
oscillation of mobile electrons, also known as plasma, at the surface of the metal 
film. These oscillating plasma waves are called surface plasmons and when they 
match with the wave vector of the light, the electrons resonate. The binding of 
molecules to the surface changes the refractive index and can be detected by a shift 
in the plasmon resonance angle. This change is measured in real time (figure 10B) 
and thus information about the association and dissociation kinetics can be obtained, 
which in turn can be used to obtain Ka and Kd using equation (11). 
The calorimeter, on the other hand, measures the rate of heat flow, resulting from 
the heat effect induced by changing the composition of the sample by titrating near 
to a constant temperature. ITC measures the heat consumed or released in 
association to injection of a known amount of reaction component. The 
measurement allows the direct estimation of the enthalpy change (ǻH°) in the 
binding reaction. In addition, it may be possible to calculate the association constant 
(Ka), stoichiometry (n), Gibbs energy (ǻG°) and the entropy (ǻS°) of binding from a 
single experiment. To understand how these parameters are related to physical 
processes at the molecular level is difficult, but complex relationships can be argued 
for with structural data (Davies, Hubbard & Tame 1999). 
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Figure 10.   Surface plasmon resonance. A; In the SPR instrument, the binding of the 
analyte in the flow cell to the immobilized molecule causes a change in the 
reflected light that can be monitored. B; An example of a sensorgram showing 
the binding of the analyte to the ligand and the kinetics of binding and 
dissociation. RU indicates resonance units. The figure is adapted from the 
original (Varki et al. 2008). 
The calorimeter measures the differential heat effects between a sample and a 
reference cell. The temperature difference between the two cells is constantly 
monitored and constant power is applied to the reference cell, which activates the 
feedback circuit to apply variable power to the sample cell in order to maintain a 
very small temperature difference between the cells. The feedback power is the 
baseline level in the absence of any reaction. When a reaction takes place in the 
sample cell, it either consumes energy (endothermic) or releases it (exothermic), and 
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has either an increasing or decreasing, respectively, effect on feedback power. The 
heat evolved, or absorbed by the reaction is then determined by integration of these 
deflections from the baseline, with respect to time (figure 11).    
 
Figure 11.    A schematic diagram of a typical cell arrangement in an ITC and the raw 
data output after the titration has been completed. The figure is adapted from the 
original (Ladbury, Doyle 2004). 
2.6 Structural features in protein-ligand binding 
In this section I will summarize the importance of larger protein structures on 
ligand-binding events, such as flexible loops and co-operative subunits. In many 
proteins, the binding of a small molecule at one site alters the structure of other 
regions of the protein. These changes can be relatively significant when two large 
domains on a single polypeptide move in relation to each other around a central 
flexible region. On the other hand, ligand binding may only cause small changes in 
loop regions in the active site. Often these changes enclose the ligand in a cage-like 
structure (Kempner 1993). 
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2.6.1 Mobile domains and flexible loop regions of proteins 
The movement of massive protein domains is not usually directly required for 
ligand binding. However, large domains might make additional interactions, which 
can stabilize the structure. The two globular regions at the amino- and carboxy-
termini of calmodulin can move and both can bind to myosin light chain kinase. 
Binding of ligand to one domain results in the movement of the other, this brings it 
near to ligand, and therefore, allows additional interactions that stabilize the 
structure (Ikura et al. 1992). In addition, domains in hexokinase (Bennett, Steitz 
1978), alanine racemase (Galakatos, Walsh 1989), bacterial neutral proteases 
(Holland et al. 1992), phosphoglycerate kinase (Pickover et al. 1979) and cAMP-
dependent protein kinase (Olah et al. 1993) have been found to move to form a 
flexible connecting region enclosing the substrate-binding region. 
Movements more common to have an effect on ligand binding than those of 
massive domains, are subtle changes in loop regions. Although restricted, these 
conformational changes may have dramatic effects on biochemical activity. Usually 
a flexible loop closes the active site and protects the ligand-receptor complex or 
enzymatic reaction from surrounding water (Tanaka et al. 1992, Pompliano, Peyman 
& Knowles 1990). Another good example of loop movement influencing ligand 
binding is (strept)avidin-BTN complex formation. When biotin enters the binding 
pocket of avidin or streptavidin, the loop between ȕ3 and ȕ4 adopts a fixed 
conformation and seals the binding site (Livnah et al. 1993b, Weber et al. 1989). 
Deletion of this loop from wild-type streptavidin reduces the association constant 
approximately six orders of magnitude (Chu et al. 1998). 
2.6.2 Co-operation between subunits 
The binding of ligand is not always a matter of only one protein subunit or a single 
protein molecule. Many times neighbouring subunits participate in the binding of a 
ligand and may even strengthen the affinity. A classical example is haemoglobin, an 
iron-containing oxygen-transport metalloprotein in the red blood cells of 
vertebrates. Haemoglobin is a tetramer consisting of four globin subunits, which all 
have a haem group in their active centre. Haem is a prosthetic group, which has a 
ferrous iron atom in the centre of an organic heterocyclic ring named porphyrin. 
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Oxygen binds with high affinity to the iron complex of the haem group by the 
coordinate covalent bond (Fermi et al. 1984). This causes the iron atom to move 
back toward the centre of the plane of the porphyrin ring, which then causes the 
imidazole side chain of the histidine residue at the other side of the iron to move in 
same direction. Together these bend the shape of the tetramer so that the other 
monomers (in the tetramer) may bind oxygen more easily and with increased 
affinity (Perutz 1976). 
Some members of the lipocalin family bind haem in a cooperative way 
(Montfort, Weichsel & Andersen 2000, Larsson, Allhorn & Kerström 2004, 
Allhorn, Klapyta & Akerström 2005). One such member D1-microglobulin, a 
yellow-brown lipocalin (Akerström et al. 2000), which binds haem at the entrance 
of the lipocalin cavity. The haem and other prosthetic groups are bonded to four 
amino acid residues from Cys34 (Escribano et al. 1991), Lys92 , Lys118 and 
Lys130 (Berggard et al. 1999). These amino acid residues have been shown to act 
cooperatively (Allhorn, Klapyta & Akerström 2005). 
The binding mechanism of avidin, which like lipocalins, is a member of the 
calycin superfamily, involves two so-called functional monomers in the binding of a 
ligand. The side chain of Trp110 participates in biotin binding from the 
neighbouring subunit and mutations to this important tryptophan reduce affinity by 
several orders of magnitude (Laitinen et al. 1999). 
2.7 Avidin – a high affinity and highly stable ligand-
binding protein 
The basic, homotetrameric glycoprotein found in the chicken egg-white was named 
avidin due to its high biotin-binding capacity (Eakin, Snell & Williams 1941). Each 
avidin subunit consists of 128 amino acid residues and one sugar moiety attached to 
Asn17. The three-dimensional (3D) crystal structure of avidin revealed the presence 
of eight antiparallel successive ȕ-strands, the structure of their interconnecting loop 
regions and the overall shape of a beta-barrel in the avidin monomer (Livnah et al. 
1993b, Pugliese et al. 1993). The schematic presentation of the avidin tetramer in 
figure 12 illustrates the four identical subunits of the tetramer and one bound biotin 
molecule in each subunit. 
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Figure 12. The stereo image of the avidin tetramer. A schematic presentation where 
four bound biotins are presented with CPK molecules in the binding pockets. 
Subunits of a different colour are numbered according to Livnah et al. (pdb: 
2AVI, Livnah et al. 1993b)   
2.7.1 Structure of the ligand-binding pocket of avidin – 
cooperative hydrogen bonds 
The most remarkably feature of avidin is its extremely high affinity to D-biotin (Kd 
§ 6×10–16 M, figure 13) (Green 1975, Green 1990).  
 
 
 
 
 
 
 
 
 
Figure 13. The structure of D-biotin. Synonyms for D-biotin include vitamin H, vitamin 
B7 and Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid. MW 
244.31 g/mol.  
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The high affinity is due to a network of eleven hydrogen bonds, hydrophobic 
interactions and near perfect structural complementarity between the ligand and the 
binding site. The binding of biotin to avidin is highly exothermic and enthalpy 
driven. The total entropy of the binding reaction is unfavourable or close to zero 
(Green 1966). It could, however, be thought to be favourable, because five 
structured water molecules that form a hydrogen-bonding network are removed 
from the binding pocket of an apoform of avidin by biotin binding (Wilchek, Bayer 
1999), and the dehydration of biotin itself, also contributes to the binding entropy by 
increasing water movement. These positive contributions to binding are 
compensated by the negative effect rising from the increased conformational rigidity 
of biotin in the binding site, as well as the decreased movement of the three-
dimensional structure of the avidin as presented in figure 14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Average per-residue RMSD-F of side chains in wild type avidin with bound 
biotin in subunit D. Colors indicate where side chain mobilities differ between the 
protein-ligand complex and the apo-protein. Red indicates increased movement 
and blue indicates decreased movement. Figure adopted from (Kukkurainen 
2009). 
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Eleven hydrogen bonds that bind biotin to avidin include both N—H…O and 
O—H…O hydrogen bonds. Streptavidin, which is an avidin like protein found in 
Streptomyces avidinii, has a structure homologous to avidin, but a 100-fold lower 
affinity to biotin. One explanation for this is the lower number of H-bonds in 
streptavidin compared to avidin as shown in figure 15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. The strereo image of the amino acid residues, which form H-bonds with 
avidin (A, pdb: 2AVI) or streptavidin (B, pdb: 1MK5). Amino acid residues Thr35, 
Thr 38, Ala39 and Thr 40 of avidin are from L3,4-loop and forms H-bond with 
biotin. However, streptavidin has only two H-bonding amino acid residues from 
L3,4-loop, Ser45 and Asn49.  
Cooperative hydrogen bonds are a network of hydrogen bonds, whose influence 
on stabilization is larger than the sum of individual hydrogen bond energies. A good 
example of cooperative hydrogen bonds is the ureido moiety of biotin in the bound 
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state in avidin and streptavidin, which forms five hydrogen bonds: three to carbonyl 
oxygen and one with each -NH group as shown in figure 15. For example, the 
charged Asp128 in streptavidin polarizes the urea of biotin and is the main reason 
for cooperativity. By removing the interaction by mutagenesis, cooperativity is 
diminished (DeChancie, Houk 2007). Cooperativity was studied with the 
streptavidin double mutant S45A/D128A by Hyre et al. 2006. The effect of 
removing both hydrogen bonds by mutagenesis evoked the loss of binding affinity 
by 11-fold more than predicted by a linear combination of the single-mutant 
energetic perturbations (Hyre et al. 2006). 
Many hydrogen bonds between avidin and biotin are furcated. There is a 
trifurcated carbonyl oxygen donor in the ureido moiety of biotin and a bifurcated 
carbonyl oxygen donor and a trifurcated hydroxyl group acceptor in the carboxylic 
tail of biotin. If new properties and applications for avidin or streptavidin are 
required, one potential option is the mutagenesis of the amino acid residues involved 
in these furcated interactions. Alanine mutagenesis of Asn23Ala, Ser27Ala and 
Tyr43Ala in streptavidin, by Stayton and his co-workers revealed that destroying 
one member of this trifurcated hydrogen bond yields affinities 282, 114 and 67 
times weaker, respectively, for biotin compared to wt streptavidin (Klumb, Chu & 
Stayton 1998). Similar results were obtained with avidin. Mutagenesis of Tyr33, 
which is equivalent to Tyr43 in streptavidin, did not have a significant effect on 
binding affinity, but it made it pH-dependent (Marttila et al. 2003). The site was 
used by Ting and co-workers to construct a triple mutant of a streptavidin 
(Asn23Ala, Ser27Asp, Ser45Ala) that binds biotin in the monovalent way (Howarth 
et al. 2006) and by Sano and Cantor to change ligand specificity to favour 2-
iminobiotin (figure 17) over biotin with Asn23Ala and Ser27Asp mutations (Reznik 
et al. 1998). 
2.7.1.1 The effects of hydrated water on ligand binding in avidin 
Before a ligand binds to a protein, water molecules at the interacting regions of both 
molecules have to be removed. Desolvation of water molecules reduces the Gibbs 
energy of hydration. At the same time dehydrated water gains freedom to form the 
ordinary water structure that increases entropy.  
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The Gibbs energy of dehydration can be computationally estimated from the 
change of areas at the contact site (Ooi et al. 1987). Estimating the entropy change 
of the association is more difficult, but can be done simultaneously with determining 
enthalpy from the change in accessible surface areas (Ooi, Oobatake 1988). This 
method has not been used to estimate the interaction energy of avidin and biotin. 
However, the accessible surface area (ASA) of the apo- and holoforms could be 
easily calculated. The difference between the AVD-BTN complex and uncomplexed 
AVD is approximately 640 Å2, and moreover, the solvent accessible area of biotin is 
414 Å2 (calculated from the pdb:2AVI complex, Kukkurainen et al., unpublished). 
Therefore, the complex formation of AVD and BTN decreases the total solvent 
accessible area of the system by 1051 Å2. If we consider that a water molecule has a 
radius of 1.4 Å, and therefore covers over 6 Å2 of the surface of the proteins, in 
theory almost 170 water molecules could be released from both avidin and biotin to 
the surroundings when they form a complex. A tight interaction causes a decrease in 
molecular freedom. The positive effect of dehydration can not be seen in 
experimental measurements as a positive entropy value, because the movements of 
avidin and biotin are more restricted after complexation, which compensates for the 
entropy increase that arises from dehydration. For example, the loop L3,4 adopts a 
significantly more defined conformation after biotin binding (Livnah et al. 1993b). 
2.7.2 Ligands of avidin 
Besides its natural ligand biotin, avidin is also able to bind biotin analogs (Green 
1975), as well as other small molecules like 4-hydroxyazobenzene-2-carboxylic acid 
(HABA) (Livnah et al. 1993a). HABA binds to the same binding pocket as biotin 
with significantly reduced affinity (Kd = 6×10–6 M) (Green 1965, Green 1970). This 
makes it an interesting molecule, because although biotin and HABA are quite 
similar in size, they have different structures as presented in figure 16. In addition it 
has been found that avidin does not bind only HABA, but also a vide variety of 
other azocombounds (Green 1963a, Green 1965, Repo et al. 2006). 
HABA is used to measure the biotin-binding sites of avidin derivatives. When it 
binds to avidin it goes though a spectral shift from yellow to red and this shift can be 
reversed by D-biotin. Other azocombounds have slightly different kinds of 
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properties. Their binding affinities vary from weak (mM) to moderate (ȝM) and 
their spectroscopic properties differ as well. 
 
 
 
 
 
 
Figure 16. The molecular structure of 4-hydroxyazobenzene-2-carboxylic acid, HABA. 
MW 242.23 g/mol 
2.7.2.1 Biotin and biotin analogues 
Biotin, also known as vitamin H (or vitamin B7), is an important component in 
several biochemical and cellular processes. This small water-soluble molecule is 
synthesised by most microbes, plants and fungi (Streit, Entcheva 2003) but for 
example humans need to obtain it from food. 
The imidazolidone ring has been show to be more important for binding to avidin 
than the thiophan ring (Dittmer, DU Vigneaud 1944) and that modifications to the 
carboxyl group have only a minor effect on binding to avidin (Wright et al. 1951). 
The affinities of biotin analogues like 2’-thiobiotin, 2’-iminobiotin and d-
desthiobiotin (figure 17) were measured by spectrophotometric titrations and were 
all found to bind with tight affinity (Kd < 10–8 M) (Green 1975). 
Biotin analogues have an important role in (strept)avidin-technology. Of 
specially importance are biotin analogues, which have a modified carboxyl group in 
their valeryl chain. This offers the possibility of attaching desired parts to biotin 
without affecting its affinity to avidin. An example of a more sophisticated 
application is the use of biotin analogues with various alkyl and poly(ethylene 
glycol) (PEG) chains coupled to DOTA. Such compounds have been used to 
monitor the survival of avidin-coated islets of Langerhans isolated from pancreas 
and used in transplantations i.e. to the liver (Blom, Langstrom & Velikyan 2009). 
 
N
N O H
O H
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Figure 17. The molecular structures of A, 2’-iminobiotin; B, 2’-thiobiotin and C, d-
desthiobiotin. 
2.7.2.2 Peptide ligands of (strept)avidin  
The size of the ligand-binding site in avidin and streptavidin also enables the entry 
and binding of small peptides. The binding affinities of the avidin binding peptides 
first discovered were significantly lower than that of biotin. Optimization has, 
however, increased the binding affinities of peptides and they have reached a 
nanomolar dissociation constant range (Voss, Skerra 1997). Peptides are therefore 
valuable for example in single-step purifications of fusion proteins (Cho et al. 2000, 
Keefe et al. 2001, Lamla, Erdmann 2004, Bessette, Rice & Daugherty 2004). 
Probably the most popular and commercially available product is Strept-tag 
(AWRHPQFGG) and its further improved version Strept-tagII (WSHPQFEK) 
(Schmidt, Skerra 1993, Schmidt et al. 1996). These peptides are used to extract 
recombinant proteins, for example. The sequence of the tag is inserted into the 
polypeptide chain of a recombinant protein. The tagged protein binds to the 
streptavidin column and can be easily eluated with biotin. The purification of 
recombinant proteins in this way has been described in several studies (Schmidt, 
Skerra 1993, Schmidt et al. 1996, Voss, Skerra 1997, Skerra, Schmidt 1999, Skerra, 
Schmidt 2000). 
2.7.2.3 Azocompounds 
Avidin binds to a variety of different dyes and peptides, which have only little or no 
structural similarity to biotin (Tausig, Wolf 1964, Green 1975, Devlin, Panganiban 
& Devlin 1990). The sizes of these small molecules are similar to biotin and they 
appear to bind completely or partially to the same site, since biotin displaces them. 
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Avidin fluoresces when the weakly interacting HABA (4'-hydroxyazobenzene-2-
carboxylic acid) is displaced by biotin. This phenomenon can be used to determine 
the amount and biotin-binding activity of avidin in solution with a spectroscopic 
method (Green 1965, Green 1970, Wilchek, Bayer 1990). HABA is also used in an 
assay where the amount of biotin linked to either proteins or nucleic acids is 
determined. The assay is based on fluorescence resonance energy transfer (FRET) 
and uses a complex of Alexa Fluor® 488 dye-labeled avidin with HABA as a 
quencher dye (Batchelor et al. 2007). The binding of HABA to avidin is an 
endothermic reaction and the moderate affinity and negative Gibbs energy of 
binding are due to the favourable entropy value of the binding. By modifying 
HABA, it has been possible to improve its affinity, and hereby the sensitivity of 
avidin-based applications (Repo et al. 2006). The binding of azocompounds to 
avidin was screened with ITC and the results are presented in Table 1. 
 
Table 1. The structures of azocompounds and the determined dissociation 
constants for the azocompound-avidin complexes. The values are from 
ITC measurements carried out in a sodium phosphate buffer at 25 °C 
(Määttä et al. unpublished) 
Ligand Structural formula 
Kd 
(×10–6) M 
4-Hydroxyazobenzene-2-carboxylic acid (HABA) 
 
7.9 
4-Hydroxyazobenzene-3-carboxylic acid 
 
13.7 
4-Hydroxyazobenzene-4-carboxylic acid  
31.1 
4-Hydroxy-3-nitroazobenzene-3-carboxylic acid 
 
1.8 
4-Hydroxy-3-nitroazobenzene-4-carboxylic acid 
 
147.0 
 47 
4-Hydroxynaphthaleneazobenzene-2-carboxylic acid 
 
0.6 
4-Hydroxynaphthaleneazobenzene-3-carboxylic acid 
 
22.6 
4-Hydroxynaphthaleneazobenzene-4-carboxylic acid 
 
NDa 
4-Hydroxy-3,5-dimethylazobenzene-2-carboxylic 
acid 
 
4.3 
4-Hydroxy-3,5-dimethylazobenzene-3-carboxylic 
acid 
 
33.1 
4-Hydroxy-3,5-dimethylazobenzene-4-carboxylic 
acid 
 
22.8 
3,4-Dihydroxyazobenzene-2-carboxylic acid 
 
5.8 
3,4-Dihydroxyazobenzene-3-carboxylic acid 
 
12.3 
3,4-Dihydroxyazobenzene-4-carboxylic acid 
 
385.0 
3,4-Dihydroxy-5-methylazobenzene-3-carboxylic 
acid 
 
22.6 
3,4-Dihydroxy-5-methylazobenzene-4-carboxylic 
acid 
 
28.0 
2,4-Dihydroxyazobenzene-4-carboxylic acid 
 
9.9 
2,4-Dihydroxyazobenzene-3-carboxylic acid 
 
2.6 
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2,4-Dihydroxyazobenzene-2,6-dicarboxylic acid 
 
10.1 
2,4,6-trihydroxyazobenzene-3-carboxylic acid 
 
15.2 
2,4,6-trihydroxyazobenzene-4-carboxylic acid 
 
18.6 
4-(diethanolamine)-azobenzene-3,5-dicarboxylic 
acid 
 
58.5 
4-(diethanolamine)-azobenzene-3-carboxylic acid 
 
158.0 
2,4-Dihydroxyazobenzene-3,5-dicarboxylic acid 
 
17.5 
2,4-Dihydroxyazobenzene-4-ethanoic acid 
 
120.0 
2,4-Dihydroxyazobenzene-4-ethanolamide 
 
NDa 
aNot determinable  
2.7.3 Stability of the avidin protein 
Avidin is a thermally stable protein. Its thermal denaturation melting point (Tm) 
measured with a scanning speed of ~1 °C/min by differential scanning calorimetry 
(DCS) was 85 ºC or 118 ºC with out and with biotin, respectively (Donovan, Ross 
1973, Nordlund et al. 2003). In addition, avidin is stable at a wide pH range of 2-13 
(Green 1975) and resists many detergents like 9 M urea (Fraenkel-Conrat, Snell & 
Ducay 1952, Ross, Carson & Fink 1986) or moderate concentrations of 
carbamimidoylazanium chloride, commonly known as guanidium chloride (GndCl, 
figure 18) (Green 1963b). Above 3.5 M GndCl the protein begins to unfold and lose 
its biotin binding activity, and at a concentration of 6 M GndCl the avidin tetramer 
dissociates (Green 1963b). 
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Figure 18. The molecular structure of carbamimidoylazanium chloride. 
Ionic and hydrophobic interactions are usually thought to be major determinants 
of protein stability, but protein intersubunit interactions confer an increased 
resistance toward thermal stress (Marabotti et al. 2008). This is also true for avidin: 
several studies with one-to-three and one-to-four monomer-monomer interactions 
have shown reduced quaternary structure stability (Laitinen et al. 2001). The set of 
Met96, Val115 and Ile117 to alanine mutants on the one-to-three interface was 
thought to reduce hydrophobic forces. Asn54 and Asn69, for one, were mutated to 
alanines in order to eliminate the hydrogen-bonding potential from the one-to-four 
interface. Asn54Ala and Asn69Ala mutations destabilized forces in the interfaces in 
such a way that avidin became completely monomeric even at room temperature. 
However, the presence of biotin induced tetramerization (Laitinen et al. 2001). The 
combination of mutants Asn54Ala and Trp110Lys produced an avidin, which 
appeared to be monomeric in solution both in the absence and presence on biotin 
with a lower biotin binding ability (Kd § 10–7) (Laitinen et al. 2003). Because 
Trp110 and Trp120 in adjacent monomers cause a significant increase in the binding 
affinity of avidin and streptavidin, respectively (Chilkoti, Tan & Stayton 1995, 
Laitinen et al. 1999), no high-affinity monomeric avidin or streptavidin has been 
developed. The closest attempt so far is a streptavidin where three out of four 
binding sites are blocked with mutations (Howarth et al. 2006). This protein has 
proved its potential in biochemical methods and it can be used to label specific cell 
surface proteins with biophysical probes on mammalian cells (Howarth, Ting 2008). 
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3. Aims of the study 
Several years of biotin-binding protein research around the world has yielded 
hundreds of products for biotechnology and has led to the rise of the so-called 
avidin-biotin technology. The characterization of new avidin-like proteins has 
increased our basic knowledge of the avidin-biotin interaction. The current study 
was based on previous findings made in our group and was aimed at generating 
novel molecules to be added to the “tool box” of avidin-biotin technology. 
 
The specific aims of the study were: 
 
1. To produce chimeric forms of avidin and AVR4/5 to study the origins of the 
high stability of AVR4/5 
2. To characterise the thermal stability and solvent stability properties of 
chimeric avidin ChiAVD(I117Y) 
3. To determine the 3D structure of ChiAVD(I117Y) 
4. To change the binding properties of avidin to prefer HABA over biotin by 
circular permutation and site-directed mutagenesis 
5. Characterize the properties of a novel biotin-binding protein A  
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4. Materials and Methods 
The materials and methods are described in detail in the original publications I-IV 
4.1 Construction of expression vectors for avidins 
The avidin cDNA core (Gope et al. 1987) or the fusion of the avidin cDNA core 
with the bacterial expression signal sequence (Hytönen et al. 2004) from Bordetella 
avium ompA protein (Gentry-Weeks et al. 1992) were used as primary templates for 
all avidin mutants (I, III). A cDNA clone of BBP-A [GenBank: BX930135] was 
obtained from the UK Chicken EST Consortium (ARK Genomics). 
4.1.1 Production of the chimeric avidin mutant in insect cells 
Chimeric avidin was originally produced using the Bac-To-BacTM Baculovirus 
Expression System (Invitrogen) in insect cells (I) and later with an E. coli 
production system (IV). DNA encoding the chimeric avidin mutant I117Y 
(thereafter referred as ChiAVD(I117Y)) protein was produced by site-directed 
mutagenesis using the QuikChange (Stratagene, La Jolla, CA) method. The 
construct (ChiAVD) for QuickChange mutagenesis was made with three sequential 
PCR reactions in which the final product was obtained from partially overlapping 
DNA fragments by annealing them with the PCR reaction. The final product was 
cloned into the pFASTBAC1 vector that was used to produce recombinant 
baculoviruses as instructed by the manufacturer of the Bac-To-Bac™ system 
(Invitrogen). 
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4.1.2 E. coli expression vectors 
In order to construct a DNA that encodes for circularly permuted cpAVD4ĺ3, two 
PCR reactions were performed with two sets of oligonucleotides and the cDNA for 
wt avidin from the plasmid pGem+Av (Airenne et al. 1994) as template. The 
resulting DNA fragments were connected by overlapping primers: PCR products 
from the first and second PCR reactions where the overlapping DNA sequence 
encoded the polypeptide linker connecting the original termini. Mutagenesis of 
cpAVD4ĺ3 was performed with the QuikChange mutagenesis kit (Stratagene, La 
Jolla, CA, USA). To create the expression construct for dcAVD2, DNA encoding 
cpAVD4ĺ3 was digested with the restriction enzymes BamHI and HindIII and 
subcloned into a pGemTeasy vector that already contained the DNA sequence 
encoding cpAVD5ĺ4 (Nordlund et al. 2004). 
A cDNA clone for BBP-A [GenBank: BX930135] was obtained from the UK 
Chicken EST Consortium (ARKGenomics). In order to express BBP-A, dcAVD2, 
cpAVD4ĺ3 and cpAVD4ĺ3(N118M) proteins in E. coli, the signal peptide from 
Bordetella avium OmpA protein(Gentry-Weeks et al. 1992) was inserted by 
subcloning the DNA fragments into the pGemTeasy vector (Promega) containing 
the OmpA-signal peptide and flanking attL recombination cloning sequences 
(Hytönen et al. 2004) (II, III). For protein expression, the constructs were 
transferred to the pBVboostFG expression vector (Airenne et al. 2003, Laitinen et 
al. 2005) using LR recombination (Invitrogen). All DNA constructs were confirmed 
by DNA sequencing (I-III). 
The chimeric avidin mutant I117Y was transformed from the insect cell 
production (I) system to the E. coli production system (IV). The OmpA secretion 
signal peptide was built into the ChiAVD(I117Y) by stepwise elongation of the 
sequence polymerase chain reaction (SES-PCR) in two separate PCR reactions 
using pFASTBAC1 (ChiAVD(I117Y)) as template. The PCR product was then 
subcloned into the pET101-D vector using directional topoisomerase (TOPO) 
cloning (Invitrogen) and confirmed by sequencing. 
 53 
4.2 Protein expression and purification 
The pFASTBAC1-cloned expression construct of ChiAVD(I117Y) was used to 
create recombinant baculovirus genomes by homologous recombination in E. coli 
DH10BAC cells. The recombinant viral genome was then used to transform Sf9 
insect cells (derived from ovarian tissue of Spodoptera frugiperda pupa, Invitrogen). 
Recombinant baculoviruses were then collected from the growth medium and used 
to infect Sf9 cells in biotin-free medium. The infection was allowed to continue for 
72 hours, after which cells were collected by centrifugation. Soluble protein was 
isolated from the supernatant after suspension into lysis buffer and sonication, in a 
single step by affinity chromatography using 2-iminobiotin-Sepharose 4 Fast flow 
(Affiland) columns as described previously (I) (Airenne et al. 1997). 
ChiAVD(I117Y) (IV) as well as BBP-A, dcAVD2 and cpAVD4ĺ3 (II-IV) and 
their mutants were later produced in E. coli BL21-AI cells (Invitrogen).  
Because of the toxicity of avidin proteins (Beaumont 1833, Steinitz 1898), a tight 
induction control is needed for expression in E. coli. This was achieved with the 
arabinose-inducible T7 polymerase gene promoter, whose expression was further 
repressed by glucose. The chemically competent BL21-AI cells (Invitrogen) were 
transformed using the manufacturers protocol and allowed to grow in LB plates 
supplemented with 0.1% glucose, and the appropriate antibiotics. Tetracycline and 
gentamycin (II-III) were used to maintain pBVboostFG whereas tetracycline and 
ampicillin (IV) were used to maintain pET101-D. After an incubation overnight at 
37 °C, colonies were transformed to 10 ml of LB medium containing the appropriate 
antibiotics and 0.1% glucose and then incubated again overnight at 28 °C in an 
orbital shaker. The bacterial suspension was diluted to the final growth volume 
containing only ampicillin or gentamysin and 0.1% glucose and allowed to grow 
until it reached an optical density of 0.1 at A600. Cultures were then induced with 
0.2% L-(+)-arabinose (w/v) and 0.1 mM IPTG. After overnight incubation of at 28 
°C, cells were collected by centrifugation. The cell pellet was then suspended into 
hypertonic SET buffer (0.5 M sucrose, 1 mM EDTA and 200 mM Tris, pH 7.4) 
supplemented with lysozyme. Sonication of the cell suspension at +4 °C was 
followed by dilution to HilloI buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton-
X100, 2 mM EDTA) and centrifugation. Soluble protein was recovered from the 
supernatant by affinity chromatography using either 2-iminobiotin- or biotin-
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Sepharose 4 Fast flow (Affiland) columns as has been previously described 
(Airenne et al. 1997). The protein concentration was determined using a UV/Vis 
spectrophotometer by measuring the absorbance at 280 nm. 
4.2.1 Fermentation 
ChiAVD(I117Y) was produced in pilot scale in a bioreactor to carry out protein 
consuming assays like for example affinity measurements with isothermal titration 
calorimetry. The fermentation was started in the same way as the Erlenmayer flask 
productions by transferring colonies from agar plates to the LB medium followed by 
overnight incubation at 26-28 °C. One ml of this culture was used to start a new, 
approximately 300 ml culture, in a medium more suitable for fermentation (50 mM 
potassium phosphate, 30 mM sodium phosphate, 2 mM MgSO4, 30 mM glucose, 
yeast extract, trace metals and glycerol). After overnight incubation at 26-28 °C in 
an orbital shaker with a stirring speed of 200 rpm this liquid culture was used for 
inoculation.  
The fermentation was carried out in a Labfors 3 (Infors, Bottmingen, 
Switzerland) bioreactor, which has a working volume of 5 l. The fermentation 
medium was the same as used for inoculation, but did not contain tetracycline. The 
fermentation chamber was sterilized together with the fermentation medium, and the 
cell culture, antibiotics, glucose, trace metals, magnesium sulfoxide, feed solution 
and induction substrates were added using aseptic methods. The oxygen 
concentration during fermentation was controlled with the stirring speed and air 
flow control. The fermentation process started with a stirring speed of 500 rounds 
per minute (rpm). It had a feed-back loop to control the stirring speed between 150 
and 900 rpm to keep the oxygen concentration (pO2) at 20%. At the beginning the 
optical density (OD) was approximately 0.3. When the OD reached 0.8 – 1.2, feed 
solution was pumped into the fermentation solution with a flow speed of 5%. 
Protein production was induced at OD 1.0 – 1.5 by adding 0.25 mM IPTG and 0.2% 
L-arabinose (w/v). The temperature was kept at 28 °C and the fermentation was 
stopped after 24 h by collecting the cells by centrifugation. The cells were stored at  
-20 °C until protein isolation was performed as described in the previous section. 
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4.3 Characterization of ligand binding 
4.3.1 Isothermal titration calorimetry 
Isothermal titration calorimetry ITC has been used in our laboratory since 2005 to 
measure binding parameters for avidin and avidin like proteins (Helppolainen et al. 
2007, Helppolainen et al. 2008). The thermodynamic parameters for the binding of 
avidin to biotin as well as to a number of other small ligands have been 
characterized (II, III, IV, Table 1). 
Proteins were dialyzed against a sodium phosphate (II, III, IV) or potassium 
acetate buffer (III), both containing 100 mM sodium chloride. After careful 
weighting, small ligands, were diluted with the last dialysate to assure identical 
buffer conditions of protein and ligand. The energetic parameters of ligand binding 
were determined with a VP-ITC Isothermal Titration Calorimeter (Microcal). 
Titrations were typically performed at 25 °C or at various temperatures to determine 
the heat capacity (CpL) of ligand binding (IV, Fig. 5).  
Both protein and ligand solution were degassed before injections to avoid air 
bubbles in the samples. Absorbed or released heat in the ligand-binding reaction was 
measured to analyze binding parameters, i.e. the binding association constant Kb, 
change in enthalpy ¨H, stoichiometry n and change in entropy ¨S. Protein and 
ligand concentrations were carefully adjusted to achieve a proper saturation curve. 
This was achieved by calculating the unitless c value: 
c  n u Mt> @uKb                  (19) 
where, n is stoichiometry, [Mt] is molar concentration and Kb the binding affinity 
constant of the macromolecule. The concentration of the macromolecule was 
adjusted so that the c value was between 5 and 50 using an approximation of the 
affinity constant. If a measurement was not satisfying, it was repeated with different 
concentrations. The ligand concentration was approximately ten times higher than 
that of the macromolecule. 
The data were analyzed with the Origin 7.0 software using the “One Set of Sites” 
method provided by the manufacturer. The titration curve (heat change 
Pcal/injection) resulting from the injections was analyzed by fitting the data into a 
nonlinear least square curve. If estimation of the binding constant of the ligand to 
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the protein was impossible due to tight binding over the limit of the instrument (Kb 
>1012, without using competitive method Kb >109), only the enthalpy and the 
stoichiometry of the binding were determined. Exceeding of the instrument’s limit 
can be seen from a high error (>15%) in the binding constant value, from the shape 
of the fitting curve and from a high Chi-square value.  
4.3.2  Fluorescence emission spectroscopy assay 
Fluorescence spectroscopy was used to measure the dissociation rate of fluorescent 
biotin from the proteins (I-III). The analysis was performed by measuring the 
reversal of quenching of the biotin coupled fluorescent probe ArcDiaTM BF560 
(ArcDia Ltd., Turku, Finland) after addition of a 100-fold molar excess of free 
biotin. Analyses were made in a 50 mM sodium phosphate (pH 7.0) buffer 
containing 650 mM NaCl. Due to the slow dissociation of some proteins at 25 °C, 
measurements were also done at 50 °C to increase the speed of complex 
dissociation. Measurements were done as previously described using a PerkinElmer 
LS55 luminometer (Hytönen et al. 2004). The fluorescence data were interpreted 
using the “single-phase dissociation model”, as described elsewhere (Hytönen et al. 
2004) and the dissociation rate constants (kdiss) were determined using the equation: 
0
ln
B
Btkdiss                     (20) 
where B0 is the maximal binding (100%) measured (the difference between the 
fluorescence of the free dye and that of the protein–dye complex) and B is the 
amount of complex measured as a function of time. The release of fluorescent biotin 
was followed for 1 h to ensure total equilibrium of measurements. 
4.3.3 Radiobiotin dissociation assay 
The dissociation of radioactive biotin (d-[8,9-3H]biotin, Amersham) from proteins 
(I-III) was determined at different temperatures as described by Klumb and co-
workers (Klumb, Chu & Stayton 1998). Briefly, the displacement of radioactive 
biotin by a 1000-fold excess of d-biotin as a function of time was followed and the 
dissociation rate constant was determined from the fraction of biotin bound at each 
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time-point using the global fit method (I) according to Hyre et al. (2000) or from the 
slope of the line fit to the plot of ln(fraction biotin bind) versus time according to the 
integrated expression for a first-order reaction rate (II, III) as presented by Klumb, 
Chu & Stayton (1998): 
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4.3.4  Surface plasmon resonance (SPR) 
The ligand-binding characteristics of avidins were analyzed with a surface plasmon 
resonance optical biosensor (I). The IAsys instrument was used to analyze 
association and dissociation from 2-iminobiotin, which was covalently linked to the 
sensor chip as previously described (Laitinen et al. 2002). 
4.4 Thermostability and solvent stability 
4.4.1 Differential scanning calorimetry 
The thermostabilities of avidin proteins (I, II) were determined by comparing the 
transition midpoints (Tm) of heat denaturation using a Calorimetry Sciences 
Corporation Nano II (Lindon, UT, USA) differential scanning calorimeter (DSC) in 
collaboration with the group lead by Professor Slotte (Åbo Akademi University, 
Turku, Finland) as described in detail earlier (Gonzalez, Argarana & Fidelio 1999, 
Nordlund et al. 2003). Proteins were analyzed both in the absence and presence of 
D-biotin. 
4.4.2 SDS-PAGE based transition temperature analysis 
The stability of proteins (II, III) was also studied with a SDS-PAGE -based 
thermostability assay (Bayer, Ehrlich-Rogozinski & Wilchek 1996). Chemically 
acetylated proteins in the presence or absence of ligands were subsequently 
subjected to thermal treatment at many different temperatures for 20 min in the 
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presence of SDS and 2-mercaptoethanol. After treatment the oligomeric state of the 
protein was analysed by SDS-PAGE and Coomassie blue staining. 
4.4.3 Microplate assay 
A microplate assay was used to determine at which temperature proteins lose their 
ligand-binding activity. Proteins were held at 99.9 qC for 32 min and the remaining 
activity was probed by measuring the ability of the proteins to bind biotinylated 
alkaline phosphatase (BTN-AP) (I). Heat-treated protein samples were coated onto 
the wells of a microplate and the amount of bound BTN-AP that was determined by 
following the colorimetric reaction on the microplate with a spectrophotometer 
(Nordlund et al. 2003). 
4.4.4 Solvent stability assay with resin linked proteins and 3H-
labelled biotin 
The solvent stability of proteins was analyzed by incubating proteins, which were 
covalently attached to the sepharose 4FF resin, in different organic solvents (IV). 
The stability of proteins was determined by measuring their ability to bind 3H-
labelled biotin after solvent treatment (IV, Fig. 4A) or in the presence of solvent 
(figure 21). The amount of bound tritium-labelled biotin could be determined by 
measuring the amount of tritium-labelled biotin remaining in the supernatant after 
separation from the functional resin-coupled protein by filtration. The solvent used 
for control samples was water or formic acid. Water was assumed to have no effect 
on protein and conversely formic acid was assumed to destroy all activity of the 
proteins analyzed. 
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4.5 Structural analysis by X-ray crystallography 
4.5.1 Circular permutated avidin Loop3-4 and Biotin Binding 
Protein A (II,III) 
The crystal structures of cpAVD4ĺ3 (II) and BBP-A (III) were solved by X-ray 
crystallographic analysis in collaboration with the group led by Professor Mark 
Johnson (Åbo Academy University, Turku, Finland). The optimal conditions for 
crystallization were screened by the sitting drop or vapour diffusion method either 
with a HamiltonSTAR robot in the Institute of Biotechnology at the University of 
Helsinki or with the ClassicsTM screen (Nextal Biotechnology, Qiagen, Valencia, 
CA, USA). After optimization, suitable crystals were harvested and diffraction data 
sets were collected at the MAX-lab beam line I711 using a MarCCD detector (Lund, 
Sweden). A more detailed experimental description can be found in the original 
publications (II, III).    
4.5.2 Chimeric avidin (I117Y) (IV) 
The X-ray crystallographic analysis was also used to solve the crystal structure of 
ChiAVD(I117Y) in collaboration with Professor Oded Livnah (The Hebrew 
University of Jerusalem, Jerusalem, Israel). Initial crystals of the ChiAVD were 
obtained by the hanging-drop vapour diffusion method. Later crystallization 
conditions were screened using the Douglas Instruments ORYX6 automatic protein 
crystallization system with the Hampton Research screening kits for better quality 
crystals. Crystals were obtained at 293 K using first the microbatch and then the 
hanging drop method. Diffraction data sets were collected at the ESRF beam line 
ID14-4 using an ADSC Q315R CCD detector. The methods and procedures are 
described in detail in the original publication (IV). 
4.6 Mass spectrometry 
Mass spectrometric analysis (III, IV) was performed in collaboration with Dr. Janne 
Jänis (University of Joensuu, Joensuu, Finland). The experiment was done on a 
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Fourier transform (FT) ion cyclotron resonance (ICR) mass spectrometer (Bruker 
Daltonics, Billerica, MA, USA) that had a mass-selective quadrupole interface and 
electro spray ionization (ESI) for ion source. Data was processed using the Bruker 
XMASS 7.0.8 software. 
4.7 Fast Protein Liquid Chromatography Gel Filtration 
The size and quality of the purified proteins (I, II, III) were analyzed using gel 
filtration chromatography. Proteins were analyzed using a Superose 6 10/300GL 
(Tricorn) (III) or SuperDex 200 10/300GL (Tricorn) (II) column in an ÄKTÄTM 
purifier 10 FPLC instrument (Amersham Biosciences) as previously described 
(Nordlund et al. 2003). Proteins were diluted with 50 mM sodium phosphate buffer 
containing 650 mM NaCl (pH 7.0). Biotin-complexed proteins were prepared by 
incubating the sample for 10 min in the presence of an excess of biotin prior to 
analysis.   
4.8 Computer programs 
The molecular representations were created with the PyMOL molecular Graphics 
System (DeLano 2008) (II,III) or MIDAS(Ferrin et al. 1988) and edited with the 
Corel Draw 11 (II) and X3 (III) or Photoshop CS3 program suite (III, IV). The 
multiple sequence aligment of BBP-A and avidin was made using the program 
Malign implemented in BODIL (Lehtonen et al. 2004). The solvent-accessible 
surface areas were calculated with the program Areaimol (Lee, Richards 1971) of 
the CCP4i suite (II,III) (Collaborative Computational Project, Number 4 1994, 
Potterton et al. 2003). The figures in “Review of the literature” section were created 
with the PyMOL molecular Graphics System (DeLano 2008) and/or prepared with 
Photoshop CS3. All the programmes used in the analyses are mentioned in the 
original communications (I-IV) 
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5. Review of the Results 
5.1 Chimeric avidin mutants (I, IV) 
The avidin gene family in chicken consists of avidin and up to seven avidin related 
proteins (AVRs) (Ahlroth et al. 2000). AVRs have been produced as recombinant 
proteins and their functional and structural properties have been carefully 
characterized (Laitinen et al. 2002). AVR proteins have many interesting features 
when compared to avidin. One of them, the identical product of the genes AVR4 and 
AVR5, and therefore, named AVR4/5, was found to be the most stable biotin-
binding protein encoded by a natural gene with a Tm of 106.4 qC (Hytönen et al. 
2004). The interest to explore the structural origins of the high stability of AVR4 
was the starting point for studies leading to the hyperthermostable protein 
ChiAVD(I117Y) (I). 
5.1.1 Expression vectors, fermentation and purification of 
recombinant proteins 
A 21 amino acid segment from AVR4 was transferred to avidin and the resulting 
chimeric protein was named ChiAVD. In another approach, effects of the mutation 
I117Y were studied, because this residue is located on the structurally important 
interface between subunits and has been shown to contribute to the stability of 
avidin by previous studies (Nordlund et al. 2003, Laitinen et al. 2001). These two 
modifications were combined in ChiAVD(I117Y) as presented in figure 19. 
The ChiAVD(I117Y) was first produced using a baculovirus expression vector in 
insect cells (I) and later in E. coli (IV) using the signal peptide from the ompA 
protein as previously described (Hytönen et al. 2004). Avidin proteins were purified 
effectively by 2-iminobiotin-agarose affinity chromatography. In order to get large 
amounts of protein for X-ray crystallography (IV) and for more detailed binding and 
stability assays, ChiAVD(I117Y) was also produced with pilot scale fermentation 
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(IV). A typical yield was approximately 50 mg per one litre of fermentation of E. 
coli bacteria. Optimization the fermentation protocol by applying dissolved oxygen 
controlled feed rise the protein yield above 200 mg/l of fermentation medium. The 
produced protein was confirmed to by mass spectrometry (figure 20). The measured 
most abundant isotopic mass (14380.31 Da) was very close to the calculated value 
(14380.51). The result confirms that the protein is as expected and that the sulphur 
bridge between cysteine 4 and 81 is formed. 
 
 
Figure 19. An aligment of chicken avidin and AVR4. Boxed areas indicate the parts of 
AVR4 which were transferred to avidin, to form ChiAVD(I117Y). 
 
 
 
 
 
 
 
 
Figure 20. The mass spectrometry result of ChiAVD(I117Y). The theoretical most 
abundant isotopic mass for ChiAVD(I117Y) is 14380.50 Da. The measured most 
abundant isotopic mass for ChiAVD(I117Y) was 14380.31 Da. 
5.1.2 Ligand-binding analyses 
The chimeric avidin mutant I117Y showed biotin binding properties similar to those 
of avidin or AVR4. The binding properties of the proteins were analyzed by SPR (I, 
Table 3), as well as radiobiotin (I, Fig. 4) and fluorescent biotin dissociation assays 
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(I, Table 4). The SPR analysis showed a slightly decreased affinity to the 2-
iminobiotin surface for ChiAVD(I117Y) when compared to avidin, (6.7±1.2) × 10–8 
M and (2.1±0.6) × 10–8 M. ChiAVD and ChiAVD(I117Y) resembled AVR4 in their 
behaviour in the radioactive biotin dissociation assay, but they had significantly 
higher dissociation rate constants than wt avidin. The fluorescent biotin dissociation 
assay showed that the I117Y mutation seemed to tighten the binding of the biotin 
conjugate to avidin. At 25 °C ChiAVD(I117Y) (1.94 ×10–5 s–1) had  a dissociation 
rate similar to wt avidin (2.04 ×10–5 s–1) and ChiAVD(I117Y)  and wt avidin both 
had a lower dissociation rate than AVR4 (2.77 ×10–5 s–1) (I, Table 4). The enthalpy 
and stoichiometry of the biotin-binding reaction for ChiAVD(I117Y) determined 
with ITC (IV, Fig. 5), were 25.7 kcal/mol and 0.93, respectively. The determination 
of biotin-binding affinity by ITC proved to be impossible because of the limitations 
of the method (Kd 10–9 M). The binding properties of the different avidins are 
shown in Table 2. 
Table 2. Binding properties of avidins 
ND = not determined 
ITC 
Biotin 25 °C 
ǻH 
(kcal/mol) 
–TǻS 
(kcal/mol) 
ǻG 
(kcal/mol) n 
Kd 
(M) 
/ǻCp 
(cal/mol °C) 
AVD –25.7 ND ND 1.0 <10–9 –461 
ChiAVD(I117Y) –26.9 ND ND 1.1 <10–9 –270 
HABA  25 °C 
  
    
AVD 1.8 9.1 –7.3 0.7 4.8 ×10–6 ND 
ChiAVD(I117Y) 0.8 6.7 –5.8 0.9 5.2 ×10–5 ND 
AVR4 1.7 8.8 –7.1 1.0 5.9 ×10–6 ND 
 SPR Biotin conjugate BF560 dissociation kinetics 
 Kd 
(M) 
kass 
(M–1s–1) 
kdiss  
(10–5 s–1)  
25 qC 
Release 
1 h (%)  
25 qC 
kdiss  
(10–4 s–1)  
50 qC 
Release  
1 h  
(%) 50 qC 
AVD (2.1 ± 0.6) x 10–8 (2.6 ± 0.2) x 104 2.04 10.7 2.74 71.5 
AVD(I117Y) (6.3 ± 1.2) x 10–8 (2.3 ± 0.3) x 104 0.81 3.0 1.61 56.5 
ChiAVD (1.1 ± 0.4) x 10–7 (1.7 ± 0.1) x 104 1.76 13.1 8.00 93.9 
ChiAVD(I117Y) (6.7 ± 1.2) x 10–8 (1.6 ± 0.2) x 104 1.94 9.5 7.33 94.8 
AVR4 (1.4 ± 0.4) x 10–7 (9.3 ± 0.4) x 103 2.77 12.5 7.88 93.7 
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5.1.3 Thermal and solvent stability of avidins 
The thermal stability of proteins was studied by DSC analysis and also with the 
microplate assay (Nordlund et al. 2003). In the DSC experiments the holoforms of 
the proteins had higher Tm values than the apoforms (I, Table 2). ChiAVD(I117Y) is 
the most heat-stable avidin analyzed so far (Tm = 111.1 °C). ChiAVD(I117Y) bound 
to biotin had a Tm value higher than the upper limit of the instrument, i.e. >130 °C.  
   The microplate assay revealed that ChiAVD(I117Y) retains 98% of its activity 
after treatment at 99.9 °C for 32 min, whereas the other proteins analyzed lost a 
significant portion of their activity during a similar treatment (I, Table 2). An SDS-
PAGE based analysis of the transition temperature (Tr) was in line with previous 
findings. ChiAVD(I117Y) had an approximately 20 °C  higher  Tr in both its apo- 
and holoforms than avidin (IV, Fig. 3B). The stability of the avidins is presented in 
Table 3. 
Table 3. Structural properties of avidins 
 
aThe results for AVD and AVR4/5(C122S) are from (Laitinen et al. 2002) and 
the results for SA are from (Gonzalez et al. 1997). 
b'Tm is the change in Tm upon addition of a three-fold molar excess of biotin. 
c'H value obtained from a sample without biotin. The value could not be 
determined accurately from samples saturated with biotin because the Tm values 
were too close to the temperature limit of the DSC instrument. 
dBiotin-binding activity after a 32 min treatment at 99.9 qC  
eCould not be determined accurately due to upper temperature limit of the DSC 
instrument. 
ND = not determined 
 SDS-PAGE DSCa Microplate  
assay 
Protein 
Tr(-biotin) 
(qC) 
Tr(+biotin) 
(qC) 
Tm(-biotin) 
(qC) 
Tm(+biotin) 
(qC) 
'Tmb 
(oC) 
'Hc 
(kJ/mol) 
Activityd 
(%) 
AVD 65 85 83.5 r 0.1 117.0 r 0.7 33.5 329 r 5 4 
AVD(I117Y) ND ND 97.5 r 0.4 123.7 r 0.1 26.2 536 r 6 47 
ChiAVD ND ND 96.5 r 0.2 124.4 r 0.2 27.9 527 r 10 47 
ChiAVD(I117Y) 95 110 111.1 r 0.2 ~130e ~19 659 r 38 98 
AVR4 ND ND 106.4 r 0.8 125.4 r 0.8 19.5 575 r 33 72 
SA 65 90 75.5 112.2 36.7 629 ND 
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5.1.3.1 Solvent stability assay with resin linked proteins and tritium labelled 
biotin 
High thermostability of ChiAVD(I117Y) gave us the idea to investigate its stability 
in different kinds of organic solvents. If the protein could stay active in the presence 
of organic solvents, it could possibly be used in applications which require the 
capacity to resist exotic chemical environments or long storage. 
ChiAVD(I117Y) showed higher stability in most of the organic solvents when 
compared to avidin or streptavidin (IV, Fig. 4). ChiAVD(I117Y) was able to bind 
radiobiotin despite of treatments with methanol, acetonitrile or DMSO at an 
elevated temperature. For example, streptavidin lost 52% of its activity after 
treatment with 100% methanol for 4 h at 50 °C whereas ChiAVD(I117C) lost only 
16% of its activity in such a treatment. Biotin increases the stability of 
ChiAVD(I117Y) as expected as shown in figure 21. Based on the earlier assays it 
was also expected that ChiAVD(I117Y) would not lose any of its binding capacity 
in water (figure 21).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. The loss of the binding capacity of ChiAVD(I117Y) after four hours 
treatment in organic solvents and at an elevated temperature (50 °C) with or 
without 3H-BTN (Määttä et al. unpublished result). 
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5.1.4 Structural analysis by X-ray crystallography 
The three dimensional crystal structure of ChiAVD(I117Y) (resolution: 2.7 Å, 
figure 22) was solved by X-ray crystallography. The structure of the chimeric avidin 
mutant was, as expected, an eight-stranded up-and-down ȕ-barrel, the other parts of 
which were similar to avidin, but the loop between ȕ strands three and four (L3,4 
loop) was shorter, like in AVR4. This shorter loop has a modest effect on biotin 
binding. In streptavidin, the corresponding loop has an evident influence, and it is 
the main reason for weaker biotin binding (Green 1990). The point mutation 
(I117Y) in the subunit interface of avidin was thought to lead to the formation of an  
ʌʌ stack between two neighbouring monomers like in the case of AVR4 (pdb: 
2FHL). This is indeed what occurs in the area between intermonomeric interfaces of 
ChiAVD(I117Y) (IV, Fig. 2 and figure 22). Overall, the structure of 
ChiAVD(I117Y) closely resembles that of AVR4/5, and the 3D structure revealed 
no simple structural explanations for the increased stability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. A Schematic presentation of two subunits of ChiAVD(I117Y). The 3D 
structure determined by X-ray crystallography was used to generate the figure 
(pdb: 3MMO). The red part represents the region taken from AVR4 (described in 
figure 19). Tyr117 residues are presented as sticks to illustrate the stabilizing ʌ-
ʌ interaction, which is formed between the interfaces of the two subunits. 
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5.2 Structure, stability and ligand binding mode of BBP-
A (II) 
Avidin is not the only biotin-binding protein found in chicken egg. It has been 
reported that the egg contains biotin-binding proteins I and II (BBP-I, BBP-II) in its 
yolk (White et al. 1976, Meslar, Camper & White 1978, White, Whitehead 1987, 
Bush, McGahan & White 1988, Subramanian, Adiga 1995). Although it is not 
known for sure whether the cDNAs encoding the proteins BBP-A and BBP-B 
(Niskanen et al. 2005) are same as the BBP I and II proteins characterized earlier, 
the chicken genome project made it possible to produce them as recombinant 
proteins and characterize them more carefully. According to the studies, BBP-A can 
be classified as a new member of the AVD family. 
BBP-A was expressed both in E. coli (bBBP-A) and in insect cells (iBBP-A) and 
isolated using 2-iminobiotin affinity chromatography.  According to gel filtration 
chromatography (II, Table 1), BBP-A is tetramer, and this was also supported by the 
3D crystal structures. BBP-A has one N-glycosylation site (II, Fig. 2), which is 
glycosylated in the iBBP-A recombinant protein, and the size of the carbohydrate is 
similar to that of wt AVD.  
The tetrameric BBP-A was less stabile (Tr = 70 °C in the presence of biotin) in an 
SDS-PAGE-based analysis than wtAVD (Tr = 90 °C in the presence of biotin) (II, 
Table 1). The reason for this may be the 10% larger solvent accessible surface area, 
which was calculated from the crystal structures of BBP-A (pdb: 2C1Q, 2.10 Å; 
2C1S, 1.75Å) and AVD-BTN complex (pdb: 1AVD; 2AVI). The crystal structure 
also revealed that BBP-A has a more positively charged surface than avidin (II, Fig. 
5c-f) and a few differences in ligand binding mode. The crystallographic analysis 
was done by adding diluted biotin to the crystallization solution before 
crystallization. To our surprise, after determining the structure, we detected a D-
biotin D-sulfoxide (BSO) molecule in the crystal, which is presented in figure 23. 
The binding mode of BSO was almost identical to that of BTN. BSO has not been 
found in any other protein structures presently in the Protein Data Bank (PDB) 
(Berman et al. 2002).  
The affinity of BBP-A towards BTN is quite similar to that of streptavidin, and 
therefore, about 50 times lower than that of egg-white avidin. Interestingly, 
according to the determined dissociation rate constants, BBP-A binds BSO even 
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more tightly than BTN, whereas AVD has a dissociation rate constant 20 times 
greater when bound to BTN compared to BSO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. The X-ray structure of the chicken BBP-A binding pocket and D-biotin D-
sulfoxide. Amino acid residues within 4 Å of BSO in the BBP-A – BSO structure 
are presented in gray. 
5.3 Rational modification of avidin by circular 
permutation and mutagenesis (III) 
The influence of the loops to the ligand affinity of avidin and streptavidin has been 
carefully studied (Pazy et al. 2002). These flexible loops near the active sites can be 
viewed as gates that are open to allow ligand association, and close to prevent 
solvent access and to form bonds, thereby minimizing dissociation. In particular, the 
shorter L3,4-loop and the longer L5,6-loop of streptavidin together with the absence 
of a few other hydrogen bonds as compared to avidin, have been shown to be the 
main reasons for weaker BTN-binding affinity. The same structural differences are 
also thought to have an effect on the HABA-binding affinity of AVD and SA. 
Avidin binds HABA more tightly (Kd § 6 ×10–6 M) than SA (Kd § 1 ×10–4 M) 
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(Green 1990). Interestingly, the L3,4-loop has an open conformation when avidin is 
complexed with HABA. Therefore, the L3,4-loop does not seem to contribute 
significantly to the binding of HABA. In theory, the removal of the loop could even 
increase affinity to HABA and significantly decrease affinity to BTN. In fact, the 
decrease in the biotin-binding affinity of streptavidin by L3,4-loop removal has been 
shown in an earlier study (Chu et al. 1998). This is also supported by previous 
findings, where Chu and co-workers found AVD to be more susceptible to 
proteolysis by proteinase K in the presence of HABA, suggesting enhanced loop 
mobility in avidin due to HABA binding (Ellison et al. 1995).  
In order to test this hypothesis, we designed and produced a circularly permuted 
form of avidin, where the loop between ȕ-strands 3 and 4 is deleted (cpAVD4ĺ3). 
The protein was successfully expressed in E. coli BL21-AI cells and characterized 
by spectrophotometric methods. Interestingly, the ITC experiments together with 
ligand-dissociation analyses using fluorescent biotin and radiobiotin assays showed 
that the biotin-binding affinity of mutant was significantly reduced (Kd = 1.4±0.3 
×10–8 M) while its HABA-binding affinity was increased by 1.5-fold (Kd = 5.4±0.7 
×10–6 M)  (III, Table 2; Fig. 2: Table 3).   
The structure of the HABA-avidin complex provides a good opportunity for 
rationally modifying avidin. To increase the HABA-binding affinity of avidin, 
Asn118, which does not make a favourable interaction with HABA in wt AVD 
(Livnah et al. 1993a), was mutated to Met (III, Fig. 6). Another aim was to reduce 
BTN’s affinity to avidin. Because Asn118 makes an important hydrogen bond with 
BTN (pdb: 2AVI, figure 15A), it was a rational target for mutagenesis. Mutagenesis 
of a corresponding site in streptavidin also led to a decrease in biotin affinity 
(Qureshi et al. 2001), supporting our strategy. Our experiments proved that the 
extremely strong femtomolar biotin-dissociation constant of wt AVD was reduced 
to a nanomolar value (Kd = 4.2 ×10–9 M) and at the same time the HABA affinity 
was slightly increased (Kd = 5.2 ×10–6 M). 
We assummed that by combining circular permutation and point mutagenesis, the 
resulting cpAVD4ĺ3(N118M) construct would be able to bind HABA tighter than 
BTN. This was not the case, as cpAVD4ĺ3(N118M) binds BTN approximately 
four times tighter than HABA. However, cpAVD4ĺ3(N118M) has the highest 
affinity towards HABA measured so far (Kd = 1.0 ×10–6 M) and the relative biotin-
binding affinity was reduced over one billion-fold to Kd = 2.4 ×10–7 M. 
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The dual chain concept of avidin made it possible to modify the binding sites of 
avidin independently (Nordlund et al. 2004, Hytönen et al. 2005b). 
cpAVD4ĺ3(N118M) was therefore attached to cpAVD5ĺ4, which is another 
circularly permutated form of avidin (Nordlund et al. 2004). The result, dual-chain 
avidin 2 (dcAVD2), has two different biotin-binding sites: cpAVD5ĺ4 that has wt 
AVD-like binding properties, and cpAVD4ĺ3(N118M) that has only moderate 
BTN-binding affinity and increased HABA-affinity. With further mutations, the 
specific binding of HABA binding in each site may be increased. Preliminary results 
from a Thr77 random mutagenesis experiment indicate that the HABA affinity of 
the Thr77Asp avidin mutant may be even tighter than the HABA affinity of the 
Asn118Met avidin mutant (Määttä et al. unpublished). 
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6. Discussion 
6.1.1 Water molecules in binding events 
Osmotic stress has been used to measure the forces of interactions between large 
molecular surfaces, and the measurements have shown that the energy involved in 
dehydration varies from 1.5 to 15 kcal/mol per 100 Å of surface area  (Rand, 
Parsegian 1989). The same method has been used to probe the energetics of the 
hydration of single macromolecules. The binding of oxygen to haemoglobin has 
been shown to release 60 water molecules (Colombo, Rau & Parsegian 1992). How 
many water molecules are released when biotin binds to avidin? Based on 
calculations of molecular surface areas, we estimated, that the binding of biotin to 
avidin could release 111 water molecules from avidin (ǻA = 637 Å2) and 72 water 
molecules from biotin (ǻA =  414  Å2), assuming a 5.7 Å2 area for a single water 
molecule (Nicholls 2000). This calculation appears to be in line with that of Bennett 
and Steitz (Bennett, Steitz 1980), who calculated from their hexokinase A structure 
that on closing there is approximately a 163 Å2 decrease in area in the cleft, which is 
involved in the removal of approximately 26 water molecules. 
So far the discussion has focused on water molecules on the surface of the 
avidin-biotin complex, but water molecules in vicinal layers may also influence 
entropy. The number of these water molecules is difficult to count, and it is even 
more difficult to estimate how much impact they have on entropy. For hexokinase, it 
has been calculated that the number of water molecules in the second and third 
layers could be equivalent to those on the protein surface (Rand, Parsegian 1989). 
This would mean that another hundred water molecules, which are organized to 
some extent, could be released when biotin binds to avidin. Water molecules in the 
outer hydration shell have a hydrogen bond network more or less similar to bulk 
water, but it has been shown that hydrophilic surfaces significantly perturb water 
well beyond the first layer (Rand, Parsegian 1989). Therefore, the increase in 
entropy due to the dissociation of water molecules from vicinal layers is less than 
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when water molecules are removed from the inner hydration shell. However, the 
simultaneous removal of a large numbers of weak bonds may have a significant 
influence on the energtics of the binding event. 
How big is the Gibbs energy contribution from the hydrophobic transfer process? 
This can be estimated based on both heat capacity changes and changes in solvent-
accessible surface area (Spolar, Ha & Record 1989, Ha, Spolar & Record 1989, 
Livingstone, Spolar & Record 1991, Sharp et al. 1991a, Sharp et al. 1991b, Spolar, 
Livingstone & Record 1992, Spolar, Record 1994, Janin 1997). Heat capacity 
change can be used to calculate the Gibbs energy change of hydration (ǻGhyd) from 
the following equation (Ha, Spolar & Record 1989):  
ǻGhyd = 80 (±10) × ǻCpL                     (22) 
And because ITC measurements state that ǻCpL for avidin is –0.46 kcal mol–1K–1 
the corresponding Gibbs energy for hydration is ǻGhyd = –(36.8±4.6) kcal/mol. This 
value is large, larger by far than the Gibbs energy change observed in the binding 
process, and therefore it must be counterbalanced by obligatory conformational 
changes together with the entropic cost of complex formation. 
It is known that the strept(avidin) binding pocket contains water molecules in the 
absence of a ligand (Weber et al. 1992, Rosano, Arosio & Bolognesi 1999). The 
organization of amino acid residues in the ligand-binding pockets are thought to be 
the reason for the tighter binding of biotin to avidin versus streptavidin, because the 
placement of Asp13 reduces the large desolvation penalty resulting from a first-shell 
charged residue, and provides good hydrogen-bond cooperativity via juxtaposition 
with Asn118 in avidin (DeChancie, Houk 2007).  
Overall, water molecules are a very important factor in ligand binding, both in 
the binding pocket and outside of the protein. DeChancie and Houk even state that 
“The evolutionary driving force for avidin to bind biotin with greater affinity is not 
achieved by strengthening interactions with the ligand, but by weakening binding 
interactions with water”, and therefore, their contribution to the binding should be 
taken into account more carefully (DeChancie, Houk 2007).  
Altogether, because the ligand-binding interaction is a very complex event, and 
the sum of many things like non-covalent interactions and the dehydration of water, 
it is important to solve the complete thermodynamic profile (ǻG, ǻH, ǻS, ǻCpL) of 
the event. This helps in understanding the binding as a process better, and in 
obtaining knowledge on the driving force of the binding. The information gained 
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will become valuable when designing new mutants or new ligands with desired 
properties. 
6.2 Development of a stable chimeric avidin (I117Y) 
(Strept)avidin appears to be a suitable target for protein engineering. Structural 
modifications (Nordlund et al. 2004, Hytönen et al. 2005b, Nordlund et al. 2005, 
Chu et al. 1998), point mutations (Laitinen et al. 2006, Laitinen et al. 2007, Chilkoti, 
Tan & Stayton 1995, Aslan et al. 2005, Avrantinis et al. 2002, Chilkoti et al. 1995, 
Le Trong et al. 2003, Pazy et al. 2003, Pazy et al. 2001, Dixon, Kollman 1999, 
Freitag et al. 1999) and the attachment of fusion partners (Hu et al. 2009, Lesch et 
al. 2009) have been successfully applied to (strept)avidin without destroying the 
functional barrel-structure, and therefore, the primary function: its high affinity to 
biotin. 
 Avidin-biotin technology is popular in numerous bioanalytical applications 
(Wilchek, Bayer 1988, Wilchek, Bayer & Livnah 2006) and more await discovery. 
Although avidin and streptavidin are reasonably thermostable proteins Tm = 85.5 °C 
(Nordlund et al. 2003) and Tm = 75.5 °C (Gonzalez et al. 1997), respectively, it 
could be useful to have an avidin protein, which is stable in conditions where wt 
avidin would not be sufficiently durable. The discovery of genes encoding avidin 
related proteins (Ahlroth et al. 2000, Keinänen, Laukkanen & Kulomaa 1988, 
Keinänen et al. 1994) and their characterization (Laitinen et al. 2002) as 
recombinant proteins, revealed many novel properties compared to wt avidin. 
Besides a variety of biotin-binding affinities, ranging from the avidin-like tight 
affinity of AVR4 (Hytönen et al. 2004) to the moderate affinity of AVR2 (Hytönen 
et al. 2005a), they also exhibited varying degrees of stability. It was found that 
compared to wt avidin, AVR4 is a very thermostable protein (Tm = 106.4 °C). 
However, the reason for the increased thermostability was unclear, and a role for 
Ile117Tyr mutation in the one-to-three interface and the shorter L4,5-loop were 
given as potential explanations (Hytönen et al. 2004). 
Could the properties of different proteins be transferred inside the gene family? 
We thought that if structurally important parts of AVR4/5 could be transferred to 
avidin, we could also change its stability, and thereby learn about the origins of the 
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high stability of AVR4/5. As the result, we made the ChiAVD, Avd(I117Y) and 
ChiAVD(I117Y) constructs. To make ChiAVD, ȕ-strand 4 and parts of its 
surrounding loops from AVR4/5 were transformed to wt avidin. Avd(I117Y) in turn 
has an AVR4/5-inspired point mutation in the one-to-three subunit interface (I, Fig. 
1). Both these changes were found to be beneficial for the stability of avidin. 
Therefore, a protein version containing both modifications was made and named 
ChiAVD(I117Y). It proved to be the most thermostable avidin protein seen so far 
(Tm = 111.1 °C) (I, Table 2). Despite its altered structure, ChiAVD(I117Y) carries 
wt-AVD like binding properties. 
This result gave us hope that ChiAVD(I117Y) could stay active in high 
temperatures longer than (strept)avidin. This property could be of advantage in, for 
example, PCR-based applications involving biotinylated molecules and 
thermostable biotin-binding proteins. ChiAVD(I117Y) seemed to maintain its 
binding properties indefinitely through a typical PCR temperature cycling whereas 
avidin and streptavidin lost theirs binding properties relatively early (IV, Fig. 3C).  
Experiments in vitro are often carried out in physiological water surroundings, 
e.g. in an isotonic sodium phosphate buffer. However, many industrially important 
enzymes catalyze processes in non-aqueous solvents (Klibanov, Koskinen 1996, 
Serdakowski, Dordick 2008). The function of enzymes (activity, specificity and 
stability) in organic solvents is strongly depended on the nature of the solvent (Zaks, 
Klibanov 1988). This drove us to study the properties of ChiAVD(I117Y) in some 
of the most commonly used solvents. We found that ChiAVD(I117Y) remained 
functional in environments and circumstances where avidin and streptavidin lost 
their binding ability to some extent (IV, Fig. 3 and 4).  
6.3 Structure-function relationships of avidin like 
proteins 
The crystal structures of proteins provide good possibilities for understanding 
structure-function relationships and for further designing and engineering proteins. 
The structures of BBP-A (II), cpAVD4ĺ3(N118M) (III),  ChiAVD(I117Y) (IV) 
together with other crystal structures of biotin-binding proteins: streptavidin (SA), 
tamavidins, avidin (AVD), avidin related protein 2 (AVR2), avidin related protein 4 
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and 5 (AVR4/5)  (Weber et al. 1989, Livnah et al. 1993b, Hytönen et al. 2004, 
Hytönen et al. 2005a, Helppolainen et al. 2008, Meir et al. 2009, Määttä et al. 2009,  
Takakura et al. 2009), have offered a reliable general view of the biotin-binding site 
and taught us how to modify these proteins to meet the needs of biotechnology. 
Although BBP-A is biochemically and structurally clearly distinguishable from 
chicken avidin and the AVRs, its biotin-binding mode is highly similar to that 
observed for the known structures. The rational mutagenesis of avidins benefits 
from the solved structure of BBP-A. Sequence comparison could be used as a guide 
to mutate amino acids in other avidins and thereby change their properties. For 
example pI could be changed without unwanted changes to secondary or tertiary 
structures (Marttila et al. 1998). The potential of such an approach has also been 
shown with the putative avidin-like protein from the sea urchin – fibropellin – and 
streptavidin (Pazy et al. 2001). Switching  tryptophan 110 in avidin or 120 in 
streptavidin to lysine, according to the fibropellin sequence, reduced the affinities of 
both avidin and streptavid towards biotin and led to the dissociation of their 
tetrameric structures into stable dimers (Laitinen et al. 1999). Later it was found that 
in avidin the Trp110Lys mutation combined with the Asn54Ala mutation weakend 
the bonding of interfaces between subunits and resulted in the dominance of the 
monomeric form of the protein (Laitinen et al. 2001). 
Rational mutagenesis has uncovered the nature of the biotin-binding process of 
streptavidin and avidin. Dozens of streptavidin and avidin mutants have been made 
as reviewed by our group (Laitinen et al. 2006). Together with the known crystal 
structures and molecular modelling, it is now possible to design new avidins with 
tailored binding properties. One target of the present study was to develop an avidin 
with increased HABA-affinity. To achieve this, we used crystallographic structures 
to design an optimized binding pocket. The known crystal structure (Livnah et al. 
1993a) and the existing potential of HABA in labelling applications (Hofstetter et al. 
2000) encouraged us to try whether the affinity of HABA to avidin could be 
increased over BTN. As the result, cpAVD4ĺ3(N118M), which has a loop missing 
between ȕ strands 3 and 4 and one point mutation resulting in a more optimal 
HABA interaction, binds HABA tighter than any known avidin protein. Preliminary 
results from random mutagenesis experiments have also shown that further 
mutagenesis of threonine 77 to aspartate could have a positive effect on HABA 
binding (Määttä et al. unpublished results). We have also tried to find better HABA 
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binders using a phage display method of random mutagenesis in particular sites or 
even in entire loop regions (Paldanius et al., unpublished). Our final aim is to 
develop, using either rational or random mutagenesis, an avidin that binds HABA 
over BTN. This “proof of principle” could be then expanded to develop avidins, 
with specificity to all kinds of molecules. Moreover, specific binding properties 
could then be combined into dual chain or single chain avidin scaffolds (Nordlund et 
al. 2004, Hytönen et al. 2005, Nordlund et al. 2005b) to produce multifunctional 
avidins. A previous study (Hytönen et al. 2005) already showed that the dual affinity 
dual chain avidin, which has two tight and two reversible biotin-binding sites, could 
be used for the affinity purification of biotinylated enzymes. Other new possibilities 
in avidin-biotin technology are novel bioseparation tools (Bayer, Wilchek 1990), 
carrier proteins (Holmberg et al. 2005), or nanoscale adapters as demonstrated by 
Zhen et al. (2004). 
Circular permutation has been used to modify avidin and streptavidin (Chu et al. 
1998, Nordlund et al. 2004, Hytönen et al. 2005b, Nordlund et al. 2005). For 
example in avidin, circular permutation has been used to cleave the loops between 
ȕ-strands L3,4; L4,5; and L5,6. This method allows the design of versatile novel 
avidins. In the future, circular permutation will be used to study how other loop 
regions affect the binding properties of avidin and whether they could be made to 
bind different kinds of small molecules.  
The known structures of avidin and AVR4 did give us hints on what the 
ChiAVD(I117Y) might look like. The X-ray structure of ChiAVD(I117Y) showed 
that beta strand 4 and the surrounding loops were more compactly folded in 
ChiAVD(I117Y) than in wt avidin. A more compact structure means that the loops 
of the protein are less exposed to the surroundings, which is one possible reason for 
the increased thermostability (Thompson, Eisenberg 1999). Other reasons, which 
commonly appear to have effect on the thermostability of proteins, are interactions 
in the interface area and between aromatic pairs (Serrano, Bycroft & Fersht 1991, 
Clackson, Wells 1995, Hu et al. 2000, DeLano 2002). Indeed, the successful 
mutation of I117Y on the subunit interface had a positive outcome on the 
thermostability of the chimeric avidin protein, and from the X-ray structure it could 
be seen that two tyrosines 117s from neighbouring subunits form a stabilizing ʌ – ʌ 
interaction as presented in figure 22. In spite of this, the reason for the higher 
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thermostability of ChiAVD(I117Y) as compared to AVR4 remains somewhat 
unclear. 
 In the future we would like to evaluate the potential of ChiAVD(I117Y) in life 
science applications. The successful pilot-scale fermentation proved that 
ChiAVD(I117Y) is also suitable for industry-scale production and ongoing studies 
of ChiAVD(I117Y) imply that it could be a industrially valuable new tool in avidin-
biotin technology. By now we have already produced several modified forms of 
ChiAVD(I117Y), for example one which enables us to link it to surfaces via the 
cysteine in its C-terminus (Määttä et al. unpublished results) and another which has 
a cysteine in the bottom of the binding pocket in order to form a covalent bond with 
the ligand (Leppiniemi et al. unpublished results). Moreover, a cysteine bridged 
form, ChiAVD(I117C), has also been produced (Hytönen and Nordlund, 
unpublished).  In the future phage display will probably offer new ligand-binding 
motifs (Paldanius et al. unpublished results) that could be combined with the strong 
structure of ChiAVD(I117Y) and applied to diagnostic methods. Another series of 
ongoing experiments are related to BBP-A, which has been used as source material 
for the development of DNA libraries of recombined biotin-binding proteins 
(Niederhauser et al. unpublished). 
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7. Summary and conclusion 
This thesis describes the structure function relationships of two novel avidins and 
one novel avidin-like protein. First we designed chimeric avidin, which is a 
combination of the avidin related protein 4 (AVR4) and wild type avidin. The part 
taken from AVR4 covers ȕ-strand 4 and parts of its surrounding loops and one 
mutated amino acid residue, isoleucine 117. The X-ray structure of chimeric avidin 
resembles that of wt avidin and AVR4 – all three are homotetrameric proteins, 
which have two cysteine residues in each subunit that form a disulphide bridge 
inside the subunits. The ligand binding properties of chimeric avidin also resemble 
those of the parent proteins. However, it came as a surprise to us that chimeric 
avidin is clearly more thermalstable than either parent. We found that the thermal 
stability correlates with stability against many organic solvents, and therefore, 
chimeric avidin is the most durable avidin protein developed so far. Thus, due to its 
high biotin affinity and good stability in harsh conditions we are now studying 
whether chimeric avidin could be used in novel applications.  
The second avidin protein was circularly permutated avidin, cpAVD4o3. Its 
original terminuses were connected with a small polypeptide linker and new 
terminuses were placed after and before the loop region between E-strands 3 and 4. 
Because cpAVD4o3 lacks the L3,4-loop, its biotin binding affinity was reduced 
significantly and HABA binding affinity became better when compared to wt 
avidin. Through the additional point mutation Asn118Met we were successfully able 
to further reduce biotin binding affinity with one magnitude and increase HABA 
binding affinity five-fold. The X-ray structure and binding properties of 
cpAVD4o3(N118M) provided us with useful information about the structure-
function relationship of the L3,4 loop. Furthermore, we combined the cpAVD4o3 
and the wt avidin-like binding subunit cpAVD5ĺ4 in a dual-chain avidin called 
dcAVD2. Only one dual affinity avidin has been produced before, and therefore, 
dcAVD2 is a valuable addition to the dual chain avidin protein family, which has 
potential use in self-assembly nanotechnology applications. 
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Structures and binding properties of new avidin-like proteins have expanded our 
knowledge of the significance of individual amino acid residues for the biotin-
binding affinity. The novel biotin-binding protein A (BBP-A) is an interesting 
adition to the growing family of avidin-like proteins. X-ray structures with D-biotin 
and D-biotin D-sulfoxide (BSO) revealed that BBP-A shares a structural fold with 
the avidin protein family. BBP-A binds free biotin with high affinity, but 
interestingly it binds D-biotin D-sulfoxide with even higher affinity. The high 
affinity towards BSO may have use in biotechnological applications. 
In conclusion, this work presents the characterization of three novel proteins: 
ChiAVD(I117Y), cpAVD4o3(N118M) and BBP-A. They all are new members of 
the avidin protein family, and provide novel information on the expression, binding 
properties, biochemical properties and structure-function relationships of avidins. 
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The chicken avidin gene family consists of avidin and
seven separate avidin-related genes (AVRs) 1–7. Avidin
protein is a widely used biochemical tool, whereas the
other family members have only recently been produced
as recombinant proteins and characterized. In our pre-
vious study, AVR4 was found to be the most stable biotin
binding protein thus far characterized (Tm  106.4 °C).
In this study, we studied further the biotin-binding
properties of AVR4. A decrease in the energy barrier
between the biotin-bound and unbound state of AVR4
was observed when compared with that of avidin. The
high resolution structure of AVR4 facilitated compari-
son of the structural details of avidin and AVR4. In the
present study, we used the information obtained from
these comparative studies to transfer the stability and
functional properties of AVR4 to avidin. A chimeric av-
idin protein, ChiAVD, containing a 21-amino acid seg-
ment of AVR4 was found to be significantly more stable
(Tm  96.5 °C) than native avidin (Tm  83.5 °C), and its
biotin-binding properties resembled those of AVR4. Op-
timization of a crucial subunit interface of avidin by an
AVR4-inspired point mutation, I117Y, significantly in-
creased the thermostability of the avidin mutant (Tm 
97.5 °C) without compromising its high biotin-binding
properties. By combining these two modifications, a hy-
perthermostable ChiAVD(I117Y) was constructed (Tm 
111.1 °C). This study provides an example of rational
protein engineering in which another member of the
protein family has been utilized as a source in the opti-
mization of selected properties.
Avidin is a homotetrameric glycoprotein isolated from
chicken egg white. Each eight-stranded -barrel subunit of
avidin consists of 128 amino acids and has one ligand-binding
site. Avidin, like its bacterial analogue streptavidin from Strep-
tomyces avidinii, is able to form a tight and specific complex
with a water-soluble vitamin, d-biotin (Kd  10
15 M) (1, 2).
This special property of avidin together with its tetrameric
nature and high stability have made it one of the most widely
exploited protein tools in the life sciences across a range of
biochemical, pharmaceutical, and biophysical applications (3, 4).
The avidin gene family consists of avidin and seven avidin-
related genes (AVRs) (5). Although avidin protein is expressed
in various tissues (6), the other members of the gene family so
far have not been found in the form of proteins in the chicken.
However, mRNA molecules of some AVRs are detected because
of inflammatory reaction (7). To study their functional and
structural properties, AVR proteins were recently produced by
a baculovirus insect cell expression system (8). Avidin and AVR41
are80% identical in amino acid sequence, and almost all of the
residues involved in biotin binding in avidin are conserved in
AVR4. It was found that recombinant AVR4 bound biotin
almost as tightly (Kd  3.6  10
14 M) as avidin (Kd  1.1 
1016 M). However, it was shown to be significantly more
thermostable (Tm  106.4 °C) than avidin (Tm  83.5 °C) (9).
It has been proposed that protein oligomerization in nature
serves to obtain more stable structures (10, 11). In addition,
stable proteins tend to have only a few intrinsic water clefts in
their structures (12, 13). Moreover, the role of ionic bonds in
establishing the high thermal stability of proteins has been
studied by Szila´gyi and Za´vodszky (14), who performed a sta-
tistical analysis of high quality protein structures obtained
from mesophilic and thermophilic organisms. They observed a
correlation between the number of ion pairs and growth tem-
perature of the organism and hypothesized that ion pairs have
structural importance especially at high temperatures. The
ionic bonds found in thermostable proteins have successfully
been transferred to their analogues from mesophilic organisms
to stabilize them (15). The importance of aromatic pairs in
thermostable proteins has also been noticed (16), and these
pairs have successfully been transferred between proteins to
improve the thermal stability (17).
In this study, we compared the structures of avidin and
AVR4. Our aim was to determine the importance of the differ-
ences in the primary and three-dimensional structures2 of
* This work was supported by the ISB (National Graduate School in
Informational and Structural Biology) and by a grant from the Academy
of Finland. The costs of publication of this article were defrayed in part
by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
§ Present address: Institute of Medical Technology, University of
Tampere, FIN-33014 Tampere, Finland.
§§ To whom correspondence should be addressed. Tel.: 358-3-
2158499; Fax: 358-3-2157710; E-mail: markku.kulomaa@uta.fi.
1 The abbreviations used are: AVR4, Avidin-related protein en-
coded by genes AVR4/5 bearing mutation C122S; DSC, differential
scanning calorimeter.
2 Eisenberg-Domovich, Y., Hyto¨nen, V. P., Wilchek, M., Bayer, E. A.,
Kulomaa, M. S., and Linvah, O. (2005) Acta Crystallog. Sect. D. Biol.
Crystallog., in press.
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these proteins for their biotin-binding and stability properties
(9). On the basis of the results, we first engineered a chimeric
avidin, in which -strand 4 and its adjacent loops were replaced
by the corresponding region from AVR4. In another mutant, a
point mutation (I117Y) was introduced into avidin from the
AVR4 sequence. Furthermore, we combined this mutation to
the chimeric avidin also. The analysis of these new forms of
avidin yields novel knowledge about the avidin protein family
and in general provides an insight into how to improve the
stability of proteins by combining characteristics from their
known analogues.
EXPERIMENTAL PROCEDURES
Mutagenesis of Avidin and the Purification of Expressed Recombi-
nant Proteins—AVR4/5(C122S) was previously found to have properties
similar with the wild type protein but lacking the tendency to form
higher order oligomers (9). In this article, term AVR4 denotes the
C122S mutant of identical proteins coded by the genes AVR4 and AVR5.
Site-directed mutagenesis of avidin encoding cDNA was performed
by using the QuikChange (Stratagene, La Jolla, CA) method of mu-
tagenesis. DNA encoding chimeric ChiAVD protein was produced by
three sequential PCR reactions in which the final product was obtained
from partially overlapping megaprimer (18) products. The final product
was then cloned to the pFASTBAC1 vector. Recombinant baculoviruses
coding for ChiAVD forms, AVR4 and AVD(I117Y), were generated as
instructed by the manufacturer of the Bac-To-Bac™ system (Invitro-
gen). Proteins were produced in baculovirus-infected Sf9 insect cells in
biotin-free medium as reported earlier (8). AVR4 was also produced in
Escherichia coli as previously reported (named AVR4-6) (19), exploiting
the bacterial signal peptide from Bordetella avium OmpA protein. The
proteins were then purified by affinity chromatography using 2-imino-
biotin-agarose, as described previously (20). The protein forms are
summarized in Table I.
Proteinase K Assay—The proteolytic resistance of the proteins was
studied using proteolysis by proteinase K as described previously (8). A
protein sample (4 g) was incubated in the presence of proteinase K
(1:25, w/w) at 37 °C for a predetermined time period, denatured by
boiling in sample buffer (SDS, 2-mercaptoethanol), and subjected to
SDS-PAGE followed by Coomassie Blue staining.
Gel Filtration Analysis—The oligomeric state of the proteins was
assayed with fast protein liquid chromatography gel filtration as de-
scribed previously (9). Sodium carbonate buffer (50 mM, pH 11) with 150
mM NaCl was used as the liquid phase. Protein samples of 5–10 g were
used in the analysis.
Optical Biosensor Studies—The biotin-binding characteristics of the
different avidins were studied by a surface plasmon resonance optical
biosensor (IAsys). The binding affinities to a fully 2-iminobiotin-covered
surface in 50 mM borate buffer (pH 9.5, 1 M NaCl) were measured as
reported previously (8).
Radiobiotin Dissociation Assay—The dissociation rate of [3H]biotin
from avidin, AVR4, and the avidin mutants was determined as de-
scribed in Ref. 21 at various temperatures. The activation thermody-
namic parameters for AVR4 and avidin were determined by analysis of
the dependence of the dissociation rate upon temperature using the
global fit of all data as described in Ref. 22.
Fluorescent Biotin Dissociation Assay—The binding of labeled biotin
to avidins was analyzed by a method based on the quenching of a
biotin-coupled fluorescent probe ArcDiaTM BF560 (ArcDia Ltd., Turku,
Finland) caused by binding to avidin as described previously (19). The
measurements were performed using a PerkinElmer Life Sciences LS55
luminometer with thermostated cuvette (25 or 50 °C). The signal meas-
ured for 3600 s (25 °C) or 2400 s (50 °C) after the addition of a 100-fold
amount of unlabeled biotin (5 M) was used to determine the dissocia-
tion rate constant.
Differential Scanning Calorimetry—The transition midpoint of the
heat denaturation (Tm) of the avidin proteins was studied using a
Calorimetry Sciences Corporation Nano II DSC as in previous reports
(23, 24). Proteins (0.5 mg/ml) were analyzed both in the absence and
presence of biotin (3:1 molar ratio, biotin:avidin monomer).
Microplate Assay—The inactivation of the proteins during heat treat-
ment was analyzed by using a microplate assay (24). The proteins were
heated to 99.9 °C in 50 mM phosphate buffer containing 100 mM NaCl
(pH 7.0) for 32 min. The remaining activity was probed by measuring
the ability of the proteins to bind biotinylated alkaline phosphatase by
coating the microplate wells with samples of the heated proteins.
RESULTS
Sequence Analysis—The sequence identity between avidin
and AVR4 is 77.8%. 15 of 28 differences between these two
proteins are found on the relatively short amino acid segment
between the end of 3 and the beginning of 5 (23 residues in
avidin and 21 residues in AVR4, Fig. 1). All residues showing
contact with biotin (25) are conserved, excluding the Thr38-
Ala39-Thr40-sequence located in the L3,4 loop (connecting 3
and 4 strands), which is replaced by Ala38-Asp39-Asn40 in
AVR4. Subunit interface residues (41 residues) (9) are also well
conserved with the only amino acid differences being T38A,
A39D, H50L, T52I, N54H, and I117Y (numbering according to
avidin sequence).
Expression and Purification of Recombinant Proteins—To
study the significance of the differing segment between 3 and
5, a ChiAVD was constructed in which this segment was
transferred from AVR4 to avidin. Furthermore, we mutated
isoleucine 117 in avidin to tyrosine according to AVR4 (Fig. 1).
The mutagenesis work was first planned using information
obtained from the primary sequence analysis, known three-
dimensional structure of avidin, and homology modeling. Dur-
ing the work, the determination of the structure of AVR42
confirmed the selected rationale. The mutated avidins were
produced using a baculovirus expression system (8). Non-gly-
cosylated AVR4-b was produced using the E. coli expression
system (19)3 to study the influence of the carbohydrate chains
on the properties of the protein (Table I). Avidin proteins were
purified effectively by 2-iminobiotin-agarose affinity chroma-
tography. Isolated proteins showed high purity in SDS-PAGE
analysis (Fig. 2). The glycosylation patterns of the purified
proteins differed because AVR4 has three potential glycosyla-
3 Laitinen, O. H., Airenne, K. J., Hyto¨nen, V. P., Peltomaa, E.,
Ma¨ho¨nen, A., Wirth, T., Lind, M. M., Ma¨kela¨, K. A., Toivanen, P. I.,
Schenkwein, D., Heikara, T., Nordlund, H. R., Kulomaa, M. S., and
Yla¨-Herttualo, S. (2005) Nucleic Acids Res., in press.
FIG. 1. A, Needleman-Wunsch alignment of chicken avidin and AVR4. The identity of the proteins is 77.8%. The area covering -strand 4 and
parts of its surrounding loops are boxed as is the mutated amino acid residue Ile117. The alignment was made using MALIGN (38). B, topology
diagram of the chimeric protein. The segments taken from avidin are shown in black, and the part inserted from AVR4 is shown in gray. The
boundaries between these segments are highlighted by white arrows.
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tion sites, whereas avidin has only one (1, 8). One of these sites
(Asn43) of AVR4 was transferred to the chimeric protein, re-
sulting in more extensive glycosylation of the chimera when
compared with that of native avidin. Bacterially produced
AVR4-b was non-glycosylated as expected (Fig. 2).
Fast Protein Liquid Chromatography Gel Filtration—All the
engineered proteins showed tetrameric appearance when sub-
jected to gel filtration analysis. Bacterially produced AVR4
showed a slightly lower apparent molecular weight as com-
pared with the other proteins, as expected, because of the lack
of the carbohydrate moiety (Table II).
Proteinase K Assay—Avidin and avidin mutant AVD(I117Y)
were found to be 50% digested after treatment for 16 h with
proteinase K (Fig. 3). When these proteins were saturated with
biotin before treatment, no cleavage was observed. AVR4,
ChiAVD, ChiAVD(I117Y), and AVR4-b, however, displayed to-
tal resistance to the proteolytic activity of proteinase K even
without biotin. This indicates that the conformation of L3,4 of
the AVR4 apoprotein2 protects it from digestion because there
are putative cleavage sites for proteinase K close to the known
cleavage sites in avidin (26) in the primary sequence (data not
shown). Furthermore, glycosylation in residue Asn43 (9) did not
seem to play a role in the protease resistance.
Differential Scanning Calorimetry—In the DSC experi-
ments the ChiAVD protein and AVD(I117Y) showed signifi-
cantly better thermal stability than avidin both as apoforms
and holoforms (Table II). When these modifications were
combined, the resultant ChiAVD(I117Y) was found to be even
more stable than AVR4. In all cases holoforms were clearly
more stable than apoforms. We observed a significant in-
crease in the unfolding enthalpy with an increasing melting
temperature. AVR4-b showed similar behavior as compared
with the protein produced in insect cells in the DSC analysis,
but the determined H of the unfolding was significantly
lower, possibly reflecting the role of glycosylation moieties in
the unfolding process (37).
Microplate Assay—The inactivation of the proteins during
heat treatment was microplate-assayed as in our previous
study (24). The remaining activity after treatment for 32 min is
shown in Table II. These results are in line with DSC analyses
showing that ChiAVD(I117Y) is the most thermally stable of
the proteins characterized.
Biotin-binding Analyses—The binding kinetics of the fluo-
rescent biotin conjugate BF560 to different avidins were com-
pared by measuring the dissociation rate constants at 25 °C
and 50 °C (Table IV). Avidin showed a lower dissociation rate
when compared with AVR4. ChiAVD showed characteristics
similar to AVR4 in this assay, i.e. faster dissociation at 50 °C.
Interestingly, mutation Ile117Tyr seemed to tighten the bind-
ing of the biotin conjugate to avidin.
Ligand-binding analyses done with an IAsys optical biosen-
sor showed a slightly decreased affinity to the 2-iminobiotin
surface in the case of ChiAVD as compared with avidin (Table
III). However, the affinity was nonetheless high resembling the
values found for AVR4 (9). We also observed a slight decrease
in the association rate constants of both ChiAVD forms as
compared with avidin and AVD(I117Y). The surface used in
this assay was fully 2-iminobiotinylated and therefore did not
exclude multiple binding events.
AVR4 showed long lived biotin binding in the radiobiotin
dissociation assay (Fig. 4). However, the measured dissociation
rate constants were significantly higher than those of avidin.
ChiAVD and ChiAVD(I117Y) resembled AVR4 in this assay.
Interestingly, bacterial AVR4-b showed a slightly slower dis-
sociation rate in this assay than AVR4 produced in insect cells.
Avidin mutant AVD(I117Y) showed very slow, avidin-like bio-
tin dissociation. The activation thermodynamic parameters
were calculated from the data as described elsewhere (22) and
combined with the thermodynamic parameters obtained for
AVR4 and avidin in a previous study (9). The values obtained
are shown in Fig. 5. The analysis indicates the increase in both
in the transition state and bound state free energies of AVR4
relative to those of avidin.
Three-dimensional Structure Analysis—The information ob-
tained from the avidin (25) and AVR42 x-ray structures sug-
gests that the substitution of 4 and its adjacent L3,4 and L4,5
loops from AVR4 to avidin cause no crucial change in the
overall shape of the resulting protein. The different conforma-
tion of the L3,4 loop of AVR4 (Fig. 6) when compared with that
of avidin should be analogously reflected in the properties of
ChiAVD, namely in a lower number of hydrogen bonds to the
bound ligand (avidin, 11 hydrogen bonds; AVR4, 8 hydrogen
bonds).2 Furthermore, the interchanged sequence includes the
two-residue deletion in loop L4,5, which was observed not to
change the structural properties of the surrounding region of
the loop in AVR4.2
DISCUSSION
In the present study we sought to clarify the features that
make AVR4 a so much more thermostable protein than chicken
avidin (9) and to transfer this higher stability to avidin. An-
other objective of the study was to explore and compare the
biotin-binding properties of avidin, AVR4, and the chimeric
proteins produced in this study. To accomplish the first objec-
tive, molecular modeling and the solved three-dimensional
structure of avidin were utilized, and the results used to trans-
TABLE I
Description of proteins analyzed in this study
Protein Modifications Source
AVD Chickena
AVD(I117Y) Mutation I117Y in 1–3 subunit interface. BEVSb
ChiAVD Residues 38–58 moved from AVR4 to avidin. BEVSb
ChiAVD(I117Y) Residues 38–58 moved from AVR4 to avidin and mutation I117Y in 1–3 subunit interface. BEVSb
AVR4 Cysteine residue forming intermonomeric disulphide bridges in AVR4 mutated to serine. BEVSb
AVR4-b As above but non-glycosylated. E. colic
a Chicken avidin obtained from S. A. Belovo (Bastogne, Belgium).
b Recombinant protein produced by baculovirus expression vector system in insect cells.
c Recombinant protein produced by bacterial expression system. This form contains three additional residues (Gln-Thr-Val) in the N terminus
from the bacterial signal peptide (19).
FIG. 2. SDS-PAGE analysis of the purified proteins. A, avidin; Y,
AVD(I117Y); C, ChiAVD; CY, ChiAVD(I117Y); 4, AVR4; 4b, AVR4-b
produced in bacteria. The marker proteins (M) with molecular masses
of 14.4, 21.5, and 31 kDa are shown in figure. The multiple bands are
caused by N-linked glycosylation occurring in insect cells (9).
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fer the stabilizing elements from AVR4 to avidin. On the basis
of the sequence comparison made between avidin and AVR4,
the highly variable segment between the two proteins is located
between L3,4 and L4,5 (Fig. 1). Thus, our initial approach was
to substitute this segment in avidin for the corresponding se-
quence in AVR4. Another substitution (I117Y) was made on the
basis of the modeling (9) This mutation rationale was later
confirmed when the three-dimensional x-ray structure of AVR4
came available during the present study,2 which was thought
to play an important role in the intersubunit interactions and
thus contribute to the thermal stability of AVR4 (Table I).
As expected, a significantly more stable protein was obtained
when a segment 21 amino acids long (residues 38–58) taken
from AVR4 was transferred to avidin, replacing a 23-residue
segment. The shortening of the L4,5 loop by two residues in
ChiAVD avidin may provide a partial explanation for the
higher stability. By comparing genomes of mesophiles, thermo-
philes, and extremophiles, Thompson and Eisenberg (27) found
shorter exposed loops in temperature-resistant proteins when
compared with those of their mesophilic analogues. The L3,4
loop, however has the same length in avidin and AVR4, yet its
amino acid composition is very different (Fig. 1). The three-
dimensional structure of L3,4 clearly shows that it has a dif-
ferent conformation in AVR4 than in avidin (Fig. 6).2 We as-
sume that ChiAVD and AVR4 share a similar L3,4 loop
conformation. The presence of the Pro41-Gly42 stretch and the
salt bridge between Asp39 and Arg112 induces stability in the
L3,4 loop in both the apo and biotin complex forms.2
The importance of certain stability “hot spot” residues in
protein interfaces has been reported (28–30). Aromatic pairs
are known to form stabilizing pairs in protein structures,
which have also been studied experimentally (17). In the
present study, we were able to optimize the subunit interface
of avidin by replacing the Ile117 residue with tyrosine accord-
ing to the AVR4 sequence. The previous modeling analysis (9)
suggested that tyrosine in this location likely contributes to
stability of the AVR4 tetramer as compared with that of
avidin. The three-dimensional structure of AVR4 indicates
the presence of - stacking between two tyrosine residues
from neighboring monomers,2 and experimental data support
the improved stability caused by interactions at this site
(AVD(I117Y), Tm  97.5 °C; avidin, Tm  83.5 °C). Kannan
and Vishveshwara (16) compared the aromatic clusters in
proteins from thermophilic and mesophilic organisms. They
found that residues comprising aromatic clusters in proteins
from thermophiles are preferably replaced by Leu or Ile in
proteins from mesophilic organisms.
Regarding stability, the most interesting result was that
combination of the chimera approach and the I117Y point
mutation produced a protein that was even more thermostable
than AVR4; the sum is greater than the parts. This indicates
that we have successfully recognized and transferred the struc-
tural factors that account for the difference in stability between
avidin and AVR4. It has been proposed earlier that recombi-
nation inside the avidin gene family is a frequent event (31).
Our results indicate that such recombination might produce
functional chimeric proteins inside the gene family because
building blocks moved from AVR4 seem to be able to function
as part of the avidin structure without negative implications.
We found that AVR4 binds biotin almost as tightly as avidin.
TABLE II
Structural properties of avidins
Fast protein liquid chromatography gel filtration elution times and calculated molecular weights of the proteins. Heat-induced unfolding of
proteins determined by DSC (average  S.D).
Protein
Gel filtration DSCa Microplateassay
Elution time Molecular mass Tm(biotin) Tm(biotin) Tm
b Ha Activityd
min kDa °C °C °C kJ/mol %
AVD 29.3 53.1 83.5  0.1 117.0  0.7 33.5 329  5 4
AVD(I117Y) 29.6 49.5 97.5  0.4 123.7  0.1 26.2 536  6 47
ChiAVD 29.0 56.9 96.5  0.2 124.4  0.2 27.9 527  10 47
ChiAVD(I117Y) 29.0 56.9 111.1  0.2 130e 19 659  38 98
AVR4 29.5 50.6 106.4  0.8 125.4  0.8 19.5 575  33 72
AVR4-b 30.3 42.1 109.9 127.1 17.2 460 56
a The results of AVD and AVR4 are from Ref. 9.
b Tm is the change in Tm upon the addition of a 3-fold molar excess of biotin.
c H value obtained from sample without biotin. The value could not be determined accurately from samples saturated with biotin because the
Tm values were too close to the temperature limit of the DSC instrument.
d Biotin-binding activity after 32 min of treatment at 99.9 °C.
e Could not be determined accurately due to the upper limit of temperature of the DSC instrument.
FIG. 3. SDS-PAGE analysis of protein samples incubated with proteinase K. The arrow shows the location of digested protein forms. The
samples marked with “c” are control samples without protease treatment. A, avidin  proteinase K; Y, AVD(I117Y); 4, AVR4; C, ChiAVD; CY,
ChiAVD(I117Y); 4b, AVR4-b. The marker proteins (M) with molecular weights of 14.4 and 21.5 are shown in figure.
TABLE III
2-Iminobiotin-binding properties of proteins
determined by IAsys optical biosensor
Iminobiotin-binding properties of the proteins analysed by an IAsys
optical biosensor at 20 °C. Affinities to 2-iminobiotin surface are deter-
mined from the equilibrium response data.
Kd
a kass
M M
1 s1
AVD (2.1  0.6)  108 (2.6  0.2)  104
AVD(I117Y) (6.3  1.2)  108 (2.3  0.3)  104
ChiAVD (1.1  0.4)  107 (1.7  0.1)  104
ChiAVD(I117Y) (6.7  1.2)  108 (1.6  0.2)  104
AVR4 (1.4  0.4)  107 (9.3  0.4)  103
a Apparent dissociation constant calculated from equilibrium values.
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The analysis of the [3H]biotin dissociation data measured at
different temperatures revealed that the energy barrier be-
tween unbound and bound states in AVR4 is somewhat smaller
than in avidin (Fig. 5). The higher free energy of the transition
state might also explain the slower association rate to the
2-iminobiotin surface of AVR4 as compared with avidin (Fig. 5,
Table III). Because the free energy of the binding is lower in the
case of AVR4 (9), the biotin dissociation barrier is still lower for
AVR4 despite the higher transition state free energy. A poten-
tial explanation for the differences in biotin-binding character-
istics between AVR4 and avidin lies in the differences in the
L3,4 loop. This region has been found to be an important factor
in biotin binding to streptavidin (32). Both the ChiAVD forms
showed biotin-binding properties similar to those of AVR4
when measured by various methods, therefore supporting this
hypothesis. We found that glycosylation may play a minor role
in biotin binding because AVR4-b produced in bacteria showed
slightly slower dissociation rates in both the radiobiotin and
fluorescent biotin dissociation analyses (Fig. 4, Table IV).
The dissociation rates observed in the fluorescent biotin as-
say were significantly faster than those obtained from the
radiobiotin analysis, but the proteins nevertheless showed sim-
ilar trend in relative characteristics (Table IV). Proteins bear-
ing 4 and its adjacent loops from AVR4 showed a higher
dissociation rate constants when compared with avidin. The
difference in radiobiotin analysis was 6-fold at 50 °C (Fig. 4),
and the fluorescent BF560-biotin showed 3-fold higher disso-
ciation rate constant at 50 °C (Table IV). Therefore, the differ-
FIG. 5. Reaction thermodynamic coordinates for biotin bind-
ing to avidin and AVR4. The activation energy of dissociation ob-
tained from the Eyring equation fitted to the dissociation data were
used to calculate the transition state energy (G‡) for the reaction,
using the total binding energy values (G) previously determined for
binding (9).
FIG. 6. Tube representation of the superposition of the avidin
(magenta) and AVR4 (cyan) in the L3,4 loop region with biotin
molecules in the binding site for reference. The side chains of
residues 39–42 are shown for AVR4 and indicate the kink in the loop
induced by the Pro-Gly tandem. Although the L3,4 loops in both pro-
teins are of the same size, they adopt an entirely different conformation.
The closed conformation of L3,4 in the AVR4 is apparent in both the apo
and biotin complex forms. The figure was constructed using MIDAS
(39).
TABLE IV
Biotin conjugate dissociation kinetics
Dissociation rate constants measured for biotin-BF560 conjugate by a
spectrofluorometer at 25 °C and at 50 °C. The total releases of the probe
after measurement for 1 h are also shown.
kdiss (25 °C)
Release 1 h
(25 °C) kdiss (50 °C)
Release 1 h
(50 °C)
105 s1 % 104 s1 %
AVD 2.04 10.7 2.74 71.5
AVD(I117Y) 0.81 3.0 1.61 56.5
ChiAVD 1.76 13.1 8.00 93.9
ChiAVD(I117Y) 1.94 9.5 7.33 94.8
AVR4 2.77 12.5 7.88 93.7
AVR4-b 2.31 10.9 6.20 88.3
FIG. 4. Radiobiotin dissociation
rate constants measured for the pro-
teins as a function of temperature.
The models for dissociation rate constants
obtained by global fit analysis are shown
by lines and the determined individual
dissociation rates by symbols.
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ences in the structure of the L3,4 between AVR4 and avidin
could explain this minor change in the binding properties of
conjugated biotin relative to free biotin (Fig. 6).2 Notably, the
stabilizing mutation I117Y decreased the dissociation rate of
the fluorescent biotin conjugate from avidin. This may indicate
that the biotin dissociation event is at least partially deter-
mined by the tetrameric integrity of avidin. Although the bind-
ing of biotin to avidin is non-cooperative (for a review, see Ref.
1), the neighboring subunit is important for the structure (25)
and function (33, 34) of the binding site. Therefore, the stabi-
lization of the tetramer can enhance the binding of biotin
conjugate in certain conditions. We have previously noticed the
importance of movement of water associated with biotin disso-
ciation from streptavidin (35). Because the residue 117 lies in
this region in avidin, the change in the local environment
caused by the mutation I117Y may also reflect to the molecular
events linked with biotin movement.
Proteinase K cleaves avidin in only one region in the loop
between -strands 3 and 4 (26). It was also found that biotin
efficiently inhibits the cleavage. On the other hand, AVR4 and
streptavidin are resistant to cleavage by proteinase K even
without bound biotin (9, 34). Because proteinase K cleaves a
variety of sequences, the explanation for the resistance to
cleavage might lie in the conformation of the L3,4 loop of AVR4.
The proteinase K resistance of ChiAVD supports these results
(Fig. 3). The different loop structure can be seen in the struc-
ture of AVR4 (Fig. 6).2 Proline in this loop seems to cause
bending in the middle of the loop. Accordingly, the correspond-
ing loop in streptavidin is three residues shorter (36) and may
not, therefore, be accessible to the protease. We did not observe
any difference between the glycosylated and non-glycosylated
form of AVR4 in this analysis; hence, the sugar moiety in this
loop in AVR4 cannot explain the resistance to the protease.
In conclusion, we were able to define two structural elements
that make AVR4 a notably more thermostable protein than
avidin. First, AVR4 has a better set of interface contacts
around position 115 (tyrosine-tyrosine) than avidin has in the
equivalent position (117, isoleucine-isoleucine). Second, the re-
gion between 3 and 5 seems, at least partially, to explain the
better stability properties of AVR4 when compared with those
of avidin. This segment might also cause the slight differences
observed in biotin-binding properties between avidin and
AVR4. The chimeras thus obtained will find a role in applica-
tions utilizing extreme conditions. For example, these proteins
can resist high temperatures used in PCR-based applications
utilizing biotinylated molecules and a biotin-binding protein,
and they can be used with crude cell extracts and other solu-
tions containing proteolytic enzymes.
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Abstract
Background: The chicken genome contains a BBP-A gene showing similar characteristics to avidin
family genes. In a previous study we reported that the BBP-A gene may encode a biotin-binding
protein due to the high sequence similarity with chicken avidin, especially at regions encoding
residues known to be located at the ligand-binding site of avidin.
Results: Here, we expand the repertoire of known macromolecular biotin binders by reporting a
novel biotin-binding protein A (BBP-A) from chicken. The BBP-A recombinant protein was
expressed using two different expression systems and purified with affinity chromatography,
biochemically characterized and two X-ray structures were solved – in complex with D-biotin
(BTN) and in complex with D-biotin D-sulfoxide (BSO). The BBP-A protein binds free biotin with
high, "streptavidin-like" affinity (Kd ~ 10-13 M), which is about 50 times lower than that of chicken
avidin. Surprisingly, the affinity of BBP-A for BSO is even higher than the affinity for BTN.
Furthermore, the solved structures of the BBP-A – BTN and BBP-A – BSO complexes, which share
the fold with the members of the avidin and lipocalin protein families, are extremely similar to each
other.
Conclusion: BBP-A is an avidin-like protein having a β-barrel fold and high affinity towards BTN.
However, BBP-A differs from the other known members of the avidin protein family in thermal
stability and immunological properties. BBP-A also has a unique ligand-binding property, the ability
to bind BTN and BSO at comparable affinities. BBP-A may have use as a novel material in, e.g.
modern bio(nano)technological applications.
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Several biotin-binding proteins have been characterized
from egg-laying vertebrates. The best known of these pro-
teins is chicken avidin (AVD) [1-4]. This tetrameric ~60
kDa egg-white protein, together with its bacterial
homologs streptavidin and bradavidin [5-7], has a fasci-
nating feature, the ability to bind a small water soluble
vitamin, D-biotin (BTN), with tremendous affinity (Kd ≈
10-15 M for AVD) [5]. The formation of the extraordinary
strong protein-ligand complex is a result of "perfect"
structural complementarity between the (strept)avidin
ligand-binding site and BTN [8,9], and optimized "pack-
ing" of the overall tertiary and quaternary structure, too
[5,10]. Although BTN is thought to be the natural ligand
of (strept)avidin, these proteins are known to bind natu-
rally-occurring as well as synthetic BTN analogous and
their derivatives, which include the biotechnologically
valuable 2-iminobiotin, 4'-hydroxyazobenzene-2-carbox-
ylic acid (HABA) and desthiobiotin (for a review, see
[1,5]). However, (strept)avidin has clearly weaker affinity
for ligands other than BTN. The biological role of AVD is
still partially unclear, but it has been postulated to func-
tion as an antimicrobial defence protein in chicken by
ensuring that no free biotin is present in egg white; a vita-
min required for the growth of bacteria [1]. Nevertheless,
it is the numerous bio(nano)technological applications,
where AVD's unique biotin-binding property has been
utilized, which have made AVD one of the most well-
known proteins.
In addition to AVD of chicken egg-white, other proteins
capable of binding BTN tightly, biotin-binding protein I
(BBP-I) [11-13] and II (BBP-II) [14,15] of chicken egg-
yolk, have been reported. Nothing is known about the
affinity of BBP-I/II for ligands other than BTN. Although
immunologically similar and having comparable N-ter-
minal sequences [15,16], BBP-I and BBP-II differ in their
thermal stability, BBP-I being more stable than BBP-II
[14]. The biological functions of the two BBP forms are
only partly resolved, but they are known to be synthesized
in the liver and believed to transport BTN via plasma to
the egg-yolk [14,16,17]. More specifically, it is believed
that BBP-I has a general role as a transport protein in hen
plasma, whereas BBP-II may be needed for the efficient
deposition of BTN into the yolk of maturating oocytes
[14].
There is a substantial evidence that the quaternary struc-
ture of BBP-I/II is tetrameric, but it is not clear whether the
tetramers are formed as a result of assembling four mon-
omers or if the tetramers result from limited proteolysis of
a single polypeptide containing all the binding sites
[13,16]. Evidence for the former hypothesis became avail-
able when the putative genes and cDNAs encoding the
BBP-I/II proteins were reported in 2005 by Niskanen and
co-workers [18]: the exon-intron structures of the BBP
genes [18], named as BBP-A and BBP-B, mimic those of
AVD and avidin-related genes (AVRs) [19-21] and they
encode proteins with a single ligand binding site per
polypeptide chain. It is worth mentioning that it is not yet
completely clear whether the BBP-A and BBP-B genes
really encode for either of the earlier characterized BBP-I
and BBP-II proteins; BBP-A in particular seems to encode
a novel protein, BBP-A, not characterized before [18].
In the present study, we show that the chicken BBP-A gene
encodes a functional homotetrameric protein. We report
two different X-ray structures of BBP-A, one in complex
with BTN and an other one in complex with D-biotin D-
sulfoxide (BSO), at 2.1 Å and 1.75 Å resolution, respec-
tively. To our knowledge, no other structures of any pro-
teins in complex with BSO have been reported before.
Using several biochemical methods, we show that BBP-A
binds BSO even tighter than BTN. A comparative study of
the ligand-binding and physicochemical properties of
BBP-A and AVD are presented together with data from
site-directed mutagenesis.
Results
Biochemical characterization of BBP-A
BBP-A, expressed both in E. coli (bBBP-A) and in insect
cells (iBBP-A), was isolated and purified using 2-iminobi-
otin affinity chromatography. A typical yield was 5 mg of
pure protein per one litre of culture medium for both
expression systems. The mutations A74S and T118F,
which were made in order to study the differences in the
molecular origin of the biotin-binding affinity and the
thermal stability of BBP-A as compared to chicken AVD,
had no significant effect on the protein yields. The iso-
lated proteins were shown to be over 95% pure using SDS-
PAGE analysis (data not shown). A molecular weight of
13999.0 Da was determined for the expressed bBBP-A
using mass spectrometry, and it matched the molecular
weight calculated from the expression construct.
The oligomeric state of bBBP-A, bBBP-A(A74S), bBBP-
A(T118F), iBBP-A, bAVD and wtAVD in solution was ana-
lysed using gel filtration chromatography. All of the pro-
teins eluted as single peaks in this analysis, demonstrating
the homogeneity of the samples. The apparent molecular
weights of iBBP-A (60.8 kDa) and wtAVD (62.5 kDa),
based on gel filtration analysis, corresponded well with
the theoretical molecular weights for their respective
tetramers. As expected, the proteins produced in bacterial
cells showed apparent molecular weights lower than the
corresponding proteins expressed in insect cells, at least
partially due to the absence of glycosylation (bBBP-A,
42.7 kDa and bAVD, 55.3 kDa). The mutations A74S and
T118F had no effect on the appearance of BBP-A in the gel
filtration analysis. Nor did the addition of BTN to thePage 2 of 20
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of the analysed proteins. This, together with the results
showing that BTN significantly stabilizes tetramers of
bBBP-A (see below; Table 1 and Figure 1), supports the
idea that the quaternary structure of bBBP-A is tetrameric,
an idea that is also supported by the crystal structures of
bBBP-A – BSO and bBBP-A – BTN (see below).
The amino acid sequence of BBP-A contains one putative
N-glycosylation site (Figure 2), which corresponds to an
N-glycosylation site known to be present and glycosylated
in AVD [1]. To see whether iBBP-A was also glycosylated,
the protein was treated with Endoglycosidase H and ana-
lysed on SDS-PAGE (Figure 3). After the deglycosylation
treatment, the iBBP-A protein had a molecular weight
comparable to that of bBBP-A, a molecular weight clearly
lower than the molecular weight of the untreated iBBP-A
sample. This result, together with the control data
(wtAVD), indicates that the N-glycosylation site of BBP-A
was indeed glycosylated in insect cells and the size of the
attached carbohydrate is comparable to that present on
wtAVD.
The immunological cross-reactivity of BBP-A and wtAVD
was studied with two polyclonal antibodies made against
chicken AVD (Figure 4). Neither of the antibodies did
cross-react with BBP-A in a Western blotting analysis. The
reactivity of both antibodies was significantly weaker with
iBBP-A (10 μg) than in the case of a 100-fold dilution of
wtAVD (0.1 μg). In dot-blot analysis, only one antibody,
the TdaVIII antibody, was used to test whether it detects
iBBP-A and bBBP-A. In agreement with the immunoblot
analysis, no or only negligible cross-reactivity was
observed.
Stability of the tetrameric assembly of BBP-A
The thermal stability of the tetrameric form of BBP-A was
analysed in the presence of 2-mercaptoethanol using an
SDS-PAGE-based method described in [22]. Both bBBP-A
and iBBP-A appeared mainly in monomeric forms on
SDS-PAGE gels already at room temperature in the
absence of BTN, whereas addition of BTN stabilised the
tetrameric form, which was stable until the temperature
was raised to 70°C (Table 1 and Figure 1). In the presence
of BTN, glycosylated iBBP-A had slightly better thermal
stability (Tr = 75°C) compared to bBBP-A (Tr = 70°C).
Both bBBP-A and iBBP-A were clearly more thermally
labile than wtAVD. The mutations A74S and T118F had
no significant effect on the stability of the tetrameric
forms of bBBP-A (Table 1, Figure 1).
Differential scanning calorimetry (DSC) was not applica-
ble to the bBBP-A forms in the absence of ligands, since a
clear, single denaturation temperature could not be meas-
ured for these proteins. For bBBP-A, two peaks at around
51°C and 68°C were obtained. In the presence of BTN,
however, the value of Tm was around 100°C for all bBBP-
A forms. These values are significantly lower in compari-
son to those measured for wtAVD (Table 1). Furthermore,
the thermal stability of bBBP-A and AVD was analysed in
the presence of BSO and D-biotin sulfone (Table 2). Only
negligible differences were, however, found between the
effects of these two ligands and BTN on the thermal stabil-
ities of bBBP-A and AVD.
The overall X-ray structures of BBP-A
The crystal structures of bBBP-A in complex with BTN and
BSO were solved at 2.1 Å and 1.75 Å resolution, respec-
tively. The statistics for the structure determinations are
summarized in Table 3. The overall BBP-A – BTN and
Table 1: Biochemical properties of different BBP-A forms.
Gel filtration SDS-PAGE-based 
thermostability assay
Dissociation of 
fluorescent BTN 
(25°C)
DSC
Elution time (min) Molecular mass (kDa)a Tr (°C) kdiss 
(10-5 s-1)
Release 
1 h (%)
Tm (°C)
-BTN +BTN -BTN +BTN -BTN +BTN -BTN +BTN
bBBP-A 29.9 30.1 42.7 40.9 N. D. 70 54.8 86 N. A. 103.4
bBBP-A 
(A74S)
30.0 30.1 41.9 40.8 N. D. 75 47.1 83 N. A. 103.2
bBBP-A 
(T118F)
30.1 29.9 41.3 42.7 N. D. 70 69.1 94 N. A. 102.3
iBBP-A 28.4 28.4 60.8 59.7 N. D. 75 20.4 53 N. M. N. M.
AVD 28.2 28.2 62.5 63.6 60b 90b 2.0 10 83.5c 117.0
bAVD 28.8 28.8 55.3 55.1 60b 90b 1.1 5 N. M. N. M.
N. D. Protein appeared mainly in monomeric form already at room temperature; N. A. Not applicable; N. M. Not measured.
aMolecular mass calculated from the measured elution times of thyroglobulin (670 kDa), gamma-globulin (158 kDa), BSA (67 kDa), ovalbumin (44 
kDa) and myoglobin (17 kDa).
bResults from ref. [30].
cResults from ref. [33].Page 3 of 20
(page number not for citation purposes)
BMC Structural Biology 2007, 7:8 http://www.biomedcentral.com/1472-6807/7/8
Page 4 of 20
(page number not for citation purposes)
SDS-PAGE based analysis of the thermal stability of the tetramers of BBP-AFigure 1
SDS-PAGE based analysis of the thermal stability of the tetramers of BBP-A. Samples saturated with BTN (+Biotin) 
prior to analysis as well as samples without added BTN (-Biotin) are shown. (a) bBBP-A, (b) bBBP-A in the presence of BTN 
and (c) bBBP-A(A74S) in the absence and presence of BTN. After acetylation in vitro, the samples were subjected to thermal 
treatment in SDS-PAGE sample buffer containing 2-mercaptoethanol and SDS. The different temperatures used in the analysis 
are indicated in the upper part of the figure (°C). The molecular weights of the standard proteins (Bio-Rad) are shown on the 
left.
BMC Structural Biology 2007, 7:8 http://www.biomedcentral.com/1472-6807/7/8BBP-A – BSO structures are practically identical to each
other; the Cα atoms of these structures superimpose with
an rmsd of < 0.2 Å. The BBP-A structures consist of four
identical subunits, each subunit adopting a β-barrel fold
of eight anti-parallel β-strands with an α-helix positioned
between the β7- and β8-strands (Figure 5a,b). The BTN/
BSO-binding site is located at the open end of each β-bar-
rel. The overall fold of BBP-A is similar to that seen for the
known structures of the AVD family complexes, i.e.
streptavidin-BTN [8], AVD-BTN [9,23], AVR2-BTN [24]
and AVR4-BTN [25] complexes. The solvent accessible
surface area is, however, over 10% larger in the BBP-A
structures (> 21000 Å2) compared to the AVD-BTN struc-
tures (< 19000 Å2 [PDB: 1AVD and 2AVI]). The electro-
static surface properties of BBP-A and AVD differ, too,
BBP-A having a seemingly more positively charged surface
than AVD (Figure 5c–f).
Mode of BTN and BSO binding
The biotin-binding site of the BBP-A – BTN structure
mimics the biotin-binding site of AVD [9,23]. The amino
acid residues within 4 Å of BTN in the complex with BBP-
A (Asn12, Leu14, Ser16, Tyr33, Thr35, Val37, Thr38,
Ala39, Thr40, Trp71, Phe73, Ala74, Ser76, Thr78, Phe80,
Trp98, Leu100, Glu102, Asn119 and Trp111) are not only
highly conserved but also have conformations similar to
those seen in AVD (Figure 6a). Actually, only one polar
(Glu102) and one hydrophobic residue (Ala74) within 4
Å of BTN are not conserved between the BBP-A – BTN and
AVD-BTN complex [PDB: 2AVI] structures. The side-chain
oxygen of Glu102 of BBP-A is hydrogen bonded to one of
the valeric oxygen atoms of BTN, whereas in AVD the
equivalent residue, Ser101, can not form a hydrogen bond
to the valeric oxygen because the distance between the two
atoms is too long (5.8 Å). The methyl carbon of Ala74 of
BBP-A, on the other hand, is positioned only 3.7 Å away
from the valeric O10B atom of BTN (numbering accord-
ing to [26]), but is not likely to be hydrogen bonded with
BTN unlike the side-chain oxygen atom of the corre-
sponding Ser73 in AVD, which is hydrogen bonded to
BTN.
In addition to the BBP-A – BTN complex structure, we
solved the X-ray structure of BBP-A – BSO, too. To our
knowledge, BSO is not found in any other protein struc-
ture presently within the Protein Data Bank (PDB) [27].
Electron density for the BSO ligand was clearly seen in the
difference map of the BBP-A – BSO structure (Figure 7).
The binding mode of BSO to BBP-A is surprisingly similar
to that of BTN (Figure 6b) despite the additional oxygen
atom that is covalently linked to the sulphur atom of the
bicyclic ring system of BSO but is missing from BTN. The
distance between the sulfur atom of BTN and the OG1
atom of Thr78 (3.4 Å), for example, is very close to the
BSO – Thr78 distance (3.6 Å). In the known AVD-BTN
Deglycosylation analysis of BBP-AFigure 3
Deglycosylation analysis of BBP-A. The BBP-A pro-
duced in insect cells was treated with Endo Hf glycosidase 
(Bi+) and analysed with SDS-PAGE. Untreated control sam-
ple (Bi) and BBP-A produced in bacteria (Bb) were also ana-
lysed. For comparison, the same analysis was performed for 
AVD isolated from chicken (Ac+). Chicken AVD control 
sample (Ac) as well as AVD produced in bacteria (Ab) [30] 
are also shown. The molecular weight markers are shown on 
both sides of the gel (14.4 and 21.5 kDa).
Sequence alignment of BBP-A and AVDFig re 2
Sequence alignment of BBP-A and AVD. Identical residues are shown in gray shading. The signal peptides are omitted 
from the alignment. Secondary structure elements are indicated according to the BBP-A – BSO structure (chain A). The amino 
acids within 4 Å of BSO in the BBP-A – BSO structure (and the equivalent residues in AVD) are boxed. The residues mutated 
in this study are indicated by an asterisk. The glycosylation site of BBP-A is indicated by an arrow.Page 5 of 20
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sponding distances are 3.2 Å and 3.8 Å. The only noticea-
ble difference around the ligands in the two BBP-A
structures was found at Glu102, which in the BBP-A – BTN
structure is hydrogen bonded to the valeric O10A atom of
BTN but in the BBP-A – BSO structure was observed either
to form a salt bridge with Arg115 (chains B and D) or to
hydrogen bond to a structural water molecule (chains A
and C). The difference in the conformation of Glu102 is
not likely to result from the varying crystal contacts of the
two BBP-A structures that crystallized as different space
groups (data not shown). Moreover, the overall confor-
mations of the BTN and BSO ligands bound to BBP-A
were very similar, too.
Subunit interfaces of BBP-A
Comparing BBP-A with AVD, we saw differences at subu-
nit interfaces 1–3 and 1–4, whereas the amino acid resi-
dues found at the 1–2 interface were conserved and had
similar conformations (numbering of subunit interfaces
according to [9]).
Of the three residues (Val116, Gly117 and Thr118) within
5 Å from each other at the 1–3 subunit interface of the
BBP-A – BSO structure (Figure 8a), valine and glycine are
conserved between BBP-A and AVD, while Thr118 is
replaced by Ile117 in the AVD structure. In BBP-A there is
no interaction equivalent to the hydrophobic or van der
Waals interactions introduced by the two Met96 residues
of AVD at the 1–3 subunit interface: in BBP-A, Met96 is
replaced by Ala97 and the distance between Ala97 in the
two subunits is about 11 Å. Generally, the 1–3 subunit
interface seems to be more loosely packed in BBP-A com-
pared to AVD, AVR4 [25] and even AVR2 [24] (data not
shown).
The total contact surface area of the 1–4 interface of BBP-
A – BSO is 2428 Å2, whereas the corresponding contact
surface area in AVD is 2319 Å2. Twenty-six of the 49
amino acid residues found at the 1–4 interface within a
contact radius of 4 Å are different between the BBP-A –
BSO and AVD-BTN [PDB: 2AVI] structures. Hydrophobic
residues located at the core of the 1–4 subunit interfaces
are well conserved in BBP-A and AVD, whereas several dif-
ferences among the polar residues were observed, espe-
cially at the interacting loop regions (Figure 8b,c). The
hydrogen bond found in AVD between the OE2 atom of
Glu28 of the β3 sheet and the NE2 nitrogen of His50 of
the β4 sheet, for example, is not seen in BBP-A where
Glu28 and His50 are respectively replaced by Thr28 and
Lys50. The hydrogen bond formed between the side-chain
atoms of Gln61 (L4,5 loop) and Glu103 (L7,8 loop) in
BBP-A is, in turn, missing from AVD, where the residues
are replaced by Thr60 and Ser102. Yet another example of
the differences at the 1–4 subunit region between BBP-A
and AVD was seen for the only α-helix and the β7-strand
Table 2: Dissociation of BTN and its oxidized forms from BBP-A and AVD. Fluorescence spectroscopy and radiobiotin dissociation 
analysis data at 40°C are shown. Binding enthalpies were measured by ITC at 25°C. bBBP-A and commercial chicken AVD was used in 
the analyses.
Ligand kdiss × 10-4 s-1 Enthalpy (kcal/mol) (ITC) Tm (°C) (DSC)
BBP-A AVD BBP-A AVD BBP-A
BSO 1.3a -29.3 ± 0.1 -25.9 ± 0.1 116.9 ± 0.2 100.4 ± 0.2
D-biotin sulfone 3.3a -25.1 ± 0.1 -21.4 ± 0.1 117.0 ± 0.0 101.4 ± 0.2
BTN 5.4b (4.4c) -22.6 ± 0.1 -20.5 ± 0.1 117.0 ± 0.7 103.4 ± 0.1
aFrom fluorescence spectroscopic analysis, excess of BTN was used as a competitive ligand.
bFrom fluorescence spectroscopic analysis, excess of BSO was used as a competitive ligand.
cValue obtained from [3H]-biotin dissociation analysis, excess of BTN was used as a competitive ligand.
Immunological cross-reactivity of chicken BBP-A and AVDFigure 4
Immunological cross-reactivity of chicken BBP-A and 
AVD. (a) Western blot analysis of 1/100, 1/10 and 1/1 
diluted samples of chicken AVD (10 μg) and undiluted bBBP-
A protein (10 μg). The polyclonal antibody TdaVII against 
AVD [51] was used as the primary antibody. (b) The same 
analysis as in A using another polyclonal antibody (University 
of Oulu, Finland). (c) Dot-blot analysis of BBP-A (10 μg) pro-
duced in bacteria 'b' and in insect cells 'i'. The polyclonal anti-
body TdaVII against AVD was used as the primary antibody. 
Serial dilutions of AVD (10 μg) were used as controls (the 
dilution factors are indicated in the figure).Page 6 of 20
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of Glu95 can form hydrogen bonds with the NE and NH2
atoms of the side chain of Arg107, whereas the atoms of
the respective residues, Lys94 and Ile106, of AVD may
introduce only van der Waals contacts. These and other
differences (Figure 8b,c) reflect the varying architecture of
the 1–4 interfaces in BBP-A and AVD.
Ligand-binding analyses
The dissociation rate of [3H]biotin from BBP-A was meas-
ured using a competitive dissociation assay (Figure 9;
Table 2). The analysis showed that bBBP-A has a dissocia-
tion rate about 100-fold higher than that of AVD [28],
indicating that the affinity for BTN is lower in bBBP-A
compared to AVD, but similar to that of streptavidin [29].
The dissociation rate of the fluorescent BTN conjugate
ArcDia™ BF560-biotin was, in turn, about 30-fold higher
for bBBP-A compared to wtAVD (Table 1). Interestingly,
iBBP-A had an almost three-fold slower dissociation rate
compared to bBBP-A. WtAVD showed a higher dissocia-
tion rate compared to the bAVD form produced in E. coli,
which is in line with previously reported observations
[30]. The A74S and T118F mutations of BBP-A did not sig-
nificantly affect the biotin-binding properties of BBP-A
(Table 1, Figure 9).
The biotin-binding characteristics of bBBP-A and wtAVD
studied by ITC analysis were similar for both proteins.
Because the binding of BTN was tight (Kd < 10-9 M) in both
cases, the binding constants could not be determined
directly from the ITC data (Figure 10). The binding
enthalpy could, however, be accurately determined, and
the obtained values are listed in Table 2. In addition to
BTN, the binding of BSO and D-biotin sulfone to wtAVD
and bBBP-A were analysed using ITC (Table 2). The oxi-
dised BTN forms exhibited a slightly higher binding
enthalpy compared to BTN for both proteins studied.
Overall, ligand binding to AVD released more heat, but a
rather similar variation in the binding enthalpies of the
studied ligands was observed in BBP-A and AVD. There-
fore, the ITC analysis of the enthalpy of binding does not
suggest different ligand preferences for BBP-A and AVD.
Table 3: Data collection and structure determination statistics for BBP-A
Data collectiona BBP-A – BTN BBP-A – BSO
Wavelength (Å) 1.063 1.063
Beamline I711 (MAX-lab) I711 (MAX-lab)
Detector MarCCD 165 MarCCD 165
Resolution (Å) 25-2.1 (2.2-2.1) 25-1.75 (1.85-1.75)
Unique observations 10571 (1351) 26447 (3993)
I/sigma 14.06 (4.31) 12.78 (3.24)
Rfactor (%)b 10.5 (48.6) 7.7 (48.2)
Completeness 99.9 (100) 99.9 (100)
Redundancy 8.6 (8.7) 4.8 (4.8)
Refinement
Space group I4122 P21212
Unit cell:
a, b, c (Å) 61.7, 61,7, 179.7 79.7, 56.0, 57.1
α, β, γ (°) 90, 90, 90 90, 90, 90
Monomers (asymmetric unit) 1 2
Resolution (Å) 25-2.1 25-1.75
Rwork (%) 19.5 19.3
Rfree (%) 22.0 23.3
Protein atoms 969 1965
Heterogen atoms 22 34
Solvent atoms 61 212
R.m.s.d:
Bond lengths (Å) 0.014 0.014
Bond angles (°) 1.6 1.6
Ramachandran plot:
Residues in most favored regions 93.3 93.3
Residues in additional allowed regions 6.7 6.7
Residues in generously allowed regions 0 0
Residues in disallowed regions 0 0
aThe numbers in parenthesis refer to the highest resolution bin.
bObserved R-factor from XDS [53].Page 7 of 20
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The overall X-ray structure of chicken BBP-AFigure 5
The overall X-ray structure of chicken BBP-A. (a, b) A tetrameric ribbon model of the BBP-A – BSO structure. (c, d) 
Electrostatic potentials mapped onto the molecular surface of the BBP-A – BSO structure. (e, f) Electrostatic potentials 
mapped onto the molecular surface of the AVD [PDB: 2AVI] [23] structure after superimposition on the BBP-A structure. The 
views shown in (a), (c) and (e) are rotated 45° around the X-axis in (b), (d) and (f). The BSO and BTN ligands of the BBP-A – 
BSO and AVD structures, respectively, are shown as spheres. The yellow arrows pinpoint visible parts of the valeric acid tails 
of BSO and BTN seen in (d), (e) and (f).
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The binding mode of BTN and BSOFigure 6
The binding mode of BTN and BSO. (a) BTN (thick sticks) and the amino acids within 4 Å of BTN in the BBP-A – BTN 
and AVD [PDB: 2AVI] structures are shown. The carbon atoms of residues from subunit 1 of the BBP-A and AVD structures 
are coloured light grey and blue, respectively. The carbon atoms of Trp111 (Trp110) from subunit 2 of BBP-A (AVD) are col-
oured green (cyan). The amino acids of BBP-A (AVD) are numbered. The labels of the non-conserved residues are indicated 
with a yellow background. (b) BTN and BSO (thick sticks), and the amino acids within 4 Å of the ligands in the BBP-A – BTN 
and BBP-A – BSO structures are shown. The carbon atoms of residues from subunits 1 of the BBP-A – BTN and BBP-A – BSO 
structures are coloured light grey and light red, respectively. The carbon atoms of Trp111 from subunit 2 of the BBP-A – BTN 
and BBP-A – BSO structure are coloured green and dark red, respectively. The amino acids are numbered. Glu102, whose side 
chain has a different conformation in the BBP-A – BTN and BBP-A – BSO structures, is labelled with a yellow background.
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bBBP-A and wtAVD were studied, too (Figure 11). All
biotin forms, BTN, BSO and D-biotin sulfone, enhanced
the emission intensity of BBP-A. In contrast, only D-biotin
sulfone increased the emission intensity of AVD, whereas
BSO and especially BTN decreased the emission intensity
of AVD. Compared to the ligand-free proteins, for each of
the ligand-protein combinations the maximum in the
emission spectra moved towards the shorter blue wave-
lengths. Altogether, these results indicate differences in
the ligand-protein interactions between BBP-A and AVD,
particularly reflecting variation in the local environment
of tryptophan residues [31].
EST database search
Chicken EST databases were searched using NCBI blastn
[32] and the BBP-A and AVD cDNAs as query sequences.
The search resulted in 9 significant (E-value < 1 × 10-100
and score > 400) hits in the case of BBP-A, whereas the
cDNA of AVD yielded 94 hits. Further analysis of the BBP-
A hits showed that they correspond to mRNAs isolated
from kidney and the adrenal glands (3 hits), the trunks of
chicken stage 36 embryos (4 hits) and multiple-tissue
preparations (2 hits). The AVD hits, in turn, corresponded
to mRNAs isolated from lymphoid tissues (1), intestine
(1), ovary (2), the chondrocytes of cartilage (6), multiple-
tissue preparations (4), splenic T cells (2), pituitary gland,
hypothalamus and pineal gland (1), and PBL macro-
phages (77).
Discussion
Here, we report the biochemical and structural characteri-
zation of BBP-A, produced efficiently both in E. coli and
Spodoptera frugiperda cells. This study demonstrates that
BBP-A can be classified as a new member of the AVD fam-
ily: BBP-A binds BTN with high affinity like all the other
known members of the family [4,24,33] and has the β-
barrel fold characteristic of AVD and of the more hetero-
geneous calycin superfamily of proteins [34]. The binding
mode of BTN to BBP-A (Figure 6) is also highly similar to
that observed in the known structures of AVD [9,23],
AVR2 [24] and AVR4 [25]. The BBP-A protein is, however,
biochemically and structurally clearly distinguishable
from chicken AVD and the AVRs [1,4,18,24,25]. There are
also differences in the immunological properties of BBP-
A and AVD, since immunoblot and dot-blot analyses with
polyclonal AVD antibodies did not show cross-reactivity
between BBP-A and AVD (Figure 4).
Does BBP-A represent the earlier reported BBPs, BBP-I or
BBPII? Based on the biochemical characterization of BBP-
I [11,35-37], and BBP-II [14,15], this seems not to be the
case. The [3H]-biotin dissociation rate constant of BBP-I
reported in 1978 by Meslar and co-workers [11] is 2–4
times higher than that determined for bBBP-A and even
5–12 times higher in comparison to the glycosylated
iBBP-A, which has a dissociation rate of [3H]biotin (Figure
9) in the same range as reported for streptavidin [29]. The
pI (4.6) of the BBP-I protein differs from that calculated
for BBP-A (pI = 9.75), too. Moreover, the reported N-ter-
minal sequences of BBP-I and BBP-II do not match the
sequence of BBP-A [18]. In conclusion, the BBP-A protein
reported here seems to be a novel protein not described in
any previous publications.
In order to study the molecular details of ligand recogni-
tion by BBP-A and compare the ligand-binding properties
of BBP-A with the previously determined structures of
AVD [9], streptavidin [8], AVR4 [25] and AVR2 [24], we
crystallized bBBP-A in complex with BTN. Surprisingly, in
one of the two BBP-A crystals that were analyzed, BSO was
found bound to BBP-A even though only BTN was added
in the co-crystallisation experiments. To our knowledge,
this complex is unique, as no other protein structure has
been reported in complex with BSO. What can be the
source of the bound BSO? Based on the crystallization
conditions (see Methods), it is not easy to say why one
structure bound BTN and the other BSO. It is known that
some BTN preparations may carry minor amounts of BSO
[38], but based on mass spectrometry analysis (data not
shown) no detectable amounts of BSO were found in the
diluted BTN solution that was used for crystallization.
One possibility is that the source of the BSO ligand seen
in the BBP-A – BSO structure is BTN that had undergone
oxidation during crystallization. Another possibility is
Stereo image of electron density around the BSO ligand of th  BBP-A – BSO structureFigure 7
Stereo image of electron density around the BSO lig-
and of the BBP-A – BSO structure. The additional oxy-
gen atom on the BSO ligand (in comparison to BTN) is 
indicated by an arrow. The 2Fo-Fc (blue) and Fo – Fc (red) 
maps calculated without the ligand but drawn around BSO of 
the final model are shown at the level of 1.0 and 3.0 sigma, 
respectively.Page 10 of 20
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Stereo images of the 1–3 and 1–4 subunit interfaces of BBP-A and AVDFigure 8
Stereo images of the 1–3 and 1–4 subunit interfaces of BBP-A and AVD. (a) The 1–3 subunit interface of the AVD 
[PDB: 1VYO] [68] structure superimposed with the corresponding interface of the BBP-A – BSO structure. The carbon atoms 
of amino acids from BBP-A and AVD are coloured light grey and blue, respectively. Amino acids and β-sheets are numbered. 
Two occurrences of Ala97 in the BBP-A structure are indicated by arrows. (b, c) A simplified view of the 1–4 interface of the 
BBP-A – BSO (b) and AVD [PDB: 2AVI] [9] (c) structure after superimposition. The atoms of the non-conserved side chains of 
amino acids within 4 Å of subunit 1 of either the BBP-A or AVD structure are shown. For clarity, Met96 and Thr110 of BBP-A 
as well as the equivalent residues of AVD (Thr95 and Asp109) are not shown, and only one half of the symmetrical 1–4 inter-
face is shown. The carbon atoms of residues from subunit 1 and 4 are respectively coloured light grey and green in BBP-A, and 
grey and blue in AVD. Amino acids and β-sheets are numbered.
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unknown catalytic mechanism, but experimental proof
for this hypothesis is lacking and the final explanation for
the presence of BSO in one of the BBP-A structures
remains to be studied.
The BBP-A – BSO structure inspired us to investigate
whether BBP-A recognizes BSO with altered affinity in
comparison to BTN. We analysed the binding of the fully
oxidised sulfone form of BTN, too. To our surprise, the
dissociation rate of BSO (fluorometric analysis at 40°C,
Table 2) from BBP-A was similar or even slower than the
dissociation rate of BTN (fluorometric and radiobiotin
analysis at 40°C), whereas in the case of AVD the dissoci-
ation rate of BSO was more than 20 times higher in com-
parison to BTN (for AVD, the dissociation rate of BSO was
determined using fluorometric analysis at 50°C (data not
shown), whereas the dissociation of BTN was determined
using radiobiotin assay at 50°C (Figure 9)).
This is the first reported case, to our knowledge, where the
product of a naturally occurring gene encoding a BTN
Biotin dissociation analysisF gure 9
Biotin dissociation analysis. The dissociation of [3H]biotin from various proteins was determined over time. The individual 
dissociation rates of [3H]biotin measured for bBBP-A (black triangles), bBBP-A(A74S) (grey triangles), bBBP-A(T118F) (white 
triangles) and iBBP-A (black circles) are shown. Solid lines represent linear fit to data sets. Data measured previously for AVR2 
(black rectangles), AVR6 (white rectangles) and AVR4 (white tilted rectangles), all produced in bacteria, are also shown [24, 
28]. Data measured for chicken AVD (tilted black rectangles) are presented, too [42]. AVR6 and AVR4 carried the mutations 
C58S and C122S, respectively, which prevented the formation of intersubunit disulphide bridges [33]. The dissociation rates 
for streptavidin are shown as a dotted line according to [29].Page 12 of 20
(page number not for citation purposes)
BMC Structural Biology 2007, 7:8 http://www.biomedcentral.com/1472-6807/7/8
Page 13 of 20
(page number not for citation purposes)
Isothermal titration calorimetry analysis of bBBP-A and AVDFigure 10
Isothermal titration calorimetry analysis of bBBP-A and AVD. Binding thermograms measured for (a) AVD-BTN, (b) 
AVD-BSO, (c) AVD – D-biotin sulfone, (d) bBBP-A – BTN, (e) bBBP-A – BSO and (f) bBBP-A – D-biotin sulfone complexes are 
shown at the upper part of the graphs. Non-linear least square curves (at the lower part of each graph) were fitted to 
enthalpies integrated from the individual titrations. For each titration, 0.5 mM ligand solution was used. The reaction volume 
was 10 μl except for the first titration, which was done in 2 μl.
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Fluorescence spectroscopy analysis of BBP-A and AVDigure 11
Fluorescence spectroscopy analysis of BBP-A and AVD. (a) Emission spectra of BBP-A in the absence of ligand (black) 
and with BTN (green), BSO (blue) or D-biotin sulfone (red) are shown. (b) Emission spectra of AVD. (c) Dissociation of D-
biotin sulfone from BBP-A displaced with excess of BTN at 40°C. The measured emission intensity is plotted over time and 
corrected using the emission decay data from control measurements, which were made for protein saturated with BTN. Exci-
tation at 280 nm was used.
BMC Structural Biology 2007, 7:8 http://www.biomedcentral.com/1472-6807/7/8binder shows equally high affinity to a ligand other than
BTN. Based on DSC analysis the studied ligands did not
differ significantly in their effect on the thermal stability
of BBP-A and AVD (Table 2). Nor did the measured bind-
ing enthalpies vary significantly over ligand sets between
AVD and BBP-A (Table 2). Overall, these ligand binding
analyses suggest that all the studied ligands are efficiently
associated (high negative binding enthalpy) with BBP-A
and AVD. However, the determined dissociation rate of
BTN from AVD was significantly lower than the dissocia-
tion rates of BSO and D-biotin sulfone, whereas the
observed dissociation rates of the same ligands from BBP-
A were rather similar to each other, the slowest observed
for BSO. As a conclusion, it is the different dissociation
rather than association rates that determines the ligand-
binding preferences of BBP-A and AVD; out of the three
ligands studied, AVD prefers BTN, whereas BBP-A seems
to prefer BSO. Moreover, it is well known that the
extremely slow dissociation of BTN from AVD is the main
determinant of the high affinity binding [1].
One possible explanation for the differences in the disso-
ciation rates of the studied ligands is the weaker structural
stability of BBP-A as compared to AVD (Table 1). It has
been experimentally shown, that binding of BTN to
streptavidin lowers the rate of H/D exchange in large parts
of the structure [10] at least partially due to the positive
structural cooperativity in the binding process (thor-
oughly explained in [39]), i.e. improved packing and
compactness of not only the ligand-binding site but of
entire subunits, too. The weaker stability, or lower level of
"compactness", of the entire BBP-A tetramer can therefore
explain the differences in the observed ligand-binding
properties of AVD and BBP-A. The BBP-A barrel fold may
also be considered more flexible or dynamic than the AVD
barrel, which could lead to a higher rate at which BTN is
dislodged from the binding pocket, possibly by a mecha-
nism similar to that presented by Hyre et al. for streptavi-
din [40].
What are the structural determinants that specify the rec-
ognition of BSO and why does the affinity of BSO meet
that of BTN for BBP-A? The BBP-A – BSO structure is strik-
ingly similar to the BBP-A – BTN structure – even the addi-
tional D-sulfoxide moiety of the ligand in the BBP-A –
BSO structure does not seem to alter the binding pocket of
BBP-A as compared to the BBP-A – BTN structure (Figure
6). One clear difference can, however, be detected: the
hydrogen bond present in the BBP-A – BTN complex
structure between Glu102 and BTN is missing in the BBP-
A – BSO structure due to the different conformation of
Glu102 in the two structures. Moreover, in the BBP-A –
BSO structure, the carboxylate side-chain of Glu102 forms
a salt-bridge with the guanidinium group of the Arg115
side-chain within the same subunit (in chains B and D) or
is hydrogen bonded to a structural water molecule (in
chains A and C), interactions that are not seen in the BBP-
A – BTN complex. Arg115 is one of the conserved amino
acids found at the 1–2 subunit interfaces of all known
structures of members of the AVD family, but its confor-
mation varies within the family (data not shown). This
suggests that, in addition to the residues at the ligand-
binding pocket, the type and conformation of residues at
the subunit interfaces may regulate ligand binding, e.g. by
allowing or disabling alternative hydrogen bonding net-
works.
Conclusion
Our present study reveals that chicken has an avidin-like
protein, BBP-A in its biotin-binding repertoire. Even
though similar to AVD according to its three-dimensional
structure and biotin-binding properties, i.e. the high affin-
ity for BTN, BBP-A has several unique features – the ther-
mal stability and immunological cross-reactivity of BBP-A
is very different as compared to AVD. Furthermore, BBP-A
is the first example of a protein from the AVD family that
naturally has equally high affinity for BTN and for a non-
BTN ligand. The biological function of BBP-A is not
known, but since it binds both BSO and BTN with high
affinity, it may have a function in the storage or delivery
of BTN to an embryo as has been suggested in earlier stud-
ies for BBP-I and BBP-II [14,17]. In addition to providing
clues of biological function and information about
biotin-binding determinants in proteins, the high-resolu-
tion structure and biochemical analysis of BBP-A makes
this novel protein attractive material for protein engineer-
ing and bio(nano)technological applications. For exam-
ple, BBP-A could be covalently combined with AVD or
AVR polypeptide using a circular permutation strategy
[41,42] or used as a scaffold in the development of artifi-
cial enzymes [43].
Methods
Preparation of expression constructs
A cDNA clone of BBP-A [GenBank: BX930135] was
obtained from the UK Chicken EST Consortium (ARK-
Genomics). For insect cell production the cDNA, which
included the sequence encoding for a putative signal pep-
tide [18], was PCR amplified and cloned into a
pFASTBAC1 vector (Invitrogen). The following primers
were used: 5'BBP-A+signal (5'-AAAAGATCTATGGAG-
CACCTCCGCTG) and 3'BBP-A (5'-ATTTAAGCTTACTT-
GACACG GGTG), in which the restriction enzyme
cleavage sites for BglII and HindIII, respectively, are
shown in italics. In order to express BBP-A in E. coli, the
original signal sequence of BBP-A was replaced with the
OmpA signal peptide from Bordetella avium [44] by clon-
ing into the pGemTeasy vector (Promega) containing the
OmpA-signal and flanking attL recombination cloning
sequences [30]. The construct was then transferred to thePage 15 of 20
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nation (Invitrogen). 5'BBP-A-core (5'-AAAGGTACCAG-
GAAGTGCGAGC; KpnI) and 3'BBP-A were used as the
primers for PCR. The nucleotide sequences of the final
expression vectors were confirmed by DNA sequencing.
The mutagenesis of BBP-A cloned in the pGemTeasy plas-
mid was performed using the QuikChange mutagenesis
method (Stratagene, La Jolla, CA, USA). The BBP-A
mutants were transferred to the pBVboostFG expression
vector essentially as described previously [46].
Protein expression and purification
BBP-A and its mutated forms were produced in E. coli BL-
21(AI) cells (Invitrogen) as previously described [30]. The
mutation A74S was created in order to study the signifi-
cance of this residue for BTN binding (in AVD the side
chain of the equivalent Ser73 forms a hydrogen bond with
BTN). T118F, in turn, was created in order to increase the
subunit contact area and consequently the stability of
BBP-A; in AVD, I117Y was found to increase the stability
of the protein [28]. iBBP-A, employing its natural signal
peptide, was expressed in the eukaryotic host, Spodoptera
frugiperda, using the Bac-to-Bac baculovirus expression
system (Invitrogen). The proteins were isolated using 2-
iminobiotin affinity chromatography (Affiland S. A.,
Liege, Belgium) as described elsewhere [30,47]. AVD iso-
lated from chicken egg-white (wtAVD; Belovo S. A., Bas-
togne, Belgium) and AVD produced in E. coli (bAVD) [30]
were used as control proteins throughout this study.
Chemical synthesis of BSO and D-biotin sulfone
The syntheses of BSO and D-biotin sulfone were per-
formed using a procedure described by Melville [48]. The
melting points of the BTN derivatives were 201–202°C
(lit. 200–203°C [48]) for BSO and 275–277°C (lit. 274–
275°C [49]) for D-biotin sulfone. From ESI-MS analysis
(see below) the following values were obtained: BSO, cal-
culated molecular weight (C10H16N2O4S1) = 260.31, [M-
H]- m/z = 259.0753 and measured m/z = 259.0388; D-
biotin sulfone, calculated molecular weight
(C10H16N2O5S1) = 276.31, [M-H]- m/z = 275.0702 and
measured m/z = 275.0184.
Stability analysis
The stability of BBP-A was analysed by SDS-PAGE as
described previously [22]. Prior to analysis, the protein
sample was acetylated in vitro and subsequently subjected
to thermal treatment for 20 min in the presence of SDS
and 2-mercaptoethanol. The oligomeric state of the
treated protein was assessed by SDS-PAGE using Bio-Safe
Coomassie (Bio-Rad) staining.
Differential scanning calorimetry
Differential scanning analysis was performed in 50 mM
NaPO4 buffer (pH 7.0) containing 100 mM NaCl as previ-
ously described [33]. The concentration of the analyzed
proteins was between 0.2 and 0.6 mg/ml. In samples con-
taining a ligand, the molar ligand concentration was three
times as high as the protein subunit concentration. The
samples were scanned from 25 to 130°C at a rate of
0.92°C/min.
Gel filtration chromatography
Gel filtration analysis was performed with a ÄKTA™ puri-
fier HPLC instrument (Amersham Biosciences) equipped
with Superdex 200 10/300 GL column (Tricorn) as previ-
ously described [50]. A buffer containing 50 mM NaPO4
and 650 mM NaCl (pH 7.0) was used as the liquid phase.
Biotin-complexed proteins were prepared by incubating
the sample in the presence of 0.22 mM BTN 15 min prior
to analysis.
Mass spectrometry
The mass spectrometric studies were performed with a
Micromass LCT ESI-TOF instrument equipped with a Z
geometry electrospray ion source TOF detector. The anal-
ysis of BBP-A was performed as previously described [30].
Before analysis, the sample was dialysed against distilled
water and lyophilised. MS analysis of the BTN used in the
crystallization experiments with BBP-A was performed to
determine whether BSO was present in the ligand solu-
tion. The amount of BSO in the sample was below the
detection limit of the method (less than 1%). The detec-
tion limit was determined by making mixtures of 10 μg/
ml (41 μM) of BTN with 1 (3.8 μM), 0.5 (1.9 μM) or 0.1
μg/ml (0.38 μM) of BSO.
Ligand-binding analyses
The dissociation rate of [3H]biotin (Amersham) was
measured at various temperatures with a competition
assay as described previously [29]. Measurements were
carried out in 50 mM NaPO4 buffer containing 100 mM
NaCl.
The dissociation rate of the fluorescent biotin conjugate
ArcDia™ BF560-biotin (ArcDia Ltd., Turku, Finland) was
measured as reported previously [30]. The measurements
were made at 25°C in 50 mM NaPO4 buffer (pH 7.0) con-
taining 650 mM NaCl using a PerkinElmer LS55 lumi-
nometer.
The energetics of biotin binding was determined with a
VP-ITC (MicroCal™) Isothermal Titration Calorimeter.
Measurements were performed at 25°C in degassed 50
mM NaPO4 buffer (pH 7.0) containing 100 mM NaCl. In
order to calculate the enthalpies of binding (ΔH) for BBP-
A and AVD, the cell used for measurements was filled withPage 16 of 20
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(0.5 mM) was then added to the measurement cell using
15 equal volume injections (10 μl) and at 240 second
intervals. The data were analysed with Origin 7.0 software
using the "One Set of Sites" method. The titration curve
(heat change μcal/injection) resulting from the 15 injec-
tions was analysed by fitting the data to a nonlinear least
square curve. We only determined the enthalpy of binding
from these experiments, since the estimation of binding
constants directly from the data was impossible due to the
tight binding.
In order to study the intrinsic fluorescence of the proteins,
the emission spectra of bBBP-A and wtAVD in 50 mM
NaPO4 buffer (pH 7.0) containing 650 mM NaCl were
measured using a PerkinElmer LS55 spectrofluorometer
and excitation at 280 nm (slit 2.5 nm). During the analy-
sis, protein solutions (100 nM) were continuously mixed
using an integrated magnetic stirrer and maintained at
25°C using a circulating water bath. The emission spectra
were also measured after addition of 200 nM ligand (BTN
or its oxidised forms) to the protein solutions.
Fluorescence spectroscopy was also used to measure the
rate of protein-ligand dissociation. These experiments
were made at 40°C in order to measure the dissociation
events within an experimentally applicable timescale.
Firstly, the emission intensity of bBBP-A or wtAVD (50
nM) was measured at 350 nm (slit 10 nm) in the presence
of BTN, BSO or D-biotin sulfone (100 nM). Secondly, in
order to detect and quantify the dissociation events, a
1000-fold molar excess (100 μM) of BTN (BSO in case of
determination of BTN dissociation) was added to the
samples and the measurements were recorded for 3600
seconds. The measured spectral properties of each pro-
tein-ligand complex (i.e. the emission intensity of the pro-
tein-ligand complex) were used to create a single-phase
dissociation model, which was fitted to the data. For
example, in the case of the dissociation of BSO from BBP-
A and binding of BTN to BBP-A, the dissociation process
was observed as a decrease in the emission intensity (Fig-
ure 11c). The decrease in the fluorescence signal obtained
in the control measurement performed in the presence of
a 1000 molar excess of BTN was corrected during data
analysis.
Deglycosylation analysis
The BBP-A protein produced in insect cells was treated
with Endoglycosidase H (New England Biolabs) to see if
it was glycosylated. Wild-type AVD was used as a control
protein. Prior to treatment, the analysed proteins were
denatured by boiling them in the presence of 2-mercap-
toethanol and SDS. Deglycosylation was performed over-
night at 37°C. The samples were then boiled and
subjected to SDS-PAGE analysis followed by staining with
Bio-Safe Coomassie (Bio-Rad).
Immunological analysis
The cross-reactivity of polyclonal AVD antibodies with
BBP-A was studied using immunoblot and dot-blot anal-
yses. The polyclonal rabbit antibodies TdaVIII [51] and an
AVD antibody (University of Oulu, Finland) were used
(dilution 1:5000) in Western blotting to analyse a 10 μg
sample of BBP-A produced in E. coli. Three different
amounts, 0.1, 1 and 10 μg of wtAVD, were used as con-
trols in this experiment.
Dot-blot analysis was performed using only the TdaVIII
antibody and 10 μg of BBP-A produced either in E. coli or
in insect cells. AVD from chicken was used as a control
(0.04–1.33 μg).
Crystallization and diffraction data collection
Random and sparse matrix screens [52] prepared with the
HamiltonSTAR robot in the Institute of Biotechnology at
the University of Helsinki were initially used to search for
suitable conditions for crystallization of BBP-A. Sitting
drops of equal volumes (100 nl) of sample and well solu-
tion were automatically prepared by the Cartesian
MicroSys robot on 96-well Greiner 3-SQ plates at 20°C.
For optimization, the drop size was increased to 2 μl and
crystallization was performed on conventional 24-well
crystallization plates (Nextal/Hampton Research) using
the vapour diffusion method and either sitting or hanging
drops. In order to prepare BBP-A – BTN complexes, BTN
(Sigma) diluted in buffer containing 5 mM Tris (pH 8.8)
and 8 mM CHES (pH 9.5) was added to the protein sam-
ples in an approximate 1:10 molar ratio before crystalliza-
tion. Two crystals were used to collect diffraction data and
were obtained from conditions where 1 μl of protein solu-
tion (~0.4 mg/ml) containing 50 mM sodium acetate (pH
4.0) and 100 mM sodium chloride, and 1 μl of well solu-
tion containing either 2 M ammonium sulphate and 5%
isopropanol (v/v) (BBP-A – BTN crystal) or 0.2 M sodium
acetate, 0.1 M Tris (pH 8.6) and 30% (v/v) PEG 4000
(BBP-A – BSO crystal) were used. The diffraction data were
collected at the MAX-lab beam line I711 (Lund, Sweden)
at 100 K using a MarCCD detector. The BBP-A – BTN and
BBP-A – BSO crystals were cryoprotected by adding 0.8 μl
of 100% glycerol and 1 μl of 4 M sodium formate, respec-
tively, to the crystallization drops just prior to flash-freez-
ing in a 100 K liquid nitrogen stream (Oxford
Cryosystem). Diffraction data were processed with pro-
grams of the XDS program package [53]. The data collec-
tion statistics are summarized in Table 3.
Structure determination
The X-ray structures of BBP-A – BTN and BBP-A – BSO
were solved using the molecular replacement programPage 17 of 20
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AVR2 [PDB: 1WBI] [24] was used as a trial model in
Amore to solve the BBP-A – BTN structure. The BBP-A –
BSO structure, in turn, was solved using the BBP-A – BTN
structure as a search model in Amore. The best solutions
from molecular replacement were selected as input for
automatic model building with ARP/wARP [57]. The
models were refined with Refmac5 [58], and modified
and rebuilt with O [59]. Solvent atoms were added to the
model with an automatic procedure in ARP/wARP [60]
and other non-protein atoms were built manually in O.
The coordinate file of the BSO ligand was obtained from
the Cambridge Structural Database (CSD version 5.26)
and molecular topologies of BSO were created with
PRODGR [61]. The BBP-A structures were analyzed with
the programs PROCHECK [62] and WHATIF [63]. The
structure determination statistics are summarized in Table
3. The coordinates and structure factors of the BBP-A –
BTN and BBP-A – BSO structures have been deposited in
the Protein Data Bank with entry codes 2C1Q and 2C1S,
respectively.
Miscellaneous methods
Figures 2, 3, 4, 5 were created with the PyMOL Molecular
Graphics System [64] and edited with the Corel Draw11
program suite. The multiple sequence alignment shown
in Figure 2 was created using the program Malign imple-
mented in BODIL [65]. Electrostatic potentials were calcu-
lated using the ABPS [66] plugin of PyMOL. The programs
Contact and Areaimol [67] of the CCP4i suite were used
to calculate the solvent accessible surface areas and to
identify residues at the subunit interfaces, respectively.
Expressed sequence tag (EST) databases at NCBI were
searched (blastn [32]) using the cDNA of BBP-A [Gen-
Bank: BX930135] and AVD [GenBank: X05343] as query
sequences.
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Dual chain avidin 2
RATIONAL MODIFICATION OF LIGAND-BINDING
PREFERENCE OF AVIDIN BY CIRCULAR
PERMUTATION AND MUTAGENESIS
Juha A. E. MÄÄTTÄ[a], Tomi T. AIRENNE[b], Henri R. NORDLUND[a], Janne
JÄNIS[c], Tiina A. PALDANIUS[a], Pirjo VAINIOTALO[c], Mark S. JOHNSON[b],
Markku S. KULOMAA[a] and Vesa P. HYTÖNEN*[a]
Chicken avidin is a key component used in a wide variety of
biotechnological applications. Here we present a circularly permuted
avidin (cpAvd4?3) which lacks the loop between beta strands 3 and
4. Importantly, the deletion of the loop has a positive effect on the
binding of 4’-hydroxyazobenzene-2-carboxylic acid (HABA) to avidin.
In order to increase the HABA-affinity of cpAvd4?3 even further, we
mutated asparagine 118 on the bottom of the ligand-binding pocket to
methionine, which simultaneously caused a significant drop in biotin-
binding affinity. The X-ray structure of cpAvd4?3(N118M) allows an
understanding of the effect of mutation to biotin-binding, whereas
isothermal titration calorimetry revealed that the relative binding
affinity of biotin and HABA had changed by over one billion-fold
between wild-type avidin and cpAvd4?3(N118M). In order to
demonstrate the versatility of the cpAvd4?3 construct, we have
shown that it is possible to link cpAvd4?3 and cpAvd5?4 to form the
dual chain avidin called dcAvd2. These novel avidins may serve as a
basis for the further development of self-organizing nanoscale avidin
building blocks.
Introduction
Avidin is a tetrameric glycoprotein which has four identical
subunits, each composed of eight antiparallel b-strands.[1] Avidin
and its prokaryotic analogues streptavidin,[2] bradavidin[3] and
rhizavidin[4] bind D-biotin with extremely high affinity (Kd?? 10–15 M
for avidin). This strong interaction is widely exploited in so-called
avidin-biotin technology.[5, 6]
Avidin and streptavidin, (strept)avidin, have previously been
genetically engineered in various ways, recently reviewed by
Kulomaa and associates.[7, 8] Recently, a circular permutation
strategy was used to join avidin subunits within a single
polypeptide chain, forming both dual chain avidin (dcAvd)[9] and
single chain avidin (scAvd),[10] which respectively display two and
four ligand-binding sites, each of which can be independently
modified to bind different ligands with varying affinities. A dual-
affinity avidin has already demonstrated the feasibility of this
concept.[11] Streptavidin has also been subjected to circular
permutation[12] and subunit fusion.[13]
 When D-biotin is bound to streptavidin, only 18 Å2 of the
ligand surface is accessible to a solvent. In a circularly permuted
form of streptavidin where the loop connecting b-strands 3 and 4
was deleted the solvent-accessible surface increased to 57 Å2,
and the carboxylate group of D-biotin became more exposed.[12]
In avidin, proteinase K cleaves the analogous loop, and protease
K-treated avidin has been reported to display enhanced affinity
towards the azo-compound HABA (4’-hydroxyazobenzene-2-
carboxylic acid).[14] Streptavidin has a lower affinity towards HABA
(Kd = 1.4 × 10-4 M)[15] than avidin (Kd = 6.0  ×  10-6 M),[16, 17] which
difference can at least partially be explained by the fact that the
L3,4 loop, known to be important for ligand binding, is shorter in
streptavidin than in avidin.[18, 19] Accordingly, it has been observed
that AVR4, an avidin-related protein,[20, 21] also exhibits lower
affinity for HABA in comparison to avidin, most probably because
AVR4 has a kinked and therefore shorter L3,4 loop.[22]
In the present study, we constructed a novel circularly-
permuted form of avidin, cpAvd4?3, in order to alter the ligand-
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2binding preferences of avidin and to increase the potential
of avidin to bind ligands larger than biotin. A point mutation
N118M (numbering according to wt avidin), was introduced
into cpAvd4?3 in order to increase affinity for HABA and to
reduce that for biotin.
Further, cpAvd4?3 was fused to the C-terminus of
cpAvd5?4, another circularly permuted form of avidin,[9]
creating a novel fusion of avidin subunits, designated dual
chain avidin 2 (dcAvd2), possessing advanced structural and
functional characteristics.
Avidin and streptavidin are examples of widely used
protein bio-tools. They are utilized in technologies ranging
from the biosciences and medicine to material science.[6, 23, 24,
25] The extreme affinity for the small biotin ligand and the high
stability of these proteins has encouraged scientists to develop
them further to meet the growing needs of bio- and
nanotechnology.
Results and Discussion
Novel circularly permuted avidins
CpAvd4?3 and dcAvd2 were successfully purified by 2-
iminobiotin and cpAvd4?3(N118M) by biotin affinity
chromatography. The final products were highly pure and had
correct size according to SDS-PAGE analysis (Figure 1).
Figure 1. Western blot and SDS-PAGE-based thermal stability assay. A,
Western blot analysis of the purified proteins, avidin, avidin(N118M) mutant,
cpAvd4?3, cpAvd4?3(N118M), dcAvd2 and low molecular weight marker. B,
thermal stability assay of cpAvd4?3 protein at temperatures of 50, 55, 60, 65
ºC and low molecular weight marker. The loss of quaternary structure of
cpAvd4?3 was observed at 55 ºC.
However, in the case of dcAvd2, a significant amount of an ~20
kDa form was observed in addition to the protein of expected size
(~30 kDa). The smaller polypeptide chain detected in the dcAvd2
samples was likely due to a proteolytic cleavage. A typical yield
after purification was ~5 mg of protein per litre of bacterial culture.
Gel filtration chromatography showed the homogeneity of the
purified proteins, all being detected as single peaks in the
analysis (not shown).
The calculated molecular masses of the protein forms
(cpAvd4?3, cpAvd4?3(N118M) and dcAvd2) produced in
Escherichia coli (E. coli) were 47-56 kDa, which are lower than
the theoretical mass values of the corresponding tetramers (57-
58 kDa) (Table 1). However, this is a typical behaviour of avidin,
as observed in our previous studies.[11]
Mass spectrometry
ESI FT-ICR mass spectrometry was used to confirm the amino
acid sequence and proper folding of the proteins (mass spectra
data not presented). For some unknown reason dcAvd2 was the
only protein which could not be identified by this method. The
most abundant isotopic masses were determined to be 14685.52
± 0.07 Da for Avd(N118M), 14285.24 ± 0.01 Da for cpAvd4?3
and 14302.18 ± 0.03 Da for cpAvd4?3(N118M). The determined
mass of Avd(N118M) was as expected (calc. 14685.50 Da), but
the masses of both cpAvd4?3 and cpAvd4?3(N118M) were
about 14 Da higher as compared to their expected, calculated
values of 14271.18 and 14288.17 Da, respectively. This result
would suggest protein methylation (theor. + 14.016 Da).
When the disulfide bridges were reduced, the most abundant
isotopic masses of the proteins increased by two Daltons as
expected, indicating proper folding. This also further supports the
conception that the mass shift of ~14 Da could be a result of
methylation. Post-translational protein methylation is a common
amino acid modification, known to occur at the side chains of
many amino acids.[26] We have further identified and localized
post-translational methylation in cpAvd4?3(N118M) using on-line
digestion combined with ESI FT-ICR tandem mass spectrometry
(Jänis J. et al., unpublished results). A single methylation site in
one of the serine residues in cpAvd4?3(N118M) was
unambiguously observed, revealing a previously unknown protein
modification.
Table 1. Oligomeric size of the proteins. [a]
Protein Elution time[b]
-BTN
MW (kDa)
-BTN
Elution time[b]
+BTN
MW (kDa)
+BTN
Avidin 28.23 52.9 27.97 56.1
cpAvd4?3 29.03 44.3 28.78 46.9
cpAvd4?3(N118M) 28.69 47.8 28.70 47.7
dcAvd2 27.91 56.8 27.95 56.3
[a] The apparent molecular weights (MW) obtained by gel filtration analysis are
indicated. [b] Elution time in minutes.
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Deletion of critical residues in the
L3,4 loop by circular permutation
reduces biotin affinity
The biotin-binding properties of the
engineered avidins were studied by
measuring the dissociation of
fluorescent biotin conjugate BF-560-
biotin. At 25 °C, cpAvd4?3 showed
an eight-
fold higher dissociation rate
compared to wt avidin. In comparison,
dcAvd2, having dissimilar subunit
pairs, showed a three-fold
increased dissociation rate compared
to avidin. Half of the binding sites
were assumed to behave as in wt
avidin (in dcAvd2 the circularly permuted subunit cpAvd5?4
should according to
our knowledge have wt-like biotin-binding properties),[9] thus  a
four-fold increased dissociation rate was attributed to the
cpAvd4?3 subunit of dcAvd2.
At 50 °C, cpAvd4?3 showed the highest dissociation rate for
biotin, evincing about 20-fold weaker binding compared to avidin.
DcAvd2 had an about five-fold faster dissociation rate compared
to avidin. When the data were analyzed as described above,
subtracting the contribution due to the wt-like subunit, the
dissociation rate of biotin from the cpAvd4?3 subunit of dcAvd2
was found to be about ten-fold faster as compared to avidin
(Table 2).
The dissociation rate of d-[8,9-3H]biotin from the protein
samples was measured at different temperatures (Figure 2).
Avidin had the slowest dissociation rate of d-[8,9-3H]biotin over
the entire temperature range analyzed, and as assumed, dcAvd2
had a slower dissociation rate for biotin than cpAvd4?3.
Figure 2. Radiobiotin assay. Dissociation rates determined using d-[8,9-
3H]biotin at various temperatures are shown.
The affinity of avidin for biotin was too tight to be measured by
isothermal titration calorimetry (ITC), but the binding constant (Kb)
and dissociation constant (Kd =  1/Kb) could be solved for the
modified avidins (Figure 3). If the wild type binding site
(cpAvd5?4) of dcAvd2 is assumed to bind biotin with femtomolar
(10-15 M; wt-like) affinity, the biotin affinity of the other circularly
permuted binding site (cpAvd4?3) can be directly determined
from the data. The cpAvd4?3 subunit in fusion with cpAvd5?4
of dcAvd2 seemed to have a slightly higher affinity for biotin as
compared to the tetrameric cpAvd4?3. Moreover, the N118M
point mutation reduces the biotin-binding affinity of the cpAvd4?3
protein about five-fold (Table 3).
Novel circularly permuted avidin has altered
thermodynamics and increased affinity for HABA
Our ITC experiment revealed that avidin binds HABA with
moderate affinity (Kd = 7.9 × 10-6 M), which is in good agreement
with the previously published result of Kd =  6  ×  10-6 M (Green
1975), whereas its bacterial analogue streptavidin has a weaker
HABA-binding affinity (Kd = 1.4 × 10-4 M).[15] The different HABA-
binding affinities of avidin and streptavidin are thought to result
from the varying architecture of the L3,4 loop, i.e., its
conformation and primary structure, as also noted in the case of
AVR4.[22] Our working hypothesis here was that by deleting the
L3,4 loop from wt avidin using a circular permutation strategy, the
HABA-binding affinity of avidin could be increased. This was
tested by measuring the HABA-binding affinities of cpAvd4?3
and wt avidin using ITC. It emerged that the cpAvd4?3 construct
had indeed stronger affinity to HABA (Kd =  5.4  ×  10-6 M)  as
compared to wt avidin (Kd = 7.9 × 10-6 M).
Table 3. Thermodynamic analysis of ligand binding using ITC.
Protein ?H
kcal/mol
-T?S
kcal/mol
?G
kcal/mol
Kd
M
BTN
Avidin -23.0±0.2 4.4[b] -18.6[b] 1.3 x 10-15[a]
Avidin(N118M) -16.4±0.1 5.0 -11.4 (4.2±0.2) x 10-9
cpAvd4?3 -17.6±0.1 7.2 -10.4 (1.4±0.3 ) x 10-8
cpAvd4?3(N118M) -8.3±0.1 -0.7 -9.0 (2.4±0.4) x 10-7
HABA
Avidin 1.9±0.03 -8.8 -7.0 (7.9±0.1) x 10-6
Avidin(N118M) -0.8±0.02 -6.4 -7.2 (5.2± 0.5) x 10-6
cpAvd4?3 -3.5±0.06 -3.6 -7.1 (5.4±0.7) x 10-6
cpAvd4?3(N118M) -5.1±0.05 -3.0 -8.1 (1.0±0.2) x 10-6
[a] Ref.[29] [b] Calculated from the Kd value.
Table 2. Dissociation analysis of fluorescent biotin.
Protein kdiss (×10-5) s-1M-1 at 25 °C Release (%) kdiss (10-5) s-1M-1 at 50 °C Release (%)
Avidin 2.3[a] 14.1[a] 27.4[b] 71.5
Avidin(N118M) >300[e]
cpAvd4?3 18.7 46.8 449.9[c]
cpAvd4?3(N118M) >300[e]
dcAvd2 5.3/7.81[d] 17.7 135.3[c]/200[d] 71.0
dcAvd 1.5 6.0 41 77.9
[a] Ref.[27] [b] Ref.[28] [c] Determined during the first 500 seconds of the measurement. [d] Half of the binding sites
were assumed to behave like wt avidin. The fitting was performed only for the first 500 seconds. [e] The
dissociation rate was already too fast to be measured accurately at 10 °C.
4The reaction between avidin and biotin is strongly exothermic
??H = -23.0 ± 0.2 kcal/mol). In contrast, that between HABA and
avidin is endothermic (?H = 1.9 ± 0.03 kcal/mol) and thus the
moderate binding affinity is entropy-driven. Our ITC analysis
showed the interaction of HABA with Avd(N118M), cpAvd4?3 or
cpAvd4?3(N118M) to be exothermic. The most markedly
exothermic reaction with HABA was measured for
cpAvd4?3(N118M), which has about six-fold more favourable
enthalpy compared to Avd(N118M) and one and a half-fold more
favourable compared to cpAvd4?3 (Table 3). The calculated
entropy term was found to be beneficial for binding in every
HABA-binding reaction analyzed here.
A problem arises in calorimetric measurements in that the wt
biotin-binding site of dcAvd2, i.e., the cpAvd5?4 subunit, binds
HABA in an endothermic manner, whereas the cpAvd4?3
subunit binds HABA in an exothermic manner. Since it is possible
to see only the sum of the energies, the net sum of the observed
heat of the binding reaction for dcAvd2 was almost zero (Figure
4) and therefore the affinity of the two different kinds of binding
sites of dcAvd2 to HABA could not be determined.
Mutation N118M increases HABA-binding and reduces the
biotin-binding affinity of avidin
The mutation N118M was designed based on the known X-ray
structures of the avidin-biotin (PDB entry 2AVI)[1] and avidin-
HABA complexes.[19] In the structure of the avidin-biotin complex,
the side chain of Asn118 is
hydrogen bonded to biotin (Figure
7(a)), whereas in the avidin-HABA
structure there is no significant
interaction between the side chain
of Asn118 of the avidin and HABA
(Figure 7(b)). Therefore, a
mutation at Asn118 which
eliminates the hydrogen bond
should lead to a decrease in the
biotin-binding affinity of avidin.
Methionine was chosen to replace
asparagine, because its long and
flexible side chain was assumed to
constitute steric hindrance for
biotin. Also preliminary
experiments between different
kinds of mutations made by
Paldanius et al. (manuscript)
revealed that methionine caused
largest changes in both biotin and
HABA binding. Indeed, using ITC,
a significant decrease in the biotin-
binding affinity of avidin was
observed for an Avd(N118M)
mutant. As a result of the N118M
mutation, the extremely strong
femtomolar biotin-dissociation
constant of wt avidin[29] was
reduced to a nanomolar value (Kd
= 4.17 × 10-9 M). Furthermore, the
enthalpy of the Avd(N118M)-biotin
binding (DH = -16.4 ± 0.1 kcal/mol)
was only two-thirds that of the
Avd-biotin binding (DH  =  -23.0  ±
0.2 kcal/mol) (Table 3). The point
mutation N118M seemed to have
a clear effect on the biotin dissociation rate: Avd(N118M) has an
~2500-times higher d-[8,9-3H]biotin dissociation rate than wt
avidin. The N118M mutation was also introduced into the
cpAvd4?3 construct (cpAvd4?3(N118M)). It had, in turn, a very
fast dissociation rate (kdiss » 4  ×  10-3 s-1) even at a low
temperature of 10 °C. The corresponding dissociation rate of
avidin would be about 10-8 s-1 if extrapolated from the measured
data (see Figure 2). At higher temperatures, the dissociation rate
of cpAvd4?3(N118M) for biotin was too fast to be determined
accurately (Figure 2).
 In contrast to biotin, HABA has been observed to bind to
Avd(N118M) slightly more strongly than to wt avidin: analysis
using fluorescence spectrometry showed an apparent Kd =  6.3
×10-5 M for the avidin-HABA complex and a Kd = 0.6 ×10-5 M for
Avd(N118M)-HABA (Paldanius et al. manuscript). Our ITC
measurements were in agreement with these results – the HABA-
binding affinity was almost the same for both Avd(N118M) (Kd =
5.2 ×10-6 M) and cpAvd4?3 (Kd =  5.4  ×10-6 M),  i.e.,  both  have
higher affinity for HABA than wt avidin (Kd = 7.9 × 10-6 M; Table 3).
Figure 3. ITC diagrams. A, avidin; B, Avd(N118M); C, cpAvd4?3; D,
cpAvd4?3(N118M); E, dcAvd2. Biotin titrations are shown on the left and
HABA titrations on the right panel. All measurements were made at 25 °C.
5Figure 4. The ligand binding sites of dcAvd2. A modelled structure of dcAvd2
with two different kinds of binding sites is presented. The cpAvd5?4 (blue) of
dcAvd2 has a wt-like binding site. It binds biotin with tight affinity (Kd = 10-15 M)
and HABA with moderate affinity (Kd = 10-6 M). The cpAvd4?3 subunit (green)
of dcAvd2 lacks the L3,4 loop (pink) and binds both HABA and biotin with
moderate affinity. The new N- and C-termini of cpAvd4?3 are marked with
purple dots. Diagrams represent thermodynamic values obtained from ITC
measurements – Gibbs free energy (DG, black bar), enthalpy (DH, red bar) and
the entropy term in measurement temperature (-TDS, grey bar). DcAvd2 –
HABA diagram shows combined energies of both cpAvd5?4 and cpAvd4?3
HABA binding events. The model was made by deleting by hand the L3,4 loop
from two of subunits from the X-ray structure of avidin.
Similarly to the result of mutation in the case of wt avidin, the
N118M mutation in cpAvd4?3 exerted the following effects: 1) it
reduced the affinity to biotin about 16-fold and 2) it increased the
affinity to HABA about five-fold compared to cpAvd4?3. Thus, of
all the avidin forms examined to date, the cpAvd4?3(N118M)
construct has the highest affinity for HABA (Kd =  1.0  ×  10-6 M;
Table 3).
Overall X-ray structure of cpAvd4?3(N118M)
The crystal structure of cpAvd4?3(N118M) in complex with D-
biotin was determined at 1.9 Å resolution. The structure
determination statistics are summarized in Table 4. Judging from
the 3D structure, the circular permutation strategy had not
affected the folding of cpAvd4?3(N118M). The overall structure
of cpAvd4?3(N118M) was tetrameric and highly similar to that of
chicken avidin[1] and bacterial streptavidin.[18, 30] However, in each
of the four b-barrel monomers of cpAvd4?3(N118M), the biotin-
binding pocket was less deeply buried and much more exposed
to solvent in comparison to wt avidin.[1, 31] This is due to the lack
of residues 39-44 of the L3,4 loop (numbering according to wt
avidin[1]) in the cpAvd4?3 construct and the artificial locations of
the N- and C-termini (Figure 5). In fact, the biotin-binding pocket
of cpAvd4?3(N118M) was even more open than the biotin-
binding site of streptavidin.[30] The average solvent-accessible
surface area of the bound biotin molecules in the avidin-biotin
(PDB entry 2AVI), streptavidin-biotin (PDB entry 1MK5) and
cpAvd4?3(N118M)-biotin complexes were
calculated to be 7, 18 and 22 Å2, respectively.
The  Ca atoms of the four subunits of
cpAvd4?3(N118M) were superimposed (subunits
B, C and D on A) with an rmsd (root mean
squared deviation) of 0.3 Å. Only slight variations
were detected in the fine architecture of the
different chains, mainly within the loop regions,
and probably caused by crystal packing effects.
Out of the 130 residues comprising
cpAvd4?3(N118M), residues 1-3 (chains A, C, D),
45-47 (A), 81 (A, C) and 82-95 (A-D) could not be
included in the final X-ray model due to the lack of
interpretable electron density around these
residues (high thermal motion). Residues 82-95
correspond to a linker region, which was
introduced in order to connect the N- and C-
terminus of wt avidin in forming the
cpAvd4?3(N118M) construct. In addition, the
subunit interfaces seen in cpAvd4?3(N118M)
were highly similar to those present in wt avidin.
Figure 5. A stereoview of the biotin-binding site of cpAvd4?3(N118M) and X-
ray structure of cpAvd4?3(N118M). Selected residues at the biotin-binding site
of cpAvd4?3(N118M) (chain C, orange; chain D, blue) and avidin-biotin
complex structure (PDB code 2AVI; chain A; green) are shown as stick models.
Only side chain atoms are shown. The amino acids are numbered according to
Ref 1. Bound biotin (BTN) ligands are shown as sticks. The labels for residues
6N12 and F72, which have clearly different conformations in chains C and D of
cpAvd4?3(N118M), as well as the N118M mutation and the C-terminal residue
(T38) of cpAvd4?3 are boxed and have yellow background. A part of the L3,4-
loop of avidin extending from T38 and not present in cpAvd4?3(N118M) is
drawn as a grey ribbon. B, structure of cpAvd4?3(N118M) showing the
secondary structure elements (ribbon model) and connecting loops. The
subunits are numbered according to ref. 1. C, molecular surface of
cpAvd4?3(N118M); D, avidin-biotin complex (PDB code 2AVI); and E,
streptavidin-biotin complex (PDB code 1MK5). The surfaces are colored blue
except for areas corresponding to atoms 6 Å from the C10 atom (naming
according to ref. 32) of biotin. These atoms are colored yellow to pinpoint the
entrances to the biotin-binding sites. The bound biotin molecules are shown as
spheres (oxygen atoms, red; carbon atoms, white; nitrogen atoms, blue; sulfur
atoms, yellow).
The biotin-binding site
All four subunits of cpAvd4?3(N118M) had biotin bound at the
ligand-binding site. However, the electron density around the
ligand of subunit C (BTN-C) was clearly weaker (data not shown),
and the B-factors for the ligand were higher in comparison to
biotin of the other subunits, indicating the higher thermal motion
and conformational flexibility of BTN-C. Phe72 at the biotin-
binding site of subunit C of cpAvd4?3(N118M) also exhibited a
conformation different from that seen in the other subunits, further
indicating the lower occupancy of BTN-C at subunit C. In
comparison to wt avidin (PDB entry 2AVI)[1] and streptavidin (PDB
entry 1MK5),[30] the overall biotin-binding mode of each subunit of
cpAvd4?3(N118M), as well as the conformations of the bound
biotin, were well conserved (Figure 6).
The hydrophobic side chain of Met118 of cpAvd4?3(N118M)
did, as expected, lead to different interactions with biotin in
comparison to wt avidin. The hydrogen bonds seen in the avidin-
biotin complex structure,[1] respectively between the side chains
of Asn12 and Asn118 of the protein and the oxygen (O2’) and
nitrogen (N3’) atom of the ureido ring of biotin (naming according
to DeTitta et al.),[32] were substituted either partially or completely
by weak (multi)polar and van der Waals interactions in the
cpAvd4?3(N118M) structure (Figure 7). In the ligand-binding
sites of subunits A-C of cpAvd4?3(N118M) (see, e.g., subunit B
in Figure 7(c)), a weak hydrogen bond between the O2’ atom of
biotin and the side chain nitrogen atom of Asn12 may exist as in
the wt avidin structure (Figure 7(a)), but in subunit D the
hydrogen bond was missing (Figure 7(d)). Moreover, the
hydrophobic side chain of Met118 could not form a strong
hydrogen bond with the N3’ atom of biotin in any of the subunits
of cpAvd4?3(N118M). This interaction is known to be important
for biotin binding in wt avidin, where the Asn118 side chain is
hydrogen-bonded to N3’.[1] In addition, the lack of the L3,4 loop
residues Ala39 and Thr40 of wt avidin at the biotin-binding site of
cpAvd4?3(N118M) made the site clearly more accessible to
solvent (see above; Figure 5),  while the biotin-binding mode was
nonetheless very similar to that in both streptavidin and wt avidin
(Figure 6). Some rearrangement of water molecules due to the
deletion of the L3,4 loop and the artificial C-terminus was,
however, detectable in the X-ray structure of cpAvd4?3(N118M).
For example, in chains C and D only, a water molecule was seen
between the C-terminal threonine residue and the carboxylic acid
group of biotin in the cpAvd4?3(N118M) structure.
Thermal stability of the novel proteins
The thermostability of cpAvd4?3, cpAvd4?3(N118M) and
dcAvd2 (Table 5) was analyzed using an SDS-PAGE assay.[35]
Tetramers of cpAvd4?3 without biotin were found to breakdown
into subunits at 55 °C and, in the presence of biotin, at 75 °C.
Similarly, cpAvd4?3(N118M) lost its quaternary structure at
50 °C without biotin and at 75 °C with biotin. DcAvd2, in turn, was
found to breakdown into subunits at less than 60 °C and with
biotin the breakdown temperature was found to be between 75
and 80 °C. By comparison, wt avidin breaks down in the presence
and absence of biotin at 95 and 60 °C, respectively (Table 5).
Conclusion
Since the cloning of the genes, numerous modified (strept)avidins
have been reported in which the pI, glycosylation, stability and
ligand-binding of these proteins has been altered, as recently
reviewed by Kulomaa and associates.[7] However, two relatively
recent innovations have had a major impact on the engineering of
(strept)avidin beyond the original products. First, the creation of
circularly permuted forms has made it possible to create mutant
proteins possessing new N- and C- termini at artificial locations. A
Table 4. Data collection and structure determination statistics for
cpAvd4?3(N118M).
Data collection[a]
Wavelength (Å)
Beamline
Detector
Resolution (Å)
Unique observations
I/sigma
Rfactor (%)[b]
Completeness
Redundancy
0.900
ID29 (ESRF)
ADSC
25 – 1.9 (2.0 – 1.9)
36425 (5172)
12.3 (3.2)
7.8 (48.2)
99.8 (99.9)
4.9 (5.0)
Refinement
Space group
Unit cell:
   a, b, c (Å)
   a, b, g (°)
Monomers (asymmetric unit)
Resolution (Å)
Rwork (%)[c]
Rfree (%)[c]
Protein atoms
Heterogen atoms
Solvent atoms
R.m.s.d:
   Bond lengths (Å)
   Bond angles (°)
P21
41.8, 79.3, 71.7
90, 98.7, 90
4
25 – 1.9
20.3
25.1
3556
64
172
0.013
1.6
[a] The numbers in parenthesis refer to the highest resolution bin. [b] Observed
R-factor from XDS.[33] [c] From Refmac 5 (TLS & restrain refinement).[34]
Table 5. Thermal stability of the proteins. [a]
Protein Tr (°C) -BTN Tr (°C) +BTN
Avidin 60 95
cpAvd4?3 55 75
cpAvd4?3(N118M) 50 75
dcAvd2 55 80
[a] Transition midpoint temperatures (Tr) of the
oligomeric disassembly measured by an SDS-PAGE-
based method are shown in the presence (+BTN) and
absence (-BTN) of biotin.
7circular permutation was originally observed in nature, as
reviewed by Grishin,[36] but was also applied to streptavidin[12] and
avidin.[9] Second, the introduction of the dual chain methodology[9]
based on circular permutation has made it possible to produce
rational designs generating chimeric avidins and, more recently,
streptavidins.[13]
 In the present study, our working hypothesis was that
removal of the L3,4 loop located between b-strands 3 and 4 of wt
avidin would alter its ligand-binding preferences, i.e., reduce the
affinity for biotin and increase for HABA. This hypothesis was
made based on results from Ellison and colleagues [14] and
comparisons of several crystallographic structures of
(strept)avidin. Furthermore, we sought to apply the recently
introduced dual chain technology to generate chimeric avidins
which would have a wt-like ligand-binding site and a binding site
lacking the L3,4 loop.
 Our topologically novel cpAvd4?3 construct was created as
follows: i) six amino acids, residues 39-44 of the original L3,4 loop
of wt avidin, were deleted; ii) the original N- and C-termini of wt
avidin were connected with a Ser-Gly-Gly-Ser (SGGS) linker and
iii) novel N- and C-termini were introduced – the translation of
cpAvd4?3 starts before the b4-strand and stops after the b3-
strand. The protein was successfully produced in E. coli, and
spectroscopic analyses showed that the affinity for HABA was
increased in comparison to the wt protein, albeit only a little. In
order to improve the HABA-binding properties of cpAvd4?3, we
introduced, based on the X-ray structures of avidin-biotin and
avidin-HABA complexes, a point mutation to the bottom of the
ligand-binding site. This mutation changed the polar side chain of
asparagine (Asn118) to the hydrophobic side chain of methionine,
thus directly modulating the physicochemical properties of the
binding site. In the X-ray structure of cpAvd4?3(N118M) (Figure
7), it can be seen that, depending on the conformation of Met118,
either one or two hydrogen bonds are eliminated. This is in good
agreement with our thermodynamic measurements (see below).
 Loss of the hydrogen bond between the ureido nitrogen and
streptavidin reduces the biotin-binding free energy by
approximately 4.3 kcal/mol.[30] Although the free energy of a
hydrogen bond can vary over -0.2 to -40 kcal/mol, as calculated
and reviewed by Stainer,[37] the hydrogen bonds in avidin-biotin
binding are thought to represent strong bonds with a free energy
of about four kcal/mol. Due to the lack of the amino acid residues
Ala39 and Thr40, which form hydrogen bonds with the carboxylic
tail of biotin,[38] cpAvd4?3 has two hydrogen bonds less than wt
avidin. The observed decrease in free energy (DDG = 8.2
kcal/mol) can be satisfactorily explained by the loss of the bonds.
Our thermodynamic measurements revealed that the difference in
Gibb’s free energy (DDG) between wt avidin and Avd(N118M)
was 7.2 kcal/mol, indicating that the N118M mutation affected
more than one hydrogen bond, or alternatively, the bond is co-
operative as in streptavidin.[30] Indeed, the bond between biotin
and the Asn12 side chain was found to be disturbed due to
mutation of N118M (Figure 7). These results could suggest that
cpAvd4?3(N118M) has significantly lower affinity for biotin in
comparison to either Avd(N118M) or cpAvd4?3. The ITC
experiments revealed that the biotin binding of
cpAvd4?3(N118M) was weakened 21% and 13% in terms of DG
when compared to Avd(N118M) and cpAvd4?3, respectively.
The ITC experiments also revealed that cpAvd4?3(N118M) had
increased affinity for HABA in comparison to wt avidin,
Avd(N118M) or cpAvd4?3. Although we were not able to convert
the ligand-binding preference of avidin to favour HABA over its
natural ligand biotin, the relative binding affinity was modified over
one billion-fold. The relative dissociation constant
Kd(BTN)/Kd(HABA)  =  1.64  ×  10-10 for wt avidin was changed to
Kd(BTN)/Kd(HABA) = 0.23 for cpAvd4?3(N118M).
Thermodynamic ITC measurements showed that the
endothermic binding of HABA to wt avidin was changed
dramatically to an exothermic binding reaction in the case of
cpAvd4?3 and cpAvd4?3(N118M). However, the net entropy
term (TDS) for both decreased at the same time, which is
thermodynamically the reason why even higher affinities were not
observed. It has been reported that the binding of HABA to avidin
leads to displacement of five water molecules from the binding
site.[19] This displacement is favourable in terms of entropy, and
although the binding of HABA is stabilized by hydrogen bonds,
binding does not take place without energy contributions from the
surrounding solution; this can be detected as a positive net
enthalpy in ITC measurements.
 These previous reasons may also clarify the observed,
enhanced HABA-binding and the reduced biotin-binding
properties of cpAvd4?3. The avidin-biotin complex, one of the
tightest non-covalent ligand-protein complexes, is known to be
well optimized, having a large number of hydrogen bonds and
van der Waals interactions.[1] Since cpAvd4?3 lacks the L3,4
loop, two hydrogen bonds stabilizing the interactions between wt
avidin and the valeryl moiety of biotin are lost, this at least
partially explains the decreased affinity of cpAvd4?3 for biotin
(Figure 6). On the other hand, the deletion of the L3,4 loop ‘opens
the lid’ of the ligand-binding pocket and leaves the pocket more
exposed to solvent. Interestingly, deletion of the L3,4 loop or the
N118M mutation alone does not cause a clear change in the
entropy term when compared to wt avidin, whereas the point
mutation N118M and loop deletion together affect the entropy
term such that it favours biotin binding. Favourable entropy is
usually observed when water molecules are liberated upon burial
of a hydrophobic surface.[39] In the case of avidin-biotin complex,
ligand binding stabilizes the structure of avidin, reducing the
number of internal degrees of freedom in the system, which leads
to the unfavourable contribution of the free energy (negative
DS).[40] In the case of cpAvd4?3(N118M), the entropy term of
biotin-binding changed to a positive sign, thus favouring binding,
which is totally opposite to any other cases of avidins or
streptavidins.[30] The effect of the positive entropy on binding at
room temperature is over 5 kcal/mol when compared to biotin
binding of wt avidin and cpAvd4?3(N118M).
 We successfully created a novel subunit fusion form of
avidin, dcAvd2, by fusing cpAvd4?3 to the C-terminus of
cpAvd5?4. Judging from our ITC measurements, the fusion of
cpAvd4?3 to cpAvd5?4 did not seem to affect the biotin-binding
properties of the subunit; cpAvd4?3 of dcAvd2 binds biotin in a
manner similar to the “non-fused” form. Importantly, analysis of
dcAvd2 using ITC indicated a HABA-binding enthalpy of -2.3
kcal/mol, which agrees with the theoretical value of -1.6 kcal/mol
obtained by summing the separately determined enthalpies for
the wt and cpAvd4?3 proteins (Figure 4).
 What is the added value of the “next-generation” avidins
presented here? There is a significant demand for advanced tools
in biotechnology and nanotechnology, especially as more and
more experimental systems are miniaturized on nanometer scale.
Furthermore, strept(avidin) with novel properties, especially
multiple binding sites which can be specifically and separately
targeted for binding, would facilitate the development of more
complicated assay systems or materials than those now available.
One demand in both biotechnology and nanotechnology is
for new binders for new ligands. The biotin-binding site of
strept(avidin) is well known and fairly flexible physically – thus
offering excellent starting material which can be modified to bind
8new or existing ligands with good specificity and affinity. Although
the avidin forms presented here do not yet completely fulfil these
requirements with regard to biotin- and HABA-binding, the
conceptual steps made here bring us closer to more sophisticated
protein engineering for that purpose.
Figure 7. Mutation N118M. The putative hydrogen bonding of amino acid
residues N12 and N118 with biotin (BTN; in A, C-E) or HABA (in B)  are
illustrated with dotted lines. A, avidin-biotin complex (chain A; PDB code 2AVI);
B, avidin-HABA complex[19]; C, subunit II of cpAvd4?3(N118M); and D, subunit
IV of cpAvd4?3(N118M). Only the side-chain atoms of residues N12 and N118,
or a portion of the BTN and HABA structures near these residues, are shown as
sticks (C, grey; N, blue; O, red; S, yellow). E, 2Fo-Fc electron density map
(blue) calculated in the absence of biotin and contoured at 1? around the
residues shown in D is drawn.
Experimental Section
D-biotin was obtained from Sigma Chemicals. Chicken avidin, a
generous gift from Belovo S. A. (Bastogne, Belgium), was used
as control protein in all analyses. Low molecular weight marker
was obtained from New England BioLabs or Fermentas. The
concentration of the avidin solution was calculated from the
absorbance at 280 nm using an extinction coefficient of 24280 M-1
cm-1 per binding site.
The nucleotide and amino acid sequences of the studied
proteins are available at EMBL (http://www.ebi.ac.uk/embl/) with
the following access numbers: cpAvd4?3, AM779410;
cpAvd4?3(N118M), AM779411 (named in the database
cp43N76M); dcAvd2, AM779412; and dcAvd, AJ616762.
Design and mutagenesis of the expression constructs
In order to construct a DNA encoding for circularly-permuted
cpAvd4?3, PCR reactions were performed using
oligonucleotides 5.4N2 and 3.4C1 in the first reaction,
oligonucleotides 3.4N1 and 5.4C1 in the second (Supplementary
data, Table SI) and the cDNA of wt avidin as template. The
resulting DNA fragments were connected together using another
round of PCR, using primers overlapping the PCR products from
the first and second PCR reactions, together with a DNA
sequence encoding the polypeptide linker connecting the original
termini. The resulting DNA (cpAvd4?3) was cloned into a
pGemTeasy vector containing attL recombination sites and a
DNA sequence encoding for the ompA signal peptide [41].
Mutagenesis of cpAvd4?3 was carried out with the QuikChange
mutagenesis kit (Stratagene, La Jolla, CA, USA). In order to
create the expression construct for dcAvd2, cpAvd4?3 was
digested with the restriction enzymes BamHI and HindIII and
subcloned into a pGemTeasy vector already containing the
coding sequence for cpAvd5?4.[9]
Production and purification of the expressed recombinant
proteins
In order to achieve bacterial secretion for cpAvd4?3 and dcAvd2,
the signal peptide from the OmpA-protein was used at the N-
terminus of the expressed proteins as previously described.[41]
For expression, the DNA constructs were transferred into a
pBVboostFG plasmid[42] using the Gateway LR-cloning reaction
(Invitrogen). E. coli BL21-AI cells (Invitrogen) were used for
protein production. The expression constructs were validated
using DNA sequencing (ABI PRISM 3100 Genetic Analyzer,
Applied Biosystems).
Protein purification was accomplished in a single step using
either 2-iminobiotin- or biotin-Sepharose 4 Fast flow (Affiland)
affinity chromatography columns as previously described.[43]
Protein concentration was determined by UV/VIS
spectrophotometer (ND-1000 NanoDrop Spectrophotometer) by
measuring the absorbance at 280 nm and using an extinction
coefficient of 23615 M-1cm-1 for cpAvd4?3 and 48320 M-1cm-1 for
dcAvd2.
Isothermal titration calorimetry
High-sensitivity VP-ITC titration calorimetry (Microcal Inc.,
Northampton, MA) was used to measure heat release or uptake,
which is mostly associated with ligand binding but may also
reflect conformational changes. All protein samples were dialyzed
against a buffer containing 50 mM sodium phosphate, 100 mM
NaCl (pH 7.0) or 0.1 mM potassium acetate (pH 5.0); solid biotin
and HABA were dissolved in the same dialysis buffer as protein.
In order to eliminate air bubbles and long equilibration periods,
prior to VP-ITC analysis, the sample solutions were degassed
and preheated near the measuring temperature (25 °C). Biotin
(0.1 – 0.4 mM) or HABA (1.0 – 1.2 mM) was injected into the
calorimeter cell containing protein samples (0.01 – 0.1 mM) at 4-5
minute intervals. The titration cell was stirred continuously at 440-
510 rpm. Both ligand-to-buffer and buffer-to-protein titrations were
made in order to detect and correct the heat effect of dilution.
The heat of binding after each injection was calculated by
integrating the area of the measured peak using the ORIGIN
software suite (v 7.0 SR4, Originlab Corporation) tuned to the ITC
instrument. All data except those related to dcAvd2 were
analyzed with the “One Set of Sites” fitting procedure. The “Two
Sets of Sites” procedure, designed for cases where two different
kinds of binding sites exist, was used for dcAvd2. The heat (Q)
evolving from each titration can be represented by equation [1]:
DQ = V0DH[M]tKa[L]/(1+ Ka[L]), [1]
where  V0 is the volume of the calorimeter cell, DH is the
enthalpy of binding per mole of ligand, [M] t is  the  total
macromolecule concentration, Ka is the association constant, and
[L] the free ligand concentration. The values of DH and Ka can be
determined directly from the chromatogram for a titration,
whereas the change in Gibb’s free energy term DG  and  its
entropic component TDS can be calculated from equations [2]
and [3]:
DG = - RT ln Ka [2]
DG = DH - TDS, [3]
where R is the gas constant and T is the temperature in
kelvins.
9Biotin dissociation assays
The biotin-binding properties of avidin, cpAvd4?3,
cpAvd4?3(N118M) and dcAvd2 were studied by measuring the
dissociation of d-[8,9-3H]biotin and fluorescent biotin from these
proteins. The dissociation of d-[8,9-3H]biotin (Amersham) was
determined at different temperatures as described by Klumb and
colleagues[44] The dissociation of fluorescent biotin was detected
by measuring the reversal of quenching of the biotin-coupled
fluorescent probe ArcDia™ BF560 (ArcDia Ltd., Turku, Finland)
after addition of a 100-fold molar excess of free biotin; analyses
were made in a 50 mM sodium phosphate (pH 7.0) buffer
containing 650 mM NaCl at two different temperatures (25 ± 1 °C
and 50 ± 1 °C) and using a PerkinElmer LS55 luminometer as
previously described.[41]
The fluorescence data were interpreted using the “single
phase dissociation model” as described elsewhere.[41] The
dissociation rate constants (kdiss) were determined using the
equation [4]:
–kdisst = ln(B/Bo),  [4]
where  Bo is the maximum binding (100 %) measured (the
difference between the fluorescence of the free dye and that of
the protein-dye complex) and B is the amount of complex
measured as a function of time. The first 500 seconds of
measurements were omitted from the analyses to abolish the
“fast initial phase” effect, which is characteristic of the avidin-
BF560-biotin interaction.[11] The release of the fluorescent biotin
was determined after one hour of measurements. In order to
determine the dissociation rate for the cpAvd4?3 subunit of
dcAvd2, half of the four biotin-binding sites were hypothesized to
behave as in wt avidin and a ligand dissociation model was fitted
to the subtracted data as previously described for other dual
chain avidins.[11]
Size exclusion chromatography
The oligomeric state of the proteins was assayed at +4 °C using
the Superose 6 10/300 GL (Tricorn) gel filtration column and the
ÄKTA Purifier 10 Chromatgraphy system as previously
described.[27] A buffer containing 50 mM sodium phosphate buffer
(pH 7.0) and 650 mM NaCl was used as the running buffer and
gel filtration was performed with a flow rate of 0.5 ml/min. The
high concentration of NaCl reduces the binding of the basic avidin
protein (pI ? 10.5)[29] to the chromatography column. The gel
filtration MW standards were bovine thyroglobulin, bovine
gamma-globulin, chicken ovalbumin, horse myoglobin and
vitamin B12 (Gel Filtration Standard, Bio-Rad).
SDS-PAGE-based thermostability assay
Protein samples with biotin, HABA or both ligands were
acetylated in vitro and the temperature-dependent dissociation of
the subunits was monitored. Samples were heated to a given
temperature between 25 °C and 80 °C for 20 minutes. The
oligomeric state of the protein was analyzed by SDS-PAGE in the
presence of 2-mercaptoethanol and the gels were stained with
Coomassie blue.[35]
Disulfide bridge reduction
Disulfide reduction was obtained using the protocol of Scigelova
and colleagues.[45] Briefly, the protein sample with an excess
amount of DL-dithiothreitol (Sigma-Aldrich, St. Louis, MO) was
incubated at 70 °C for 5 min, after which the sample tube was
placed on ice and diluted with an appropriate solvent for mass
spectrometry.
Mass spectrometry
All mass spectrometric experiments were performed on a 4.7-T
Bruker APEX-Qe hybrid Fourier transform ion cyclotron
resonance (FT–ICR) instrument (Bruker Daltonics, Billerica, MA,
USA), having a mass-selective quadrupole interface. Ions were
produced in an external Apollo II dual ion-funnel electrospray
ionization (ESI) source. For broadband spectra (m/z 400-4000),
the quadrapole was operated in an RF-only mode and ions were
accumulated in the second hexapole (collision cell) for 50-100 ms.
Ions were then transmitted through a high voltage ion optics
region, prior to “Sidekick” trapping inside the Infinity ICR cell. Ions
were excited by a conventional “RF-chirp” and detected in a direct
broadband mode. A total of eight co-added, 512-kWord time-
domain transients were acquired, zero-filled twice, followed by
magnitude calculation, fast Fourier transform and external
frequency-to-m/z calibration with respect to the ions of an ES
Tuning Mix (Agilent Technologies, Santa Clara, CA). All data
were processed using Bruker XMASS 7.0.8 software.
Determination of HABA affinity by fluorescence
spectroscopy
The HABA-binding affinity of Avd(N118M), cpAvd4?3,
cpAvd4?3(N118M) and dcAvd2 was measured using
fluorescence spectroscopy. The protein samples (50 nM) in
neutral 50 mM phosphate buffer containing 650 mM NaCl were
titrated with increasing concentrations of 4’-hydroxyazobenzene-
2-carboxylic acid (HABA). The samples were excited using a
wavelength of 280 nm, emission was measured at 350 nm, and
the decrease in intrinsic fluorescence of avidin as a result of
HABA binding was monitored. However, since HABA absorbs
light also when not bound to protein, there is an error component
which cannot be fully subtracted from the data. Thus only the
apparent dissociation constants could be measured using this
method.
The affinity of HABA to different avidin forms was determined
using UV/VIS spectrometer. The assay is based for the colour
change of the HABA due to complexation with avidin [16]. The
concentration of the avidin-HABA complex was determined by
using extinction coefficient of 35500 cm–1 at 500 nm wavelength.
X-ray structure determination
The ClassicsTM (Nextal Biotechnology) screen, the vapour
diffusion method and sitting drops on 96-well plates (Corning Inc.)
were used to search for suitable conditions for crystallization of
cpAvd4?3(N118M). Using a 10:1 (v/v) ratio of protein and ligand,
a protein solution of cpAvd4?3(N118M) (1.7 mg/ml) containing
50 mM sodium acetate (pH 4) and 100 mM sodium chloride was
mixed with a D-biotin (Sigma) solution (1 mg/ml) containing 5 mM
Tris (pH 8.8) and 8 mM CHES (pH 9.5). After optimization,
crystals formed at 22 °C in conditions where 0.6–1.2 ml of the
sample solution and 0.5–0.7 ml of a well solution containing 0.18–
0.20 M magnesium chloride, 0.09–0.10 M Tris-HCl (pH 8.5) and
27–30% (w/v) PEG 4000 were used. For data collection, two
“cubic”-looking crystals with dimensions less than 0.2 x 0.2 x 0.2
mm were used. The first data set (2.6 Å resolution) was collected
from a flash-frozen crystal using MPD as a cryoprotectant (0.7 ml
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of 100% MPD was added to the crystallization drop immediately
prior to freezing) at the MAX-lab beam line I911_2 (Lund,
Sweden) at 100 K using a MarCCD detector. The second, higher
resolution (1.9 Å) data set was later collected at the ESRF beam
line ID-29 (Grenoble, France) using a 100 K liquid nitrogen
stream (Oxford Cryosystem) and an ADSC detector. Sodium
formate was used as cryoprotectant (1 ml of 4 M sodium formate
was added to the crystallization drop immediately prior to
freezing).
 Both data sets were processed with programs from the XDS
program package.[33] The 2.6 Å data set was used to solve the
structure of cpAvd4?3(N118M) by molecular replacement with
the program Phaser[46] from the  CCP4i  suite[47, 48]; four copies of
the polypeptide chain A of a known avidin structure (PDB entry
2AVI)[1] were used as search models. After molecular
replacement, the initial 2.6 Å X-ray model of cpAvd4?3(N118M)
was extended to higher resolution and completed using the 1.9 Å
diffraction data: 1) the initial model was selected as input for
automatic model building with ARP/wARP,[49] 2) the structure was
refined with Refmac5[34] (TLS & restrained refinement)[50] and 3)
modified and rebuilt with Coot.[51] Solvent atoms and other non-
protein atoms were added to the model either by an automatic
procedure in ARP/wARP[52] or in Coot, and the final structure was
analyzed using the inbuilt tools of Coot. The data collection and
structure determination statistics for the 1.9 Å structure of
cpAvd4?3(N118M) are summarized in Table 4, and the
coordinates and structure factors of it have been deposited in the
Protein Data Bank with entry codes 2JGS and 2JGSSF,
respectively.
Miscellaneous methods
The solvent accessible surface areas were calculated with the
program Areaimol[53] of the CCP4i suite.[47, 48] Figures 5-7 were
created with the PyMol Molecular Graphics System.[54]
CorelDRAW X3 was used to edit Figures 5-7. The Suplementary
figure S3 was generated using VMD 1.8.6.[55]
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Suplementary data
Supplementary Figure S1. Quenching of the intrinsic tryptophan fluorescence of different avidins by HABA. Protein sample in 50 mM Na-PO pH 7.0 containing 650
mM NaCl was titrated with HABA. The measured fluorescence intensity (excitation wavelength 280 nm, emission measured at 350 nm) is plotted normalized by the
intensity of the free protein. The decrease in intensity caused by the absorbance of unbound HABA is not subtracted from the data. X-axis is logarithmic and data
points are connected by dotted line. Measurement is carried out with PerkinElmer LS55 instrument at 25°C and the sample is continuously mixed with magnetic
stirrer.
Supplementary Figure S2. The affinity of HABA to different avidin forms was assayed using UV/VIS spectrometer. A, The absorbance at 500 nm wavelength
measured for avidin in the presence of various concentrations of HABA. B, Scatchard analysis for the binding reaction shown in (A) and a linear fit to the data. C,
Absorbance of Avd(N118M)-HABA mixture at 500 nm wavelength plotted over HABA concentration. D, Scatchard analysis for the binding reaction shown in (C) and
a linear fit to the data. E, Absorbance of cpAvd4?3(N118M)-HABA mixture at 500 nm wavelength plotted over HABA concentration. F, Scatchard analysis for the
binding reaction shown in (E) and a linear fit to the data. The measured points are connected by lines in (A), (C), and (E). Extinction coefficient value of 35500 cm–1
at 500 nm wavelength was used for the avidin-HABA-complexes.
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Supplementary Figure S3. Ligand binding to cpAvd4?3 as compared to avidin-biotin and avidin-HABA. The structure of cpAvd4?3(N118M) is superimposed with
avidin-biotin [1] (PDB 2AVI) and avidin-HABA [19] complexes. The residues of cpAvd4?3 at the ends of the L3,4 are shown as white sticks whereas the rest of the
protein is shown as gray ribbon. The L3,4 of wt avidin is shown as orange ribbon model representing the closed state of the loop (biotin bound). The biotin bound to
cpAvd3->4 is shown as white sticks. The side chain of the residue 118 is also shown for cpAvd4?3 (methionine, white sticks) and for wt avidin (asparagine, cyan
sticks). The HABA of avidin-HABA complex [19] is shown as cyan sticks. A, Stereo view from the top of the binding site. B, Stereo view from the side of the binding
site. The figure was generated using VMD 1.8.6 [55].
Supplementary Figure S4. Structure of HABA. The coordinates of HABA were obtained from avidin-HABA complex [19]. The figure was generated using VMD 1.8.6
[55].
Table S1.  Oligonucleotides used in polymerase chain reactions (PCR)
Oligonucleotide Sequence
5.4N2 5’-ATATAGGATCCAAAGAGTCACCACTGCAT-3’
3.4C1 5’- CTACATCACAGCCGTAACAT -3’
3.4N1 5’-GGAGGCTCCGGAGGCTCCGCCAGAAAGTGCTCGCTG-3’
5.4C1 5’-GGAGCCTCCGGAGCCTCCCTCCTTCTGTGTGCGCAG-3’
